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Abstract 
Despite the incredible technological advancements of the last 100 years much is still to be 
learnt about the biological function of DNA. In particular, the importance of non-coding 
DNA sequences and the mechanisms by which these sequences can regulate gene expression 
is an area of growing research. Genetic information must be decoded by a single cell embryo 
to allow development into an adult organism. Each cell type resulting in the process of 
development has a signature of specifically expressed genes and conversely a set of 
specifically silenced genes. Genes are preceded by non-coding promoter regions which 
contain the regulatory cis- elements, read by the trans-acting transcription factors, some of 
these promoters are known to adopt unusual DNA structures. In general, less is known about 
DNA regions that may adopt non-canonical DNA structures than other sequences and 
specifically little is known about the non-conventional ways that transcription factors can 
interact with unusual DNA structures. There are several different DNA conformations, one 
of which is A-form. DNA sequences with A-form propensity have been proposed to be 
involved in gene regulation through an indirect readout promoter recognition mechanism. 
Here a novel bioinformatic tool was used to screen the Xenopus genome for combined 
promoter sequences consisting of an A-DNA secondary structure in combination with a 
known sequence motif. Circular dichroism was used to validate the presence A-form 
elements within five identified promoters and EMSA confirmed these putative cis-acting 
elements were targets for specific DNA binding proteins. One of these promoters drove a 
previously unknown gene which was selected for further functional analysis. This novel 
gene, designated as gdi3, was shown to belong to the gdi family of proteins known to 
function as Rab-GTPAse effectors. Phylogenetic and synteny analysis supported gdi3 as a 
novel gene currently found only in Anura and Teleosti.  RT-PCR using gdi3 specific primers 
showed differential expression of gdi3 between Xenopus laevis and Xenopus tropicalis in 
both embryos and adult frogs. In situ hybridization determined the neural specific expression 
of gdi3 in both species and was consistent with the knock down phenotype in Xenopus 
embryos exhibiting a lack of head structures and a shortened A-P axis. Finally further 
promoter analysis was conducted on an extended gdi3 promoter DNA sequence of 2.8 kb 
using an in vivo using I-SceI transgenesis approach.  
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Chapter 1: Introduction 
1.1 General introduction 
Understanding the molecular basis of development can significantly contribute to our 
knowledge of complexity of living organisms. For instance, the human body contains a total 
of 3.72 × 1013 cells (Bianconi et al. 2014); these cells are highly organised in organs and 
systems of organs that all arose from a single, fairly featureless, fertilised egg. DNA is stored 
inside nearly every cell nucleus of these trillions of cells and encodes the entire information 
required to build an organism. Cells read the encoded instructions and apply them in the form 
of various molecular networks acting within or between cells. DNA is a universal molecule, 
carrying and expressing genetic information in all cells and therefore the main principles 
governing it are shared between all life. Therefore, using model organisms such as the Xenopus 
frog, in developmental and genetic studies can give us information which is transferable to 
humans and other species.  
Following fertilization of the frog egg, a single cell begins its developmental journey to give 
rise to the multi-cellular, adult frog. Interfering with this developmental process, in particular 
at the genetic level, can shed light on the complex pathways cells undergo. This interference 
could be done through incorporation or deletion of foreign DNA into the host organism`s 
genome, treatment with drugs or by physical stress such as UV light. When this interference 
is performed, under rigorously controlled conditions, we can use the data produced to draw 
hypotheses of how cellular processes operate. In this thesis the main focus is on a region of the 
frog genome suspected to regulate specific gene expression and also on characterization of the 
downstream gene which is associated with an example of this region. Using frog, and more 
specifically Xenopus, as a model species allows scientists to explore the role of specific DNA 
elements in development efficiently. In the broader context exploring the genetic mechanisms 
governing the DNA transition from a passive to an active state is essential for improving health 
monitoring together with the prevention and treatment of illness. 
 
1.2 Xenopus as a model species 
Xenopus is a genus of South African clawed frog which is widely used as a model research 
organism. Two species of Xenopus, Xenopus laevis and Xenopus tropicalis, are the most 
commonly used for developmental, cell and molecular biology studies (Figure 1.1). Their  
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Figure 1.1 Adult Xenopus frogs. (A) Xenopus laevis, three year old male (♂) and female (♀). 
(B) Xenopus tropicalis two years old male (♂) and female (♀). 
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popularity stems from the use in the early 20th century of Xenopus laevis as a test for human 
pregnancy. Urine from a potentially pregnant female human would be injected into the dorsal 
sacks of the frog, in the case of pregnancy the human hormone (human chorionic 
gonadotropin) would cause the frog to lay eggs (Stanley S. Polack 1949). The appearance of 
more sophisticated methods for pregnancy testing meant that the frogs were adopted for 
scientific studies, where their eggs and early embryos have been developed as ideal research 
tools (Tadjuidje, E. and Heasman 2010; Koide et al. 2005). Several properties make Xenopus 
very convenient for research, first of these is the availability of eggs all-year round in abundant 
quantities. Frogs can be induced to lay eggs after simple hormonal injection of human 
chorionic gonadotropin. Secondly their eggs are robust, big and develop externally in a simple 
saline solution which makes them easy to observe and manipulate. They can be injected with 
a variety of specific molecules e.g. antisense morpholino (www.gene-tools.com), RNAs, 
plasmids, chemicals or used for transplant experiments.  
Depending on the research topic, either Xenopus tropicalis or Xenopus laevis, eggs can be 
used.  Xenopus laevis and Xenopus tropicalis develop through the same embryonic stages 
(physiologically and morphologically) with the only difference being the latter requires a 
higher incubation temperature.  Although Xenopus laevis have bigger and more robust eggs 
Xenopus tropicalis is preferred in genetic studies since it is diploid in contrast to the allo-
pseudotetraploid Xenopus laevis.  In addition, Xenopus tropicalis takes only 4 months to 
mature rather than 1-2 years for Xenopus laevis. The importance of Xenopus as a scientific 
model is demonstrated by Xenopus laevis being the first organism to have its 18S and 28S 
ribosomal genes cloned into a plasmid (Morrow et al. 1974). Moreover, Xenopus laevis is the 
first vertebrate to be cloned after a nuclear transplantation from somatic cell into enucleated 
egg (Gurdon et al. 1958) This experiment was performed by Sir John Gurdon who also was a 
pioneer of Xenopus laevis as a model system in the 1950s. Xenopus tropicalis and Xenopus 
laevis both have their genomes sequenced and largely annotated with constant updates. All of 
this information can be freely accessed via Xenbase (www.xenbase.org) and Ensembl 
(www.ensembl.org) websites. Having Xenopus genome sequence data allows for a broad range 
of genetic and biochemical experiments to be executed both in vitro and in vivo. The main 
principles of genetics and developmental biology are largely shared amongst the popular lower 
vertebrate model systems, such as Xenopus and zebrafish, both of which are used to draw 
conclusions that can be extrapolated to human medical applications. However, although the 
Xenopus tropicalis genome is the same size as the Zebrafish the Xenopus tropicalis genome 
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has greater synteny conservation to amniotic genomes (Hellsten et al. 2010), thus allowing for 
simpler annotation of orthologues and identification of non-coding regions (Timothy J. et al. 
2012). 
1.3 Early Xenopus development  
1.3.1 Overview of the anatomical structures of the developing embryo 
Frogs, like all amphibians, develop externally to the parents’ body. When eggs are required 
the Xenopus female frog is injected with solution of human chorionic gonadotropin in order to 
initiate egg laying. On the following day the female is gently squeezed and the released eggs 
are spread on a petri dish surface. The eggs are fertilized with a crushed suspension of a quarter 
of Xenopus laevis or Xenopus tropicalis male testis. The fertilized egg has two distinct 
hemispheres. The upper is called the animal pole, which is dark brown, and below that is the 
vegetal pole, which is a light cream colour. Upon fertilization the eggs orientate animal pole 
up and the dark colour of the animal pole may serve as a camouflage to hide the eggs from 
predators flying above, while the pale vegetal pole acts to camouflage from below. The sperm 
entry point can occur anywhere and can be seen as a pigmented dark point. The anatomical 
changes that occur after fertilization have been illustrated and well annotated in a table 
published by Nieuwkoop and Faber in 1956 (Nieuwkoop & Faber 1967). Their table has been 
used as a standard atlas for identification of Xenopus embryo stages, also known as the 
Nieuwkoop, Faber (NF) stages. According to the developmental progress every stage is 
associated with a number. For example, stage 2 is a two-cell stage, NF stages 13 to 21 are 
known as the neurula stages when the neural tissues develop (appendix VII).  
Once the eggs are fertilized they become activated and go through a series of cleavages (cell 
divisions) and the anatomical structures of the embryo form (figure 1.2). The cell divisions 
take place more quickly on the animal pole since the viscous egg yolk is mainly concentrated 
at the vegetal pole slowing the cleavage furrow. The first cleavage is symmetrical and begins 
at the animal pole and occurs at about 90 minutes post fertilization at 18 °C. While the first 
cleavage is proceeding a second cleavage begins, also at the animal pole but perpendicular to 
the first. The third cleavage is horizontal relative to the first two and is close above the 
equatorial area. These three cleavages divide the embryo into four small animal blastomeres 
and four large yolky vegetal blastomeres. These cells continue dividing every 20-30 minutes 
and as they divide they become smaller due to the absence of cell growth from the cell cycle 
during the first 12 divisions. At NF stage 7 to 9 the blastomere cells form a compact cell mass, 
called morula (one cell layer), however once the blastocoel cavity (an opening separating the 
presumptive mesoderm from the ectoderm) becomes regular by NF stage 6, the embryo 
becomes a blastula. 
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St 2 – 9 
St 10 – 12  
St 13 – 21  
St 1 
St 51- 66 
St 22 – 50  
Figure 1.2 The Xenopus life cycle.  Xenopus development begins with fertilization (NF stage 
1) and then progresses through a number of developmental processes including blastula (NF 
stage 2-9), gastrulation (NF stage 10-12), neurula (NF stage 13-21) and organogenesis (NF 
stages 22-50) which lead to a free swimming tadpole. The tadpole subsequently 
metamorphosises into a frog.   
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The compartmentalization of cells into distinct domains determines their future commitment 
into specialized cell types and this was demonstrated by tissue grafting experiments (Jones & 
Woodland 1987). At NF stage 8.5 the mid-blastula transition occurs when the zygotic genome 
becomes activated and the blastula begins transformation into a gastrula embryo. There are 
two main cell motility processes known at gastrula: epiboly and convergent extension. The 
epiboly process begins with a small involution of a group of cells known as the dorsal lip at 
the dorsal side of the embryo directly opposite of the sperm entry point. Formation of the dorsal 
blastopore lip is observed as a darkened line of cells, this group of cells adopt a bottle like 
shape and involute to lead the rest of the animal pole cells to cover the roof surface of the 
blastocoel cavity. The purpose of the blastocoel is to permit cell migration during gastrula 
stages and to insulate interactions between vegetal from animal cells. As the involuting cells 
migrate and fill the blastocoel cavity, they form a new opening known as the archenteron which 
is where the future gut will form. Now these cells compose several layers which intercalate 
with each other to form a thin ectodermal layer of cells. Once the bottle cells reach the 
blastopore lip at the other side they involute again and cause a second intercalation which 
subsequently causes a convergent extension (figure 1.3) which leads to embryo elongation 
(Wallingford & Harland 2001). At the end of gastrulation endoderm, mesoderm and ectoderm 
layers are in place and all the cells are positioned in order to differentiate into more specialized 
structures. Neurula begins at NF stage 13 and is characterized with further convergence and 
extension movements, reorganizing the cell layers and forming the neural plate. The inner 
layer of the ectoderm of the neural plate thickens and forms the neural groove. A dark line is 
formed along the dorsal side of the embryo. The neural groove deepens and eventually folds 
in order to form the neural tube. The most lateral cells of the neural plate that do not participate 
in the neural tube formation give rise to pigment cells and other neural structures. In the next 
section the molecular signalling events driving the main events during development will be 
described. 
 
1.3.2 Signalling events after fertilization and during blastula  
The sperm entry point activates a 30° cytoplasmic cortical rotation thus defining the second 
embryo axis and setting up the dorso-ventral domains. This rotation occurs right beneath the 
cell membrane and begins after 40 minutes post fertilization. Opposite the sperm entry point 
is where the dorsal region will form later in development. If the cortical rotation is prevented, 
for instance by UV irradiation, no dorsal-anterior structures such as the head or the neural tube 
form (Vincent & Gerhart 1987). In the Xenopus oocyte there is a maternal pool of   
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Figure 1.3 Cell movement during gastrulation stages of Xenopus development.  The 
schematic above represents cross sections of Xenopus embryos at early (A, B), mid- (C, D) and 
end (E, F) gastrulation. AP corresponds to the animal pole. The colours blue, yellow and red 
indicate ectoderm, endoderm and mesoderm tissues, respectively. The arrows show the 
direction of cell migration which begin with the bottle cells which form the dorsal blastopore 
lip (B). The bottle cells keep involuting inwards covering the roof of the blastocoel (C, D). The 
bottle cells are followed by the mesoderm precursor cells which fill in the blastocoel cavity but 
forming a second cavity behind them called the archenteron (D, E, F). At the end of gastrulation, 
the blastocoel is completely displaced by the archenteron and the three germ layers are 
positioned so that the ectoderm covers the embryo, endoderm is internalized and the mesoderm 
in between (F). (taken from Guilbert, 9
th
 edition) 
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mRNA and proteins which are involved in defining the three cell layers (Schnapp et al. 1997). 
This maternal pool contains transcriptional repressors such as Tcf3 (Houston et al. 2002), 
transcriptional activators such as forkhead proteins (Kofron et al. 2004), the T-box protein 
VegT (Zhang et al. 1998a), cAMP response element binding protein (CREB) (Sundaram et al. 
2003) and TATA-binding proteins necessary for the transcriptional complexes (Jallow et al. 
2004). These maternal factors can be localised to specific regions so that they are inherited by 
a defined subset of embryonic cells. In the animal hemisphere of the oocyte and early embryo, 
there is an enrichment of different maternal factors such as Zic2 and Xgrhl. However, in the 
vegetal pole, there is a variety of different maternal mRNAs. For example, VegT mRNA is 
localized at the oocyte vegetal hemisphere and is inherited only by the vegetal cells of the 
dividing embryo (Zhang & King 1996; Stennard et al. 1999). Another maternal factor is Vg1 
mRNA and which is also concentrated at the vegetal pole, but more specifically at the dorsal 
vegetal region (Birsoy et al. 2006). Other vegetally localized mRNAs have been identified in 
Xenopus and these include Wnt11, Otx1 and bicaudal C (Ku & Melton 1993; Pannese et al. 
2000; Wessely & De Robertis 2000) these maternal mRNAs are anchored to cytokeratin 
filaments (Kloc et al. 2005). Moreover, VegT mRNA and non-coding Xlsrts mRNA 
degradation leads to cytoskeleton network disruption (Heasman et al. 2001) and this phenotype 
can be rescued by VegT mRNA injection. This suggests that these maternal RNAs could 
potentially have an architectural role (Kloc et al. 2005).  
Once fertilization has occurred, vegetal cells accumulate the β-catenin transcription factor 
which later will activate a cascade of genes important for nervous system development (figure 
1.4). Initially, β-catenin is synthesized from a maternal mRNA however it accumulates at the 
dorsal marginal zone of the egg, opposite the sperm entry point. In ventral areas of the embryo, 
β-catenin is degraded by a pathway involving Gsk3 while at the dorsal side β-catenin is 
stabalised via dishevelled (Dsh). Dsh inhibits Gsk3 which would otherwise lead to β-catenin 
degradation. Tcf3 is a repressor which resides at the promoters of twin and siamois and 
represses their expression, however, β-catenin interacts with Tcf3 and turns it into a 
transcriptional activator (Brannon et al. 1997).  
 
1.3.3 Signalling events at gastrula 
The zygotic genome activation defines early gastrula stages. At this point, zygotic genes begin 
to be transcribed and cells can potentially migrate, this stage is called the mid-blastula 
transition (MBT). Activation of some genes has been related to promoter (DNA) 
demethylation thus defining the timing of MBT (Stancheva et al. 2002). Coupled with zygotic 
genome activation  
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β-catenine 
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Figure 1.4 Maternal signalling after fertilization. (A) The sperm entry point activates 30⁰ 
cytoplasmic cortical rotation setting up the dorso-ventral axis. This cortical rotation translocates 
Dishevelled (Dsh) to the future dorsal part of the embryo. (B) Gsk3 stimulates β-catenine 
degradation across the embryo. As Dsh is moved to the dorsal part of the embryo it now inhibits 
Gsk3 only at the dorsal areas hence β-catenine is stabilised. (C) In the cell nucleus upstream 
Siamois, β-catenine binds and converts Tcf3 from a repressor to an activator thus activating 
Siamois transcription. Siamois now binds together with Vg1 and Xnrs and activates the 
expression of Goosecoid which in turn induces the Spemann organiser formation.  
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is rapid degradation of the maternally stored mRNAs (Duval et al. 1990). The location of the 
cells during gastrulation is crucial as their position with respect to each other determines their 
fate. For example, in the blastula embryo, the presumptive ectoderm cells are positioned 
at the animal pole, the endoderm cells are positioned at the vegetal pole and the presumptive 
mesoderm cells lie between and are induced by the endoderm cells (Keller 1975; Landström 
& Løvtrup 1979). During gastrulation, these layers migrate to form the most basic part of the 
body plan, inside to outside. These cell fates are controlled by the maternal factors VegT and 
Vg1. VegT determines the endodermal cells and induces mesoderm fate of the ectodermal cells 
positioned at the lateral regions of the blastocoel cavity (Joseph & Melton 1998; White JA 
n.d.; Zhang et al. 1998). VegT activates the transcription of activin like ligands such as Xnr 1, 
2, 4, 5, 6 and derriere (Clements et al. 1999; Zhang et al. 1998). Cell autonomously, these 
nodal-related signals will activate endoderm specific genes such as  mix1, mixer, bix4, sox7, 
sox17, and endodermin, which will determine the endodermal cell fate (Engleka et al. 2001; 
Taverner et al. 2005; White et al. 2002). The Nodal-related proteins diffuse and have been 
proposed to form a dorsal to ventral morphogen gradient across the endoderm layer thus 
allowing for mesoderm patterning. Depending on the positional concentration across the 
gradient, different mesoderm types will form. For example, at low concentrations of Xnrs, 
Brachyury is activated and subsequently initiates ventral mesoderm specification. At the dorsal 
vegetal pole is the Nieuwkoop centre which induces the overlaying cells to become dorsal 
mesoderm which is also known as the Spemann organiser (reviewed by De Robertis 2006).  
The Nieuwkoop centre is induced by dorsal endodermal VegT, high concentrations of Xnrs, 
Wnt8, and Wnt11 (Fagotto et al. 1997; Tao et al. 2005; Vonica & Gumbiner 2008). 
 
1.3.4 The Spemann organiser and anterior-posterior (AP) axis formation  
All of the tissues in the early gastrula have an undetermined fate except the self-regulating 
cells of the dorsal lip of Xenopus embryos (reviews by De Robertis et al. 2001; De Robertis 
2009). Remarkably when Spemann and Mangold grafted the tissue area containing the dorsal 
lip to the presumptive belly skin of another gastrulating embryo, it formed a second embryo 
conjoined to the first one. In further experiments in 1938, Spemann identified a set of cells on 
the dorsal side of the embryo which he called ‘the organiser’ due to their unique properties. In 
his experiments, they were not only able to organise both the host and the donor cells into a 
whole new embryo but also change the fate of the host dorsal ectoderm cells to become neural 
tube and dorsal mesoderm. The organiser cells are themselves induced as a consequence of 
their spatial location within the early embryo which is above (animal to) a specific group of 
vegetal cells called the Nieuwkoop center (Gerhart et al. 1989).  
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At early gastrula stages, specification of the mesoderm has been defined by Xnrs, VegT, and 
Wnts. However, more specialised dorsal-ventral patterning of the mesoderm and ectoderm is 
still to take place, two gradients across the lateral marginal zones of the embryo are to be 
formed (figure 1.5). In the ventral lateral mesoderm, a Bmp4 gradient is generated specifying 
the dorsal-ventral axis (Dale et al. 1992; Fainsod et al. 1994; Baker et al. 1999; reviewed by 
Baker et al. 1999). Bmp4 is a ventral mesoderm marker and at its highest concentrations 
specifies ventral mesoderm and non-neural ectoderm, while its lowest doses specify dorsal 
mesoderm and neural ectoderm. The Bmp4 activity gradient is set up by the Spemann organiser 
(figure 1.5). The Spemann organiser secretes a gradient of Chordin, Noggin, and Xnr3, all of 
which are Bmp4 inhibitors. They down-regulate Bmp4 and Bmp2 activity via binding to them 
and preventing its binding to its receptors, thus inducing neural fate in the ectodermal cells 
(Piccolo et al. 1996; Smith & Harland 1992; Zimmerman et al. 1996). At the highest 
concentrations of Noggin and Chordin, Bmp4 is completely inhibited. Decreasing amounts of 
Bmp4 inhibitors means different doses of active Bmp and hence different tissue specification. 
The highest doses of Bmp4 activate vent1, vent2, and vom which contribute to patterning of 
the ventral and lateral mesoderm (Onichtchouk et al. 1998).  
The Spemann Organiser also secretes Wnts which form a gradient, decreasing in the anterior 
zone of the embryo. The Wnt gradient is specifying the anterior-posterior axis with the highest 
doses defining the tail and trunk formation (Hoppler et al. 1996; reviews by Niehrs 2004 and 
Hikasa & Sokol 2013). Wnts are inhibited at the most anterior parts of the embryo by Cerberus, 
Dickkopf (dkk) and Frzb. Cerberus inhibits both Bmps and Wnts, Dkk directly interacts with 
Wnts preventing downstream signalling (Mao et al. 2001). In order for head structures to form 
both Bmps and Wnts need to be inhibited. Retinoic acid has also been shown to posteriorize 
the neural tube in a concentration dependant manner (Cho & De Robertis. 1990). Another set 
of signals important for the further development of neural tissues are the insulin-like growth 
factors (IGFs); these are also required for neural tube, brain and sensory placode formation 
(Pera et al. 2001). If mRNA encoding IGFs is injected into ventral blastomeres, ectopic heads 
are formed; in contrast, when IGFs are knocked-down head structures fail to form (Pera et al. 
2001). This complex series of signalling events during gastrulation is controlled as a result of 
gene activation or repression events. The principles of such genetic regulation will be 
discussed in the following sections. 
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Figure 1.5 Gastrula and Spemann organiser signalling events. The main signalling 
concentration gradients expressed during gastrulation in order to specify the three germ layers 
into tissues from which organs are going to develop. Across the ventral-dorsal marginal axis a 
Bmp4, Bmp2 ventralising gradient (orange) is formed which is inhibited at the most dorsal 
marginal zone by the Spemann organiser (blue) secreted molecules noggin, chordin and 
follistatin. Wnt8 signalling is also inhibited by the organiser secreted molecules Dickkopf (Dkk) 
and Freezbe (Frzb). Inhibiton of Wnt8 is required for head formation. At the Vegetal pole of the 
embryo region there is a concentration gradient of Xnrs and Derriere (yellow, green) which 
patterns the overlaying marginal area into mesoderm.  Low concentrations of Xnrs will activate 
brachyury which is a mesodermal marker, medium Xnr concentration will activate locally 
endodermal markers such as Sox7, Sox 17, mixer and at the highest concentrations Xnrs and 
Wnts induce the Nieuwkoop centre which subsequently induces the Spemann organiser. At the 
Animal pole in the neural ectoderm region (dark blue) there is a concentration gradient of 
Wnt3a, eFGF and RA which which will pattern the neural tube. 
Sox 7, Sox 17, 
mixer 
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1.4 Overview of eukaryotic gene regulation 
The movement of cells and their ultimate differentiation is a consequence of a sequential series 
of gene activation events. The genetic code in nearly every cell of an organism is identical and 
the realization of different aspects this genetic information is a tightly controlled process. A 
gene is expressed when an mRNA copy is synthesized from a DNA template and this is a key 
step in control of the final active protein concentration. Although in eukaryotes gene 
expression can also be regulated at post-transcriptional, translational, and post-translational 
levels transcriptional control is most efficient. In humans, there are approximately 20,000 
genes encoding proteins but not all these genes are expressed at the same time and place. As 
cells become differentiated certain genes are silenced whilst others are expressed, every cell 
type which forms a different tissue has its own signature of expressed genes, the transcriptome 
of that cell type. However, gene expression patterns are not static but vary through a life-time 
and can depend on environmental conditions (Lobo I. 2008; Ralston, A. & Shaw K. 2008).  
 Some genes stay switched on permanently, so called house-keeping genes, and their products 
are usually involved in critical metabolic cellular processes. Other genes need to be on or off 
depending on their environment and developmental signals. Which gene is to be affected, in 
terms of number of mRNA copies made, initiation time and location for transcription to occur 
is determined by DNA cis-regulatory elements (promoters, enhancers, silencers (reviews by 
Noonan & McCallion 2010; Hernandez-Garcia & Finer 2014) and interacting protein trans-
acting factors (transcription factors) (reviewed by Spitz & Furlong 2012). Transcription factors 
(TF) interact with promoters in response to external stimulus or internally encoded signals 
expressed during development. In general transcription initiation at a promoter occurs as a 
result of epigenetic modifications (See section 1.4.2) and the availability of the required set of 
transcription factors in an active form (reviewed by Voss & Hager 2013).  
In order for the transcription process to begin, the preinitiation complex (PIC) needs to 
assemble at the core promoter of a gene. There are three RNA polymerases RNA polymerase 
I, II and III, which are involved in the transcription of different types of genes. RNA 
polymerase II transcribes protein coding genes and is at the core of the mRNA basal 
transcriptional machinery. RNA polymerase II is associated with general transcription factors 
and other protein complexes, such as co-activators and co-repressors in order to transduce 
regulatory information. For example, well known co-activators and co-repressors are the 
steroid receptor co-activators (Src) and nuclear receptor co-activators (NCoA), the nuclear 
receptor co-repressors (NCoR) and silencing mediator for RXR and TR (Smrt), respectively 
(Torchia et al. 1998). Gene promoters consist of a core promoter and proximal as well as distal 
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promoter elements. The core promoter is a genomic region generally located within a ± 50 bp 
of a transcription start site (TSS) and is the minimal promoter required for transcription to 
occur. The core promoter may contain a TATA box, CCAAT box or initiator element (Inr) 
which directs the formation of the pre-initiation complex. Approximately 20% of mammalian 
core promoters contain a TATA box and about 60% of them are close to a CpG island, which 
is a DNA stretch with high content of GC dinucleotides relative to the rest of the genome, 
methylation of which turns off transcription. RNA polymerase II does not read a specific 
sequence of DNA itself but rather is guided by the transcription factors. The first transcription 
factor that binds sequence specifically at the core promoter is TFIID. TFIID contains the highly 
conserved TATA box binding protein (TBP) which binds more than 15 TBP-associated 
proteins. Subsequently, TFIIB is the next protein that binds TFIID and with another complex 
TFIIB binds a GC rich region of the promoter. The N-terminus of TFIIB recruits RNA 
polymerase II and indicates the direction of transcription and the template strand. At this stage 
due to the conserved spacing between the TATA box and a GC rich region, the +1 base from 
the TSS is positioned in the polymerase active site. The next transcription factor to bind is 
TFIIF which stabilizes the RNA polymerase II binding. TFIIE is the next complex to bind the 
transcription complex, its function is to facilitate RNA polymerase II initiation competency 
and thus helps in promoter clearance. TFIIE then recruits TFIIH which is the most complex of 
all general transcription factors and possesses diverse functions such as DNA-repair, cyclin-
dependant protein kinase activity, helicase activity and completes the pre-initiation complex.  
RNA polymerase II itself is not responsive to specific transcription factor based regulation. 
Therefore, other protein complexes are required to transfer the signals to regulate transcription 
via RNA polymerase II. One of these is the mediator complex which reads signals from 
proteins associated with enhancers and other regulatory elements and transmits them to the 
PIC (figure 1.6). In yeast, there is just one complex but in higher eukaryotes there are different 
mediator complexes consisting of about 30 highly conserved proteins. Most of the mediator 
complexes act as transcription co-activators or in some cases both as co-activator and co-
repressors. Mediator interacts with regulatory proteins such as site-specific transcription 
factors while another part of the complex interacts with the basal transcriptional machinery. 
The mediator sums the output from the regulatory proteins to the transcription machinery in 
order to obtain a composite response. Mediator is involved in the regulation of nearly all 
human genes, site specific transcription factors bind to proximal or distal promoter elements 
and via DNA looping interact with the mediator which transmits the signal to the basal 
transcription machinery.  
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Figure 1.6 DNA transcription and looping. (A) Standard structure of a gene regulatory unit.  
A core promoter right upstream a protein coding gene and distal regulatory elements further 
upstream of the TSS known as enhancers (enh) (1). RNA Poll II, TBP and the mediator bind at 
the core promoter (2) while TFs bind enh (3). (B) As TFs are bound to enh they interact 
indirectly with RNA Pol II via the mediator which is enabled through DNA looping (4). RNA 
Polymerase II begins transcription after its CTD subunit is phosphorylated (5). CTD 
phosphorylation also allows for Capping Enzyme (CE) and Methyl Transferase (MT) to bind 
RNA polymerase and modify the 5` end of the nascent mRNA transcript (6). 
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1.4.1 Eukaryotic promoters in more detail 
Promoters are critical cis-elements required for a gene to be expressed. Core promoter 
elements are conserved across orthologous genes, however, the whole set of regulatory cis-
acting elements within a species is difficult to locate due to the high sequence variability away 
from the consensus. As described above the entire promoter of a gene consists of a core 
promoter and a subset of proximal and distal regulatory elements. The minimal promoter that 
is sufficient to initiate transcription is called the core promoter. On a DNA level, the core 
promoter is represented by a stretch of DNA which contains diverse functional and structural 
elements which guide the assembly of the basal transcriptional complex. The different types 
of core promoters contain variable nucleotide motifs that confer the distinct promoter features. 
The best studied core promoter element is the TATA box which is a conserved sequence of 
TATAWADR and is specifically recognized by the TBP subunit of the TFIID complex. In 
eukaryotes the TATA box is positioned at approximately -30 bp upstream the TSS.  
There are other elements in conjunction with the TATA box and which may be positioned 
either upstream or downstream of it. These elements are called TFIIB recognition elements 
and are designated BREu or BREd. BRE has the consensus sequence SSRCGCC and is most 
frequently positioned upstream of the TATA box. BREu and BREd can have different effects 
on transcription depending on the proximal and distal associated elements (Lenhard et al. 
2012). Since only 10-20% of mammalian promoters contain a TATA box (reviewed by 
Sandelin et al. 2007) there must be alternative options for starting formation of the basal 
assembly. For instance, the initiator element (Inr) is analogous to the TATA box as it directs 
the assembly of the transcription initiation complex. Inr is known to interact with TFIID 
complex (reviewed by Smale & Kadonaga 2003) as does the TATA srequence. The consensus 
sequence for Inr in human is YYANWYY and varies among species (Javahery et al. 1994). 
The Inr element overlaps with the TSS where the “A” in the consensus sequence is the +1 base 
of TSS. Other motifs found in promoters with no TATA box are the downstream promoter 
element (DPE) and the motif ten element also known as the downstream core promoter element 
(MTE). The DPE element has the consensus sequence RGWYV. The DPE is located 
approximately +30 bp downstream of the TSS and often acts alongside an Inr element to 
initiate transcription. MTE sequences are located +18 to +27 bp downstream of TSS and have 
the consensus CRARCS or VAACGS. The MTE binds TFIID and is normally associated with 
a DPE element. Other motifs within core promoters are CG-rich motifs which can be bound 
by the transcription factor specificity protein 1 (SP1) (Kuwahara et al. 1993) or CCAAT boxes 
recognized by CCAAT-binding protein CEBP (Osada S, Yamamoto H, Nishihara T 1996). 
Depending on the mode of transcription there are “broad” and “sharp” core promoters. In broad 
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promoters the TSS is not located at a strict nucleotide position but rather the +1 bp is dispersed 
within a 70 bp range. The observed pattern is sharp promoters are more likely to contain a 
TATA box while broad promoters are associated with CpG islands. Furthermore, sharp core 
promoters are preferred for tissue specific gene expression and broad promoters are associated 
with ubiquitously expressed genes. As distal regulatory elements can be bidirectional so are 
some of the gene promoters themselves. Approximately 1300 protein coding human genes 
have bi-directional core promoters with broad transcription start sites (Trinklein 2004). Some 
genes may have more than one promoter which may contribute either to distinct temporal or 
spatial regulation of the same gene (Singer et al. 2008). Moreover, it may allow for inclusion 
of extra exons to the mRNA thus producing a greater variety of protein products or it can also 
provide additional gene regulatory elements. This mechanism allows diversification of protein 
products encoded by a single gene. 
One characteristic of some promoters is their common proximity to CpG islands. CpG islands 
are proximal, regulatory elements associated with core promoters.  Some 60% of human genes 
are situated close to CpG islands hence, this is one of the main clues for a potential, nearby 
TSS (minireview by Illingworth & Bird 2009). A distinctive feature of eukaryotic promoter 
regions is that they also contain distal regulatory elements such as enhancers, silencers, and 
insulators which can be positioned hundreds even thousands of base pairs away from the core 
promoter. These types of elements normally interact with the transcription complex via co-
activators and require DNA looping (Rippe et al. 1995), (figure 1.6). Promoters contain 
regulatory elements formed by conserved sequences important for transcription factor 
recognition and binding. Usually, transcription factors bind the promoters through a direct 
read-out mechanism, where the amino acids of the protein interact directly with the nucleotides 
within the promoter motif i.e. the extrinsic information of the DNA is recognised. However, 
there is an alternative mechanism of transcription factor binding to a promoter motif. This 
alternative mechanism is called in-direct read out and in this case, the transcription factor 
partially recognizes the promoter motif but its binding is facilitated by the DNA conformation 
induced by the promoter sequence i.e. the intrinsic structure of the DNA is recognised. 
Generally, most of the DNA contained in the cell nucleus is in B-form conformation which is 
favoured under the physiological conditions of pH and salt. However, alternative structures 
may form within certain sequences under physiological conditions. A-form DNA seems to be 
formed favourably under cell nucleus physiological conditions for some sequences of 
nucleotides come together. It is intriguing when these sequences appear close to the TSS of 
genes since this implies potential transcriptional regulatory function. Moreover, other nucleic 
acid structures have been implicated in transcriptional activity, for instance, Z-DNA 
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alternative structures are involved in gene regulation, for example, of the human c-myc 
oncogene (Wittig et al. 1991; Wölfl et al. 1995). Z-form, tetraplex, and i-motif DNA are 
elements which is involved in in-direct read out mechanism of transcription regulation. These 
types of DNA structure and their role in gene regulation will be discussed in more detail in 
section 1.4.2.3. 
 
1.4.2 Other factors involved in regulation 
1.4.2.1 Epigenetic modifications of histones  
The diploid human genome consists of 2 x 3.26 billion bp which in total is about 2 m in length, 
200 000 times the diameter of a cell nucleus. In order to fit this length of DNA inside the cell 
nuclei, every 147 bp of DNA is wound around a histone octamer composed of a histone H3/ 
H4 tetramer and two histone H2A/H2B dimers, thus forming thirty million nucleosomes per 
cell. When DNA is wrapped around the histone proteins it is condensed and forms 
nucleosomes which then fold further (reviewed by Woodcock & Ghosh 2010) hence the high 
level of compaction. In order for transcription factors to access DNA and activate gene 
expression, DNA needs to be in a “looser” mode (Li et al. 2010). In order for this to occur, 
histones are post-translationally modified thus allowing greater accessibility to DNA; these 
modifications occur at the N-terminal tails of the histone proteins (reviews by Kouzarides 
2007; Tan et al. 2011). Examples of histone modifications are acetylation, methylation, 
phosphorylation, ubiquitylation, and ADP-ribosylation. Out of these, the most common ones 
are acetylation and methylation at lysine residues: lysines can be mono-, di- or tri- methylated, 
arginines can be mono- or dimethylated and histidines can be monomethylated (reviewed by 
Bannister & Kouzarides 2011). Methylation modifications have been mostly studied at lysines 
H3K4, H3K9, H3K27, H3K36, H3K79 and H4K20 and arginine sites H3R2, H3R8, H3R17, 
H3R26, and H4R3. The turn-over rate of methylation is generally lower than acetylation since 
some methylation modifications need to be maintained at the silenced chromatin during 
mitosis. All of the known histone modifications have been interpreted into a potential histone 
code (reviewed by Kakutani et al. 2001). The histone code suggests that all of the histone 
modifications together form a specific nucleosome state that allows for specific levels of gene 
expression.  
There are two classes of histone modifying enzymes that transfer acetyl or methyl groups 
called histone acetyl or methyl transferases (HATs or HMTs). The antagonist enzymes of those 
are histone deacetylase or histone demethylases, respectively (HDACs and HDMs). Histone 
acetylation and de-acetylation have been associated with transcriptional activation of genes. 
On the other hand histone, methylation has been associated with gene repression, with the 
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exception of methylation at H3K4 which leads to gene activation (Schneider et al. 2004). Many 
proteins recognize certain histone modifications through specific domains such as the 
bromodomains which recognise acetylated chromatin and chromodomains (Polycomb), which 
recognize methylated chromatin (reviewed by Bottomley 2004). In humans, there are many 
modifying enzymes that “read”, “write” or “erase” histone modifications and these enzymes 
are expressed in a tissue specific manner. 
 
1.4.2.2 Chromatin remodelling 
As previously stated, nucleosomes are folded into higher order structures ultimately forming 
euchromatin (loose) and heterochromatin (highly compacted). Multiple levels of regulation 
determine which areas of the chromatin will be accessible for genes to be expressed. In the 
euchromatin, state DNA is looser allowing for cis-acting elements to bind, in heterochromatin 
DNA is condensed and inaccessible thus these states regulate gene activation or repression. 
Nucleosome positioning is dependent on gene categories. For instance house-keeping genes 
which are constantly expressed are nucleosome depleted while nucleosome repositioning is 
required for transcriptional regulation of genes involved in development (reviewed by Ho & 
Crabtree 2010). Regions 200 bp upstream of the TSS are found to be nucleosome depleted but 
flanked on either side by positioned (Yuan 2005; reviewed by Struhl & Segal 2013). The 
nucleosome positioning at TSS and specifically a nucleosome positioned at the +1 bp is a 
major factor defining RNA Pol II activity. RNA Pol II can be held at the +1 bp of TSS by a 
nucleosome, the phenomena where RNA Pol II has stalled at +1 bp is “poising” until an 
activation signal is received (Jonkers & Lis 2015). In this way, nucleosomes physically block 
the RNA Pol II progression or regulate the accessibility for transcription factors. 
Chromatin remodelling is facilitated by multi-protein complexes that utilize ATP in order to 
control the exposure of DNA to transcription factors (minireview by Vignali et al. 2000). These 
remodelling complexes can affect nucleosome remodelling in four ways: 
 Sliding the histone octamer to a new position 
 Ejection of the histone octamer in order to completely displace it 
 Replacing the general histones by their variants 
 Removal of H2A-H2B dimers and leaving only H3-H4 tetramer. 
There are four main families of remodelling complexes: SWI/SNF, ISWI, CHD and INO80 
(Längst & Becker 2001). They have common properties but they also specialize in particular 
tasks. Primarily they function as slide and eject nucleosomes, but with varying consequences 
(Lorch et al. 1999). Their activity is affected by the presence of histone variants (Mizuguchi 
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et al. 2004) and also by post-translational modifications of histones (reviewed by Bannister & 
Kouzarides 2011). For example, histone acetylation can increase or inhibit remodelling 
complexes efficiency where CHD and ISWI are inhibited and SWI/SNF is activated (reviewed 
by Cairns 2009). 
In general, developmentally regulated genes are in a default repressed state and tissue-specific 
genes become locally activated by particular regulatory factors (reviewed by Weintraub 1985). 
In order for a transcription factor to bind the promoter of a repressed gene at least one multiple 
cis-acting element must be partially accessible at the linker DNA region or the nucleosome 
edge. Trans-acting factors that bind first at these sites are called pioneer factors. They can re-
organise the local chromatin or act passively through binding cis-regulatory sequences 
(reviewed by Magnani et al. 2011). The actively functioning pioneer factors such as FoxA1 
can allow for opening the chromatin structure thus giving access to transcription factors, 
chromatin remodelers, and modifiers (reviewed by Zaret & Carroll 2011). In addition to 
chromatin, gene expression can also be affected at the DNA level, where DNA secondary 
structures within promoters may contribute to TFs` binding affinities as detailed in the 
following sections. 
 
1.4.2.3 DNA structures 
Approximately 98% of human genomic DNA does not encode proteins (reviewed by Elgar & 
Vavouri 2008). Some of these non-coding sequences perform a structural function. For 
instance, it is known that the telomeric DNA sequence forms G quartet (Phan & Mergny 2002) 
secondary structures which are important in chromosome stability (Preston J. 1997). In some 
other cases, where secondary structure has regulatory function, DNA structures are influenced 
by the conditions of the environment pH, temperature, salt concentration, and hydration. The 
overall shape that DNA can adopt is dependent on both nucleotide sequence and the nucleotide 
conformation that the DNA polymer is composed of. Nucleotide conformations are determined 
by the conformation of the deoxyribose (C-2` or C-3` exo- and endo puckering conformations), 
rotation of the bonds of the phosphodeoxyrybose backbone and the possible rotation about the 
C-1`-N-glycosyl bond (syn and anti-conformations). Based on these three variations and 
environmental conditions, DNA can adopt several helical and non-helical secondary 
structures. DNA helical structure include A-form, B-form, and Z-form DNA and known non-
helical structures are Guanosine (G-) tetraplexes and i-motifs amongst others (figure 1.7). For 
example, at low pH, a stretch of only purines or only pyrimidines can form triplexes and 
guanosine stretches can form tetraplexes. A-form DNA has a wide and shallow minor groove, 
unlike B-form which has a narrow and deep minor groove. Most DNA is in the B-form  
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Figure 1.7 DNA structures and parameters. (A) Various DNA secondary structures, B- DNA 
is the most common, A-DNA has a shallow and wide minor groove and deep major groove. Z- 
DNA is elonagated with a deep minor and flat major groove. (B) Parameters associated with 
the three well known DNA structures A, B and Z-DNA. (C) G-quadruplexes and I-motifs can 
form at G-rich regions and C-rich regions, respectively and form four strands of DNA bonded 
through Hoogsteen base pairing. 
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conformation but it can be converted to A-or Z-DNA forms responding to fluctuations in the 
environment. These can be monitored by a variety of spectroscopic techniques. B-DNA is the 
canonical DNA form and is the most stable at physiological conditions for most sequences. B-
from DNA is right handed and contains 10.5 bp per helical turn with helix pitch of 34 Å. The 
base pair plane is 90° with respect to the helix axis. In B-form, the deoxy-ribofuranose has a 
C-2` endo puckered conformation. With respect to the deoxyribose, the C-1`-N glycosil bond 
nucleotides in B-form are in anti-conformation.  Usually, four out of the five ribose atoms lay 
in the same plane, however, the C-2` is on the same (endo) side of the plane with respect to 
the C-5` atom. These parameters give B-DNA a narrow minor groove and a wider major 
groove. Many sequence specific proteins interact with the major groove through which it is 
easier to access the bases. The B-DNA structure parameters are taken as a reference for 
defining A-form and Z-form DNA. Similar to B-DNA, A-DNA is also right-handed however 
it contains 11-12 bp per turn with a helix pitch of 28 Å. This means that the A-DNA is wider 
and shorter than the B-form DNA. Unlike B-form, in A-form DNA, the base pair plane is tilted 
20° with respect to the helix axis. The deoxy-ribofuranose is in C-3` endo puckered 
conformation and the nucleotides are, like in B-form, in anti-conformation with respect to the 
C-1`- N glycosil bond. A-DNA has a shallow wide minor groove and deep wide major groove. 
Z-DNA is the most distinctive helical variation of B-form DNA. It is named “Z” after the 
distinctive zig-zag pattern of its phosphodiester backbone. Z-DNA is a left-handed helix and 
contains 12 bp per helical turn with helix pitch of 18 Å. Similar to A-form DNA, Z-form 
deoxyribose is in C-3` endo puckered conformation. The nucleotide conformation with respect 
to the glycosil bond is syn-conformation for purines and anti-conformation for pyrimidines. 
Z-DNA has a deep minor groove and flat major groove. The arrangement of the phosphate 
backbones of the two strands are closer together than in B-form which gives the impression of 
just only one groove.  
G-quadruplexes are stretches of guanosines which are able to form a four stranded DNA 
structure, which is quite stable over a range of conditions particularly in the presence of 
potassium. The guanosines can form hydrogen bonds through Hoogsteen base pairing. 
Hoogsteen base pairing is bonding which is made possible when a nucleotide is rotated in the 
syn-conformation with respect to the deoxy-ribose ring and bonds with a nucleotide in an anti-
conformation.  
I-motifs are four stranded DNA structures which are formed by cytosine rich stretches. Two 
pairs of parallel strands are bonded in the antiparallel direction. I-motifs can form at low pH 
where one of each cytosine per base pair becomes protonated in order to form a hydrogen 
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bond. The cytosine base pairs are intercalated and can do so in different topologies. Depending 
on the pH levels these structures can fold or unfold which makes them applicable for use in 
the nanotechnology field (Day et al. 2014). 
Recent studies have strongly suggested that non-canonical DNA structures are involved in 
transcriptional regulation. For instance, there is evidence that Z-DNA is required for the 
normal core promoter function of myristoylated alanine-rich C kinase substrate (MARCKS) 
in mouse immortalized hippocampal cells (Wang et al. 2002a).  It has also been proposed that 
A-form DNA structures have a potential transcriptional regulatory functions. In studies on the 
subject performed (Llewellyn K. J. et al. 2009) an A-form DNA element within the gata2 
promoter was shown to be important for high levels of gata2 gene expression (Llewellyn K. 
J. et al. 2009). Non-canonical DNA structures have also been shown to be involved in 
transcriptional regulation of c-myc. A G-quadruplex structure within the c-myc promoter is 
predicted and when a single G is mutated the structure is destabilized which has resulted in 3-
fold gain of gene expression levels. This has led to the suggestion that the presence of G-
quadruplex is a repressor within c-myc promoter (Siddiqui-Jain et al. 2002). 
 
1.5 A-form DNA structures in gene regulation  
1.5.1 Regulation of the gata2 gene by A-form DNA 
During early Xenopus development, prior to the mid-blastula transition, maternal factors guide 
gene expression. Once the zygotic genome becomes activated the production of zygotic 
transcription factors commences, thus contributing to the developmental process. One of the 
key genes in the developmental process is gata2. This gene is a critical regulator of 
hematopoietic progenitor in the developmental program and also important in stem cell 
induction (Kelley et al. 1994; Walmsley et al. 1994; Ciau-Uitz et al. 2000). It is necessary for 
the embryonic brain development and is also expressed by endothelial cells, fibroblasts, 
kidney, liver and cardiac muscle (Nagai et al. 1994; Mouthon et al. 1993; Leonard et al. 1993). 
In mouse, the gata2 expression is regulated from two promoters, an upstream promoter (IS) 
and downstream promoter (IG) (Minegishi et al. 1998). The upstream promoter includes an 
extra exon and it is responsible for gata2 expression specifically in hematopoietic progenitors 
in mouse and human (Pan X. et al. 2000). The IG promoter allows for ubiquitous expression 
of gata2 including in hematopoietic cells (Minegishi et al. 1998). The IG promoter structure 
is well conserved within various species, human, mouse, Xenopus, zebrafish and chicken (Pan 
X. et al. 2000). Abolishing gata2 expression leads to embryonic lethality in mice and the dead 
embryos exhibited a deficiency of various hematopoietic precursors (Tsai et al. 1994).  The 
minimal IG promoter of 66 bp is sufficient for correct temporal expression of gata2 (Brewer 
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et al. 1995). This minimal promoter contains an inverted CCAAT box at -42 and a single 
mutation of the central nucleotide sequence prevents gata2 activation even in the context of a 
longer promoter construct (Brewer et al. 1995). The control of gene expression of gata2 in 
Xenopus has been well characterised and the initiation of gata2 transcription has been shown 
to require the Ilf3-containing complex CBTF (Brewer et al. 1995). The CBTF binding site 
within the gata2 promoter contains non-canonical A-form DNA structure which is also 
adjacent to the conserved CCAAT sequence (Llewellyn K. J. et al. 2009). Sequence changes 
in the A-form region that reduce the A-form propensity also reduce both the binding CBTF 
and the levels of transcription from this promoter. However, mutations that increase the A-
form propensity marginally increase CBTF binding and transcription. Mutation of either the 
CCAAT sequence or the A-form element reduces the CBTF binding and transcription by 
similar amounts while the combination of these changes reduces binding and transcription by 
half again. This argues that the CCAAT sequence and the A-form element are independent but 
requisite components of the promoter. In prokaryotes, A-form DNA has been shown to form 
within the core-promoter of copA. CopA is a copper homeostasis gene and its core promoter is 
bound by repressor which bends the DNA. This repressor turns into an activator upon copper 
binding. The activator then stabilises an A-form DNA structure within the central base pairs 
of the core promoter bringing the -10 element close to RNA-polymerase thus initiating 
transcription (Philips, S., et al. 2015).  
 
1.6 CBTF and Ilf3 
CBTF is a multi-subunit transcription factor complex which binds the inverted CCAAT box 
of the gata2 IG promoter (Brewer et al. 1995). When injected into Xenopus embryos CBTF 
has been also shown to be required for transcriptional activation of the human hsp70 gene 
(Ovsenek et al. 1991). It should be noted that hsp70 and gata2 gene promoters share 10/10 bp 
identity (Brewer et al. 1995). CBTF contains a protein subunit known as Ilf3 (Orford & 
Robinson 1998). Ilf3 contains two RNA binding domains which have been shown to interact 
with A-form DNA structures in vitro (Scarlett et al. 2004). Moreover, when the engrailed 
repressor domain is fused to Ilf3 and injected into Xenopus embryos transcription of the gata2 
gene is down-regulated (Scarlett et al. 2004). The subsequent down-regulation of gata2 led to 
a double axis phenotype, which phenocopied the gata2 engrailed fusion form.  
CBTF is held within the cytoplasm of Xenopus embryos and with the onset of zygotic 
transcription, it moves to the nucleus where it activates gata2 transcription (Brewer et al. 
1995). CBTF has been shown to be anchored in the cytoplasm via association of the Ilf3 double 
stranded (ds) RBDs with translationally quiescent mRNP complexes (Brzostowski et al. 2000). 
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This interaction is required and sufficient in order to withhold CBTF from translocating to the 
nucleus (Brzostowski et al. 2000). Destruction of the maternal mRNA pool with RNAse 
initiates premature translocation of CBTF to the nucleus (Brzostowski et al. 2000). 
Furthermore, the Ilf3 RBDs have been shown to interact with A-form DNA which is 
structurally similar to dsRNA (Scarlett et al. 2004). In addition to holding CBTF in the cytosol, 
Ilf3 allows CBTF to activate gata2 transcription through its interaction via its RBDS with an 
A-form DNA structure element at the promoter. CBTF is hypothesised to also interact with a 
CCAAT sequence through another as yet unidentified subunit (Scarlett et al. 2004; Llewellyn 
K. J. et al. 2009). Ilf3 is a protein with diverse functions and it would be interesting to 
understand in more detail its A-form promoter binding during Xenopus development. 
ILF3 is well characterised in human.  The human orthologue of the ILF3 gene is localized on 
human chromosome 19 and is made up of 22 exons (Saunders et al. 2001) and exist in two 
forms, a long (L), containing exon 3 and a short (S) one lacking it (Viranaicken et al. 2006; 
Viranaicken et al. 2011). ILF3 protein contains a predicted nuclear localization signal, two 
dsRNA binding domains and an RGG-rich sequence (reviewed by Thandapani et al. 2013). It 
also contains two glycine-rich motifs which are predicted to form coils that may be involved 
in protein-protein interactions. ILF3 is also known to be involved in various cellular processes 
such as transcription regulation, translational regulation, viral replication/translation 
regulators, miRNA biogenesis (Castella et al. 2015). 
 
1.7 Aims of this thesis  
The aims of this thesis are (1) to validate a perl-script software which screens for a set of 
physical characteristics of DNA associated with gene regulation. Using a defined set of 
parameters this program will analyse the Xenopus genome (assembly JGI 4.2) for regions 
containing A-from DNA in close proximity to the TSS of genes and adjacent to a known 
promoter motif. A subset of these resulting bioinformatics hits will be analysed as potential 
promoter elements. (2) Any novel and previously uncharacterised genes downstream of the 
identified promoter hits will be studied and their role in development elucidated. (3) To study 
the temporal and spatial expression pattern of any novel genes identified in aim 2 by transgenic 
Xenopus technologies. 
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Chapter 2:  Materials and methods 
2.1 Molecular biology methods 
2.1.1 Obtaining oligonucleotides  
Oligonucleotides for use as PCR primers and for in vitro studies were synthesized by 
Invitrogen. The oligonucleotides (appendix II) used for the EMSA experiments and circular 
dichroism (CD) were synthesized at the 200 nmole scale and HPLC purified while PCR 
primers (appendix II) were synthesized at 25 nmole scale and purified by desalting column. 
All oligonucleotides were dissolved in high purity nuclease-free water (Sigma) to obtain a 100 
µM stock from which working stocks at lower concentrations were prepared.  
 
2.1.2 Annealing oligonucleotides  
Single stranded oligonucleotides were diluted to a 2 µg/µl final concentration. Equimolar 
quantities of each complementary strand were mixed together in 100 µl 1 X TNE (10 mM Tris, 
100 mM Sodium chloride, 1 mM EDTA) buffer or 100 mM phosphate, 5 mM potassium 
fluoride buffer to 1 µg/µl final concentration. The mix was then incubated at 95 °C for 5 min 
and allowed to cool slowly to room temperature. The success of the annealing was assayed by 
12% native acrylamide gel electrophoresis (2.3.1).  
 
2.1.3 Small scale preparation of plasmid DNA via alkalyne lysis  
A single colony containing the plasmid of interest was grown in 5 ml Luria broth (L-broth) 
containing ampicillin (100 µg/ml) for 16 hours at 37 °C, with shaking. 1 ml of saturated culture 
was centrifuged for 3 min at 4 °C, 11 000 g. The supernatant was removed and the cell pellet 
was resuspended in 100 µl of ice cold solution I (appendix I), then 200 µl of freshly made 
solution II (appendix I) was added and the sample was mixed 6-8 times by repeated inversion. 
The samples were left for 5 min at room temperature to allow cell lysis to occur. After lysis 
150 µl ice cold solution III (appendix I) was added to each sample and mixed 6-8 times by 
repeated inversion. The mixtures were left on ice for 30 min and then centrifuged for 10 min 
at full speed in a microfuge (16 000 g). The supernatant was transferred to a fresh tube 
containing 10 µl NEB buffer 2 and 3 µl of 10 mg/ml RNAse A. The samples were incubated 
at 37 °C for 2 hours to allow the RNA to be digested. The samples were then purified by 
phenol/chloroform extraction (2.1.13) after which the DNA was ethanol precipitated (2.1.14). 
The DNA pellets were washed with 500 µl of 70% ethanol and centrifuged for further 5 min 
at 4 °C for 5 min. The supernatant was discarded and the DNA pellets were left to dry before 
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resuspending in nuclease-free water (Sigma). The plasmid DNA quality was assayed by 1% 
agarose gel electrophoresis (2.1.5) and UV spectroscopy (2.3.5).  
 
2.1.4 Preparation of DNA using Qiagen midi prep kit 
In order to produce plasmid DNA of sufficient quality and quantity necessary for micro-
injection and in vitro transcription, they were purified using Qiagen midi and maxi kits 
according to the manufacturer`s instructions. Initially, 5 ml L-broth containing 100 mg/ml 
ampicillin was inoculated with a single colony containing the plasmid of interest and grown at 
37 °C overnight with shaking. On the following day, 100 µl bacterial culture was transferred 
to a flask with 100 ml L-broth, containing 100 µg/ml ampicillin. The inoculated flask was kept 
in an incubator at 37 °C, overnight with shaking at 200 rpm. On the next day, bacterial cells 
were harvested by centrifuging for 15 min, at 4 °C, 6000 g. The bacterial pellet was 
resuspended in 4 ml pre-chilled buffer P1, after which the cells were lysed by 4 ml buffer P2. 
The samples were mixed by repeated inversion and the lysis reaction was incubated for 5 min, 
at room temperature. Buffer P3 was added and again mixed by repeated inversion and 
subsequently kept on ice for 15 min before the cell debris was pelleted by centrifugation for 
30 min at 4 °C, 20 000 g.  Meanwhile, the Qiagen column was equilibrated by applying 4 ml 
of buffer QBT and allowed to empty by gravity flow. Once centrifuged, the supernatant was 
applied on the equilibrated filter column and allowed to drain, the Qiagen column was then 
washed twice with 10 ml of buffer QC. The plasmid was eluted with 5 ml of buffer QF into a 
clean 30 ml vessel. The plasmid DNA was precipitated with 3.5 ml 70% room temperature 
isopropanol, mixed thoroughly and pelleted for 30 min at 4 °C, 15 000 g. The pellets were 
washed with 2 ml 70% ethanol and again centrifuged for 10 min at 4 °C, 15 000 g. The pellets 
were air dried and then resuspended in high purity nuclease-free water (Sigma). The quality of 
plasmid DNA was assayed by 1% agarose gel electrophoresis (2.1.5) and UV spectroscopy 
(2.3.5). 
 
2.1.5 Agarose gel electrophoresis 
DNA or RNA samples were routinely analysed by agarose gel electrophoresis (2.1.5). 
Typically, a 1% agarose gel was prepared using 1 g of agarose mixed in 100 ml 1 X TBE 
(National Diagnostics) and dissolved by melting in a microwave oven. The solution was 
allowed to cool down before adding ethidium bromide (stock: 10 mg/ml) to obtain a final 
concentration of 5 µg/ml. The molten gel solution was poured into clean taped gel tray with 
well-forming comb and allowed to solidify. Once the gel had solidified it was placed in a gel 
electrophoresis tank and 1 X TBE buffer was poured in until the gel was submerged. The well-
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forming comb was then removed and each sample was mixed with 0.2 volumes of 6 X Orange 
G loading buffer (appendix I).  Each well can contain a maximum of 30 µl sample volume. 
The applied voltage on the gels was between 60 V and 120 V. The gel was run untill the Orange 
G dye reached 2/3 of the way down the gel. The DNA bands were visualized on a G box UV 
transilluminator system (SynGene) and image captured with GeneSnap software (SynGene). 
The minimum amount of DNA that could be visualized using ethidium bromide was 25 ng. 
The DNA samples were run alongside an appropriate size marker (appendix V). RNA samples 
were assayed in a different gel electrophoresis tank used specifically for RNA gels in order to 
avoid degradation by RNA nucleases. 
 
2.1.6 Reverse transcription using SuperScript II 
In order to synthesize cDNA from purified RNA, a reverse transcription reaction was prepared 
in a 20 µl final volume. The reaction mixture contained- 1 X First Strand buffer (Invitrogen), 
10 mM DTT, 0.5 mM dNTP mix (New England Biolabs), 40 units recombinant RNAse 
inhibitor (Promega), 10 mM Random Hexamer primers (GE Healthcare), 1-5 ng total RNA 
template, 200 units SuperScript II reverse transcriptase (Invitrogen) and finally the reaction 
volume was made up to 20 µl using nuclease-free water (Sigma). A negative control was set 
up, where instead of SuperScript II nuclease-free water was added. The reaction mixtures were 
incubated at 55 °C for 45 min. The cDNA quality was assayed by ODC PCR and agarose gel 
electrophoresis (2.1.5). The remaining stock of cDNA was stored at -20 °C for further use.    
 
2.1.7 Reverse transcription- polymerase chain reaction (RT-PCR) 
2.1.7.1 Reverse transcription 
In order to examine the quality and quantity of the cDNA after reverse transcription, a PCR 
was performed in order to amplify the house keeping gene, ODC (ornithine decarboxylase). 
This is a positive control PCR reaction which also allows for quantitative analysis of gene 
expression levels in relation to stable ODC expression. 
 
2.1.7.2 PCR 
Standard PCR reactions were set up in 0.2 ml tubes using 1 X PCR buffer, 200 µM dNTP mix 
(NEB), 1 µM forward/reverse primer, 1 U of  Q5® Hot start high-fidelity DNA Polymerase 
(NEB), 2 µl of each reverse transcription reaction. A negative control was also set up where 
the DNA template was omitted and nuclease-free water was added instead. All samples were 
made up to 25 µl with nuclease-free water. The PCR samples were incubated in a G-Storm 
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GRI thermal cycler and the PCR program selected depending on the required reaction 
conditions, typically: 
 
95 °C            3 min 
95 °C             30 sec – 1 min 
50-70 °C        30 sec                                25-40 cycles 
72 °C             30 sec – 10 min 
72 °C 5 min – 30 min 
  PCR products were assayed by agarose gel electrophoresis.  
 
2.1.8 DNA ligation 
Ligation reactions were set with a molar ratio vector:insert of 1:3 and the total mass of DNA 
was no more than 1 µg, then 1 X ligation buffer (NEB) was added along with 20 units T4 DNA 
ligase and the reaction volume was made up to 15 µl using nuclease-free high purity water. 
The reaction mix was incubated at 18 °C overnight. In order to screen for correct recombinants 
1 µl (max 100 ng DNA) of the ligation mix was transformed into E.coli chemically competent 
cells. Plasmid DNA was extracted and digested with suitable restriction endonucleases in order 
to check for the presence of the insert. Once the correct clone was identified, it was sent for 
sequencing (Eurofins/MWG) for verification.  
 
2.1.9 Restriction digest of DNA 
Restriction digests were performed in standard 50 µl reaction containing 1 x restriction 
endonuclease buffer 1, 2, 3 or 4 (NEB), depending on the enzyme and 10 µg/µl bovine serum 
albumin (BSA) was added. The reaction volume was made up to 50 µl and incubated at a 
temperature recommended by the manufacturer for 1-2 hours. The DNA products were 
assayed by agarose gel electrophoresis (2.1.5). 
 
2.1.10 DNAse I treatment of isolated RNA samples 
In order to degrade DNA from a DNA/RNA mix  samples were made up to 50 µl and 5 µl of 
DNAse I buffer was added, 2 µl DNAse I (NEB) and 1.5 µl RNase OUT (Promega). The 
reaction was incubated at 37 °C for 30 min then 2 µl of DNAse I was added and the reaction 
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was kept for 30 more min at 37 °C. The RNA quality and quantity was assayed by agarose gel 
electrophoresis (2.1.5). 
 
2.1.11 Phosphodiesterase I (Snake venom) digest  
A total amount of 50 ng of annealed oligonucleotide was dissolved in 100 mM Tris pH 8, 1 
mM MgCl2. Firstly, the OD of the oligonucleotide was measured at 260 nm by UV 
spectroscopy (2.3.5). Five units of phosphodiesterase I was then added to the cuvette and a 
time course was set in order to follow the OD change of the oligonucleotide at 260 nm. The 
reaction was conducted at room temperature in a Spectrophotometer (Perkin Elmer 
Instruments, Lambda 25). The reaction was completed when the OD was constant over time.  
When the phosphodiesterase digest reaction was completed, the absorbance of the 
oligonucleotide was again measured over the 330-220 nm range and the OD was taken at 260 
nm. The measurement before the phosphodiesterase I was substracted from this measurement 
and the percentage difference calculated. This percentage difference gave the hyperchromicity 
of the oligonucleotide which value was used to calculate the true extinction coefficient. 
 
2.1.12 Eluting DNA from an agarose gel 
In order to obtain a DNA fragment of interest from a mixed population of lengths, it was first 
resolved on a 1 X TAE 1% agarose gel. A blue light transilluminator was used to avoid damage 
to the DNA while visualizing. The correct size band was excised using a clean scalpel blade 
and placed in pre-wetted dialysis tubing clipped at one end. Then 600 µl 1 X TAE buffer was 
added and the other end clipped and all the air was removed from the tubing. The agarose slice 
within the tubing was placed back on the agarose tray and electrophoresed at 100 V for 1 hour. 
After which the current was reversed for 30 sec in order to detach any DNA stuck to the tubing 
walls. The solution containing the eluted DNA band was taken out with a pipette and ethanol 
precipitated (2.1.14). 
 
2.1.13 DNA purification by phenol/chloroform extraction  
The sample was made up to 100 µl with high purity nuclease-free water (Sigma) and an equal 
volume of equilibrated Phenol:Chlorofom:Isoamyl alcohol (25:24:1) was added to the sample. 
The sample was vortexed for 1 min and then centrifuged for 3 min at 16 000 g. Once the spin 
was finished, the top layer was removed to a fresh tube and an equal volume of chloroform 
added. The sample was again vortexed for 1 min and centrifuged for a further 3 min at 16 000 
g and the top layer again removed to a fresh tube.   
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2.1.14 Ethanol precipitation of DNA and RNA 
In order to precipitate nucleic acids to the starting volume, 3 volumes of 100% ethanol and 0.1 
volumes of 3 M sodium acetate was added. The mixture was kept at -70 °C for at least 30 min 
or ideally overnight and then centrifuged at 16 000 g for 15 min at 4 °C. The supernatant was 
discarded carefully and the pellet washed with 500 µl 70% ethanol and then centrifuged at 16 
000 g for 5 min at 4 °C. The supernatant was discarded and the pellet left to air dry at room 
temperature before resuspending in nuclease-free water or TE buffer. 
 
2.1.15 Whole embryo RNA extraction using Trizol® method 
Xenopus tropicalis or Xenopus laevis embryos were collected in batches of 10 in 
microcentrifuge tubes. Any excess of liquid was removed and embryos stored at -70 °C untill 
needed. Embryos were thawed at room temperature and 400 µl of Trizol (Invitrogen) added 
before being vortexed and homogenized by pipetting up and down. Then 0.2 volumes of 
chloroform were added to the embryo mix and vortexed prior to centrifuging at 16 000 g for 5 
min at room temperature. The aqueous top layer containing the nucleic acids was gently 
removed and transferred to a fresh tube to which 0.5 starting volumes of isopropanol was 
added. Samples were vortexed and kept for 15 min at room temperature and then centrifuged 
at 16 000 g for 15 min at 4 °C. The supernatant was discarded and 1 ml 70% ethanol was 
added, samples were centrifuged at 16 000 g for 5 min at room temperature. The supernatant 
was discarded and the pellet was air dried prior dissolving in highly pure nuclease-free water 
(Sigma) to 4 µl per 1 embryo equivalent.  
 
2.1.16 Whole embryo RNA extraction using NETS buffer method 
Sets of 4 or 10 Xenopus laevis or Xenopus tropicalis embryos at defined stage were defrosted 
at room temperature and homogenized by pipetting up and down in 600 µl of NETS buffer 
(appendix I). An equal volume of phenol was added and the samples were vortexed for 30 sec. 
Embryo homogenate was centrifuged at 16 000 g for 5 min at room temperature. The top 
aqueous layer was carefully transferred to a fresh tube and 600 µl phenol/chloroform was 
added and mixed by vortexing for 30 sec. Samples were centrifuge at 16 000 g for 5 min at 
room temperature. The top aqueous layer was carefully removed to a fresh 2 ml tube and 
nucleic acids were precipitated with ethanol (2.1.14). The pellet was resuspended in 100 µl 
high purity nuclease-free water. In order to degrade the DNA from the nucleic acid mixture 
DNase I treatment was performed, as described in 2.1.10. Following degradation of the DNA, 
the samples were purified from DNAse I using phenol/chloroform extraction (2.1.13). RNA 
pellets were resuspended in high purity nuclease-free water (Sigma) and the volume used 
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would depend on the followed by procedure, in case of RT-PCR, a volume of 20 µl was 
routinely used.  
 
2.1.17 Whole embryo protein extraction using Freon 
A set of 10 embryos or frozen were homogenized with 50 µl EMSA extraction buffer 
(appendix I) using 1 ml pipette tip. Once homogenized an equal volume of Freon was added 
and then the suspension was vortexed for 30 sec. The sample was then centrifuged at 14 000 
g, 4 °C for 5 min. The top layer containing the protein extract was carefully removed to a clean 
eppendorf tube. 
 
2.1.18 Genomic DNA extraction using DNeasy® Blood and Tissue Kit     An 
adult transgenic frog toe was removed and stored in an eppendorf tube at -20 C until required. 
To dissolve the tissue 180 μl of Buffer ATL was added followed by 20 μl Proteinase K. The 
mix was then incubated at 56 °C until completely lysed. The mixture was periodically vortexed 
to enhance the homogenisation process. Once homogenised 200 μl of Buffer AL was added 
and the mix was vortexed.  200 μl of 100% ethanol was added and mixed. The mixture was 
transferred to a DNeasy Mini spin column and centrifuged at 6000 g for 1 min. The flow-
through was discarded then the column was placed in a fresh collection tube and washed with 
500 μl Buffer AW1. Followed by centrifugation for 1 min at 6000 g. The spin column was 
transferred to a new tube and washed with 500 μl Buffer AW2 and centrifuged for 3 min at 20 
000 g. The flow-through was discarded and the column placed in a new collection tube. The 
DNA was eluted by adding 200 μl Buffer AE to the centre of the spin column and incubated 
for 1 min at room t °C and centrifuged for 1 min at 6000 g.  
 
2.1.19 SDS-PAGE 
To assemble the sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
apparatus the glass gel plates, rubber gasket, and well forming comb were first cleaned and 
dried. The plates were assembled, ensuring that the gasket correctly sealed the plates to prevent 
leakage of acrylamide solution and the plates were then clamped together. In order to make a 
10% SDS-PAGE, 3.3 ml 30% acrylamide to bisacrylamide (37.5:1) stabilized solution stock 
(National Diagnostics) was mixed with 2.6 ml Protogel resolving buffer (National Diagnostics) 
and made up to 9.8 ml with distilled H2O. The liquid gel was polymerised by adding 100 μl of 
10% APS, 20 μl TEMED absolute. In order to ensure an even interface after pouring the 
resolving gel, 2 ml of isopropanol was layered on top. Once the gel had set the isopropanol 
was removed by inversion and the gel washed repeatedly with distilled H2O and drained.  
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The 4% stacking gel was prepared by mixing 30% acrylamide to bisacrylamide (37.5: 1) 
stabilized solution stock (National Diagnostics) and Protogel stacking buffer (National 
Diagnostics) and made up to 9.9 ml with distilled H2O, polymerisation of the liquid gel 
required the addition of 40 μl 10% APS and 10 μl TEMED. The solution was then poured in 
between the gel plates and allowed to set. The cassette was placed in the tank and the upper 
and lower reservoirs were filled with 1 X Tris glycine running buffer (National Diagnostics). 
Once the upper reservoir was filled the comb was removed. Samples were prepared in 1 X 
SDS-PAGE loading dye (appendix I) and heated to 95 °C for 5 min to denature the protein 
sample and then centrifuged briefly to collect any condensation on the roof of the 
microcentrifuge tube. Finally, the samples were loaded onto the gel along with an appropriate 
marker. Approximately 100 ng protein can be visualised in a single band, band concentrations 
above 1 μg overload the gel and made accurate estimation of size difficult. Gels were 
electrophoresised at 250 V until the bromophenol blue dye front left the gel (on a 10% gel the 
dye-front migrated at a rate equivalent to a protein of 10-20 kDa). The gel was disassembled 
and the running gel submerged in Coomassie brilliant blue (Sigma) staining solution (appendix 
I). Excess Coomassie brilliant blue was removed by placing the gel in destain solution 
(appendix I) overnight with shaking.  
 
2.1.20 Western Blot 
Total protein extract was prepared as per 2.1.17 and separated by SDS-PAGE (2.1.19), but 
instead of staining with Coomassie Blue Stain, proteins were transferred to HyBond-ECL 0.2 
μm nitrocellulose membrane (GE Healthcare). The SDS-PAGE gel, blotting paper and 
nitrocellulose membrane were soaked in Transfer Buffer (appendix I) for 30 min before a gel 
cassette was set up from cathode to anode in the following order: 
1. Fibre Pad 
2. Whatman 3M Filter Paper (x2) 
3. Nitrocellulose Membrane 
4. SDS-PAGE Gel 
5. Whatman 3M Filter Paper (x2) 
6. Fibre Pad 
Air bubbles were removed and the cassette was transferred to a western blot tank filled with 
Transfer Buffer. The proteins were transferred onto the membrane at 300 mA for 2-3 hours. 
The membrane was blocked in the blocking solution (TBSTw/PBSTw-5% Milk/BSA) for 1 
hour at room temperature. The primary antibody was diluted in blocking solution to the 
appropriate concentration and incubated with the membrane for 2 hours at room temperature 
and the membrane was then washed three times in blocking solution for 15 min each. The 
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secondary antibody was diluted to 1:5000 in blocking solution and membrane was soaked for 
1 hour at room temperature. The membrane was then washed three times in blocking solution 
for 15 min each, followed by two washes in TBSTw and twice in PBS, each wash was for 5 
min. The membrane was developed by mixing together ELC Solution I and ECL Solution II 
(Appendix I), then adding this to the membrane for 1 minute. The chemiluminescence from 
the membrane was captured using a FujiFilm FLA-5000. 
 
2.2   Bacterial and embryological methods 
2.2.1   Growth and maintenance of bacterial strains 
Bacterial cells were grown in L-broth (Fisher) at 37 °C. If bacterial cells were transformed 
with a plasmid carrying antibiotic resistance gene they were inoculated in L-broth containing 
the appropriate antibiotic. Permanent cultures of cells were prepared using 1 ml of saturated 
bacterial culture mixed with 70 µl sterile 100% DMSO and stored at -70 °C. The generally 
used strain for propagating plasmids was Escherichia coli strain DH5α.  
 
2.2.2   Competent cell preparation 
A frozen stock of Escherichia coli DH5α strain was defrosted and streaked onto an agar plate. 
The plate was incubated at 37 °C overnight and the next day 5 ml L-broth was inoculated with 
a single colony for overnight growth. The following day 100 ml L-broth was inoculated with 
100 µl of the overnight culture. The newly inoculated 100 ml L-broth was incubated at 37 °C 
at 200 rpm shaking and the culture was grown until OD = 0.6. The cell culture was then 
transferred to a Beckman centrifuge tube and spun down at 6000 g for 30 min at 4 °C. The cell 
pellet was resuspended with 33 ml ice cold FB1 (appendix I) and kept on ice for 15 min. The 
cells were then centrifuged at 6000 g, 4 °C for 30 min and the pellet was again resuspended in 
8 ml ice cold FB2 (appendix I) and kept on ice for 5 min. The cells were transferred to fresh 
eppendorf tubes in 400 µl aliquots and snap frozen in liquid nitrogen and then stored at -70 °C 
for further use. The competent cells efficiency was tested with trial transformation, effective 
competent cells give 105 to 106 colonies per 1 µg of plasmid DNA. 
 
2.2.3 Plasmid transformation of E. coli cells 
Chemically competent E.coli cells were defrosted on ice and their volume adjusted to 150 µl 
per transformation reaction. Once ready, no more than 100 ng of DNA (plasmid/ligation mix) 
was added and kept on ice for 30 min longer. A negative control cell mix was also set up where 
instead of DNA an equal volume of Sigma water was added. The cell suspensions were then 
heat-shocked at 42 °C for 45 sec then placed back on ice for 5 min. Pre-warmed 850 µl L-
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Broth was added to them and they were incubated at 37 °C on a heat block for 1 hour with 
shaking at 200 r.p.m. The cells were then centrifuged at 6000 g for 1 min, the supernatant 
discarded and the cell pellet was resuspended in fresh 100 µl L-Broth. The total volume of 100 
µl cell suspension was plated on agar plates containing an appropriate antibiotic at the required 
concentration. The type of antibiotic was dependant on the type of antibiotic resistance gene 
carried by the transformed plasmid. Aseptic technique and sterile conditions were maintained 
at all time during handling bacterial cultures.  
 
2.2.4   Care and maintenance of Xenopus laevis and Xenopus tropicalis 
embryos 
The day before the eggs were required a female frog was injected with 600-800 units of human 
chorionic gonadotrophin into the dorsal sacs. The frog was kept overnight before being gently 
squeezed the next morning. A male frog was sacrificed by tricane anaesthesia before the testes 
were dissected and kept in 1 X Modified Barth`s Saline (MBS) (appendix I) at 4 °C. A quarter 
of a testis was crushed in 400 µl 0.1 X MBS and after the squeeze, the eggs were fertilized 
with the sperm solution. Eggs were kept for 5-10 min in order to be fertilized after which they 
were flooded with 0.1 X MBS. Embryos were then treated with 2% cysteine/1 X MBS solution 
(pH 8) in 50 ml falcon tube to remove their jelly coats. The embryos were gently agitated while 
dejellying. They were then washed 5 times in 1 X MBS and transferred to a new plate 
containing 0.1 X MBS.  Xenopus tropicalis embryos were maintained at 0.3 X MBS and kept 
at 23 °C. The embryos were checked several times a day in order to remove dead embryos and 
the solution was changed with fresh 0.1 X MBS regularly. 
 
2.2.5 Microinjection of Xenopus embryos for transient expression 
Needles used for microinjections were made of a glass capilliary (Harvard Apparatus GC100-
10), pulled with micropipette puller (Sutter Instrument Co. p-87). Prior to the microinjection, 
the needle was placed into a micromanipulator (Sutter-M33) connected to a microinjector 
(Medical Systems Corp. PLI-100) and the needle was then set and calibrated using fine 
forceps, the end of the needle was gently removed and filled with Sigma water. The calibration 
was done using a 30 mm capillary tube. The capillary tube was placed at the end of the needle 
and then water was injected 10 times for 1 sec. Once the water level of the capillary tube 
reached 3 mm it would be equal to a single injections worth (10 nls) and the needle was ready 
to be used. The DNA or RNA solution to be injected was first spun down at 16 000 g for 1 
min to pellet any particles that may block the needle.  The needle was then filled from a droplet 
of the desired solution placed on a parafilm. The embryos were placed on a nylon mesh grid 
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and submerged in 4% Ficoll in 1 X MBS. Once the needle and embryos were set each embryo 
was injected at one cell stage. Once injected the embryos were transferred to a Petri dish 
containing fresh 4% Ficoll in 1 X MBS and allowed to recover for several hours at 14 °C. 
Embryos were then moved to 0.1 X MBS solution at 19 °C and monitored until the required 
stage. 
 
2.2.6 Whole-mount in situ hybridization 
In order to determine a gene expression pattern in different NF stage embryos, RNA probes 
had to be synthesized. A region of 500 bp of gdi3 (appendix III) was amplified from cDNA by 
PCR and then ligated into pGEM-T Easy (appendix IV, appendix VIII) vector. The new 
construct was then linearized with 4 µl SacII (20 000 U/ml, NEB) in order to obtain the sense 
strand and with 4 µl SpeI (10 000 U/ml NEB) to obtain the antisense strand.  The restriction 
digests were set up in 50 µl reactions at 37 °C, overnight. SP6 and T7 RNA Polymerase were 
used to synthesize sense and antisense mRNA probes, respectively. Two 20 µl in vitro 
transcription reactions were set up as follows: 2 µl of 10 x Transcription buffer; 100 µM DTT; 
DIG-mix, containing all nucleotides; 1 µl RNAseOUT (Invitrogen); 1 µl SP6 RNA 
Polymerase. The DNA template was then degraded with DNase I. The RNA was assayed by 
agarose gel electrophoresis (2.1.5) prior usage. Once the RNA probes were made the actual in 
situ hybridization experiment was performed. Fixed embryos were rehydrated through 75%, 
50%, 25%, 0% methanol in PBS series for 5 min at each concentration. After which they were 
incubated with hybridization buffer at 60 °C for 6 hours. After the prehybridization step, the 
DIG-labelled probe (200 ng - 1 µg) was added to the embryos and they were incubated at 60 
°C overnight. The next day the probe was washed away after series of incubations with 5 X 
SSC/50% formamide; 2 X SSC/25% formamide; 2 X SSC/12.5% formamide; 2 X SSC/0.1% 
Tween and a final wash in 0.2 X SSC/0.1% Tween. All washes were done at 60 °C. The 
following washes were in PBSTw for 5 min each, at room temperature before a wash in MAB 
for 10 min and a final wash in MAB/2% blocking solution. An antibody conjugated to AP was 
then added in 1/2000 dilution to the blocking solution. The embryos were incubated overnight 
at 4 °C with rocking. Next day any excess antibody was washed off by 5 X 1 hour in MAB at 
room temperature with gentle rocking. After which the developing solution was added in a 
darkened environment. The colour change was observed periodically to avoid over staining. 
Buffer recipes can be found in the appendix I. 
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2.2.6.1 Fixing of embryos in MEMFA 
Embryos were collected at the required stages in batches of 20 and transferred to glass vials 
where they were fixed in MEMFA solution (appendix I) for 30-45 min.  The MEMFA was 
then replaced with methanol for 30 min. The methanol was replaced twice for 30 min per wash. 
Fresh methanol was added and the embryos were stored at 4 °C until needed. 
 
2.2.6.2 Rehydrating and bleaching 
In order to be rehydrated embryos were transferred to eppendorf tubes and washed in 1 ml of  
75%, 50%, 25% methanol in PBSTw and final wash in PBSTw alone. All washes were 
performed in 1ml for 5 min unless otherwise stated. Then the PBSTw was replaced with 
Bleaching Solution and the tubes were placed on a light box for 15-20 min, thus degrading the 
embryo pigmentation. The Bleaching Solution was removed and embryos were washed three 
times in PBSTw- 5 min per wash. 
 
2.2.9 pTransgenesis using the Gateway® site specific recombination cloning 
system 
2.2.9.1 PCR, DNA extraction, and purification 
Primers (appendix II) containing attB sites were designed to amplify the putative regulatory 
element (appendix III) in order to be cloned into p2 (pDONR™ 221) vector (appendix IV). The 
PCR mix contained 9 µM of forward and reverse primers; 2.5 µM dNTPs; 50 ng fosmid 
template and 1 U Dream Taq Polymerase or Extensor Long Range Taq Polymerase for DNA 
fragments ≥ 3 kb; 10 X Dream Taq buffer and the reaction was completed with sigma water 
to a 25 µl final volume. Once the PCR was completed the end product, the putative regulatory 
element, was analyzed on a 1% agarose gel and if the size was as expected the DNA band was 
gel eluted and purified as described in 2.1.12. The purified DNA was again analyzed by 1% 
agarose gel electrophoresis (2.1.5) and its concentration measured by UV spectroscopy (2.3.5), 
prior proceeding with the BP recombination set up.  
 
2.2.9.2 BP recombination 
The BP recombination was set up as follows: 150 ng p2 vector, 30 ng putative promoter 
element, 1 µl BP clonase II, complete with TE buffer, pH 8 to 5 µl final volume. The reaction 
was then incubated overnight at 25 °C. On the following day 1 µl Proteinase K was added and 
the reaction was kept at 37 °C for 10 min. 1 µl (50 ng/µl) of the BP reaction was transformed 
into DH5α competent cells and grown overnight on ampicillin containing agar plates (100 
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ng/µl).  Several colonies were picked and recombinants were confirmed by restriction enzyme 
digest. 
 
2.2.9.3 LR recombination 
Once all the pDonr clones were obtained, the LR reaction was conducted in order to generate 
the final expression clone to be injected. Listed here are the vectors necessary for the LR 
recombination: p1 (pDONR™ P4-P1R) (appendix IV), p2 (pDONR™ 221) (appendix IV) and 
p3 (pDONR™ P2R-P3) (appendix IV) DONR vectors. All vector maps can be found in 
appendix IV. The LR reaction is set up with equal molar concentration of each recombinant 
pDONR plasmid-10 fmol of p1, p2 and p3   and 20 fmol of the destination vector pDEST 
(appendix IV). Finally, 1µl LR clonase II was added and the 5 µl reaction was incubated at 25 
°C overnight. On the next day 1 µl Proteinase K was added and the reaction incubated at 37 
°C for 10 min prior to a transformation (2.2.3).  
 
2.2.9.4 Microinjection of the constructs into Xenopus laevis embryos for transgenesis 
The construct to be injected was purified using phenol/chloroform extraction (2.1.14). The 
final concentration of the DNA was made up to 1 µg/µl and an aliquot was taken and diluted 
10 fold with high purity water to obtain a 100 ng/ µl working stock. Prior to starting injections, 
the DNA construct was digested with I-SceI restriction endonuclease (NEB) according to the 
following protocol: 1 X I-SceI buffer, 1 X BSA, 700 ng DNA, 5 U I-SceI and the reaction was 
made up with high purity water to 20 µl final volume. The reaction was kept at 37 °C for 40 
min and it was started 5 min before the frog was squeezed. The best integration of DNA into 
the genome occurs during the first 20 min after fertilization, hence, the injections were done 
during this window of time. Microinjections of embryos were conducted as described in 2.2.5.   
 
2.2.10 Dual-luciferase reporter assay 
Plasmids pGL4.10-S, pGL4.10-M, pGL4.10-L and TK/Renilla (appendix IV) were diluted to 
a final concentration to facilitate to injection of 50 ng plasmid into the embryos. One cell stage 
embryos were injected and kept in 4% Ficoll (appendix I) at 14 °C for 1 hour, allowing the 
embryos to recover. Embryos were grown until stage 18 when they were lysed in 1 X passive 
lysis buffer (Promega). The dual luciferase assay allows testing the embryo lysates for 
luminescence. The reagents LarII and Stop & Glo were prepared according to the Promega 
protocol and then applied to the lysates. Firstly, 50 µl lysates were added to a 9 by 12 cell 
cassette reader and 50 µl LarII was mixed with each sample. Secondly, luminescence was 
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measured with luminometer for 10 sec.  Finally, 50 µl Stop & Glo solution was added to the 
mixture and luminescence was measured again for 10 sec and the data plotted.  
 
2.3 Biochemical and biophysical methods 
2.3.1 Native-polyacrylamide gel electrophoresis 
In order to prepare native polyacrylamide gel, a set of gel plates were thoroughly cleaned and 
a rubber gasket was seated correctly between them to prevent leakage. Then using bulldog 
clips the plates were clamped together and left to stand upright. In a standard reaction, a 
solution of 12% polyacrylamide was prepared where 6 ml of 40% polyacrylamide stock (29:1 
National Diagnostics) was mixed with 2 ml 10 X TBE and completed with 12 ml of distilled 
H2O. The polymerization reaction was initiated after mixing 400 µl 10% (w/v) ammonium 
persulphate (Sigma) and 10 µl TEMED (Sigma) which were then poured immediately into the 
assembled gel plates. The comb was inserted and the gel left to set. In order to run the gel, the 
gasket was removed and the plates placed in an electrophoresis tank with a glass plate on the 
opposite side to seal the chamber in the middle of the tank which was filled with 1 X TBE 
buffer. The well pockets were cleaned using a 100 µl pipette and air bubbles underneath the 
gel plates removed. The samples were loaded onto the gel in 1 X Orange G (appendix I) and 
run at 100 V for an hour alongside a DNA ladder. In order to visualize the DNA samples, the 
gel was carefully taken off the plates and incubated in 100 ml dH2O/30 µl ethidium bromide 
solution for 20 min with shaking. Native polyacrylamide gels used for EMSA were made to a 
final concentration of 4% polyacrylamide (29:1) in 0.25 X TBE buffer. 
 
2.3.2 Radioactive labelling of nucleic acids 
The DNA probes were used for EMSA experiments and were 5`- radioactively labelled by 
incorporation of γ-P32 ATP. The reaction protocol is as follows: 4 pmols of double stranded 
(ds) DNA was mixed with 3 µl γ-[P32] ATP (Perkin Elmer), 1 X Polynucleotide kinase (PNK) 
buffer and 10 U PNK enzyme (NEB). The reaction volume was made up to 30 µl final volume 
with high purity water and incubated for 30 min at 37 °C. The unincorporated γ-[P32] ATP was 
removed using G-25 MicroSpin™ columns (GE healthcare) according to the manufacturer`s 
protocol. The concentration of the radioactively labelled DNA was measured using a Picodrop 
spectrophotometer (Cambridge Bioscience).  
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2.3.3 Electrophoretic mobility shift assay (EMSA) analysis of embryo 
extracts 
Protein-DNA binding was examined using the EMSA assay. Total protein was extracted from 
ten Xenopus laevis embryos with freon to remove the yolk proteins (2.1.17). The extract was 
homogenized with 1 X EB (appendix I) buffer containing ½ mini-complete™ protease 
inhibitor tablet (Roche) per 5 ml 1 X EB. Radioactively labelled oligonucleotide at 1 ng was 
mixed with the total protein extract, 100 ng poly dI-dC non-specific competitor (Amersham 
Pharmacia Biotech) in 1 X EMSA buffer completed to a final volume of 20 µl. Binding was 
conducted for 30 min at 4 °C. Once the binding reaction was completed the samples were 
loaded on pre-electrophoresed 0.25 X 4% polyacrylamide gel (2.3.1) and the gel was run at 
200 V for 95 min. The ready gel was pealed from the back plate onto a piece of filter paper 
and the gel covered with cling film. The wrapped gel was placed on another sheet of filter 
paper on a vacuum drier and dried for 1 hour at 80 °C. The dried gel was placed in a 
phosphoimager cassette and exposed overnight. On the next day the phosphoimager screen 
was scanned (Fujifilm FLA-5000). Phosphoimager software (Image Gauge 4.0) was used to 
analyse the obtained images.  
 
2.3.4 Circular dichroism (CD) 
The concentration of the DNA duplexes to be examined by CD was estimated after 
experimental determination of their exact extinction coefficients.  The DNA concentration 
required for CD was 1 µg/µl in 200 µl final volume.  In order to prevent damage to the optics 
the instrument was flushed with nitrogen for 10-15 min before switching the lamp on and the 
instrument was purged for the duration of the experiment. The lamp was switched on and the 
instrument left to warm up for 30 min before making any measurements. Once the instrument 
was set a 1 cm cell filled with water and the baseline was determined between 250 nm and 320 
nm. The CD machine was calibrated with previously prepared camphor sulfonic acid and the 
CD was measured between 250 nm and 320 nm where a 0.5 mg/ml solution in a 1 cm path 
length cell had ellipticity of 168 milidegrees at 290.5 nm. After that the cell was filled with 
phosphate buffer (appendix I) and a baseline was run between 250 nm and 320 nm. The 
phosphate buffer was replaced with the DNA sample of interest and the spectrum taken under 
the same conditions. 
 
2.3.5 Ultraviolet (UV) spectroscopy 
In a clean cuvette 495 µl high purity nuclease-free water and a baseline was taken between 
220 and 360 nm.  Then 5 µl DNA sample was dissolved in the cuvette with water and the DNA 
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absorbance was scanned from 220 nm to 360 nm.  A peak is expected at 260 nm since this is 
the maximum wavelength at which DNA absorbs UV light. Absorbance unit of 1 OD equals 
50 µg/µl for dsDNA and for oligonucleotides, small DNA and RNA fragments < 100 bp. 
Theoretical extinction coefficient is used to determine the concentration via the Beer-lambert 
law. The absorbance peak value of dsDNA sample was multiplied by 50 µg/µl and the dilution 
factor of that sample to give the DNA concentration value. 
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Chapter 3: Identification of A-form promoters by APTE 
3.1 Background 
There are two main approaches whereby transcription factors recognise their cognate DNA 
binding sites. The first mechanism is known as direct read-out in which transcription factors 
(TFs) recognize a defined DNA sequence, normally a conserved promoter motif. However, 
there is an alternative recognition mechanism by which TFs recognise DNA secondary 
structural elements, which differ from the canonical B-form. In this approach the TFs recognise 
shape and not sequence per se, this is known as indirect read-out. Examples of known non B-
form DNA structures are A-form, Z-form, G-quadruplex, and i-motifs. There is increasing 
evidence that these structures can form under physiological conditions within the cell 
(Llewellyn K. J. et al. 2009; Maruyama et al. 2013; Brooks et al. 2010; Rhodes & Lipps 2015). 
There is also evidence that Z-DNA can act as a transcriptional regulator when coupled with a 
CCAAT motif or nuclear factor I (Liu et al. 2001). Furthermore,  Z-DNA  formed at the core 
promoter of mouse immortalized hippocampal cells (MARCKS), is important for basal 
transcription (Wang et al. 2002b). Z-DNA, coupled with nuclear factor I, also maintains active 
transcription of BAF regulated genes (Champ et al. 2004).  
Studies have shown that A-form DNA is important for Xenopus gata2 expression (Llewellyn 
K. J. et al. 2009). Initiation of gata2 transcription has been shown to require the transcription 
factor complex CBTF (Brewer et al. 1995). Ilf3 is a known subunit of CBTF and is a member 
of a family of double-stranded RNA binding proteins, some of which can bind both RNA and 
DNA (Brzostowski et al. 2000; Scarlett et al. 2004). In order for CBTF to bind the promoter 
of gata2, it requires the conserved CCAAT sequence, which if absent, dramatically reduces 
CBTF binding affinity (Brewer et al. 1995). Moreover, the Ilf3 subunit preferably binds the 
A-form rather than B-form DNA structure of the -51 to -31 region of the gata2 promoter 
(Scarlett et al. 2004). Therefore, the CCAAT box and the A-form DNA have been suggested 
to be synergistic cis-acting elements of crucial importance for gata2 transcription initiation. 
The CCAAT motif is essential for transcription factor binding and the A-form DNA is critical 
for higher affinity of the gata2-CBTF interaction and hence high levels of gata2 expression 
(Llewellyn K. J. et al. 2009). In the studies presented here, the focus will be on A-form DNA 
as an in-direct read-out mechanism of transcriptional regulation in a wider genome context. 
 Basham et al, presented a set of thermodynamic rules which demonstrate a difference in the 
DNA hydration surface of A- and B-form DNA and this can be used to distinguish between 
these forms (Basham et al. 1995). These rules are based on A-DNA propensity energy (APE), 
the values (kcal/mol) which are experimentally derived from solvent free energy calculations 
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indicating the thermodynamic propensity for DNA to adopt A-form or B-form. Each base 
within a sequence taken as a centre (bi) has an estimated value which depends on the two 
flanking bases 5` (bi-1) and 3` (bi+1) to the central base. These values are presented in a table 
(appendix VI) where any base taken as a central base (bi) is read as a triplet code with the 
flanking (bi-1) and (bi+1) bases. Once one base has been read the next base can be analysed 
as part of a three base moving window sliding along the sequence. The sum of all values will 
give the overall APE value for a given sequence of DNA. The more negative the value the 
higher the A-form DNA propensity and, conversely, the more positive the value the more B-
form the propensity. This algorithm together with the data from the gata2 promoter studies in 
Xenopus have been implemented as a perl program called APTE, allowing bioinformatic in 
silica prediction of whether DNA sequences are more A-form or B-form under physiological 
conditions (Whitley et al. 2014). In summary, APTE is a Perl script implementation of the 
Basham et al. algorithm that locates blocks of DNA sequence with negative A-form propensity 
energy. APTE takes into account both neighbouring sequences motifs and transcription start 
sites whose parameters can be varied through a graphical user interface.  
 
3.2 Screening of the Xenopus tropicalis genome with APTE for A-
form promoter elements  
We employed APTE as our search program to search the Xenopus tropicalis genome version 
JGI 4.2 (the latest version of the genome assembly available at the time) genome assembly for 
putative A-form promoters. In the algorithm described above we have defined the predicted 
A-form promoter sequence (APS) as a sequence with a pre-determined minimum of 
consecutive negative APE values, together with the two flanking bases required for the APE 
calculation. Initial searches have been restricted to promoters containing a particular direct 
read-out promoter motif. For each gene, the algorithm searches a region upstream of the 
transcription start site (TSS) for instances of the motif or its reverse complement preceded by 
an APS of pre-specified minimum length, with the APS and motif separated by at most a pre-
specified maximum distance. The identified combined promoter sequence (CPS) extends from 
the start of the APS to the end of the motif (figure 3.1).  
The APTE program screened for APS sequences of length ≥ 12 bp preceding several common 
promoter sequence motifs and also within 500 bp of a TSS. A minimum APS of 12 bp was 
selected as this length of APS and has been reported to reliably give an A-form structure as 
identified by circular dichroism (Peter Cary personal communication). A limit of 20 bp 
between the APS and motif was chosen based on previous DNA footprinting experiments  
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Figure 3.1 A combined promoter sequence (cps) consists of an A-form promoter element 
followed by a standard sequence motif.  The top row indicates the signs of the APE values 
(positive is indicated in red and negative in blue) for each nucleotide displayed below it, where 
X denotes an undetermined APE value. The main parameters that can be adjusted in APTE are 
the APE length (apelen), and the gap between the APS and the motif. 
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performed on the CBTF complex (Scarlett et al. 2004).The total number of APS and CPS (for 
the motifs CCAAT, GGGCGG, AGATA and TGATA) in the 4.2 assembly of the Xenopus 
tropicalis genome are shown in table 3.1A and also, their occurrence within 500 bp regions 
upstream of a TSS is shown alongside. Table 3.1B contains the numbers of the total occurrence 
of the four motifs, in the whole genome and also constrained to CPS or regions of 500 bp 
upstream a TSS. Table 3.2 contains a full list of identified genes associated with a CPS within 
500 bp of their TSS. In general, the CCAAT, GGGCGG, AGATA and TGATA motifs can be 
found in multiples near 7.02% of genes. The A-DNA promoter sequences, however, occur 
before only 3.2% of genes. An APS, therefore, occurs only rarely in comparison with the 
motifs, and the combined promoter sequences only appear before approximately 0.47% of 
genes (Whitley et al. 2014). This raises the question of what would be the occurrence of APS 
and CPS randomly within genomes. 
In order to approach this question, a Monte Carlo simulation was performed. A Monte Carlo 
simulation is a method used to statistically analyse the probability of a given scenario. In a 
Monte Carlo simulation, the scenario is computationally enacted a very large number of times 
and the outcomes recorded. In this case, the simulation was done using 106 randomly generated 
500 bp fragments which had base composition ratio of 0.299733 A, 0.200318 C, 0.200317 G 
and 0.299632 T. This base composition was equivalent to that estimated for the Xenopus 
tropicalis genome. The numbers obtained for APS and CPS occurrence after the simulation 
were 5.90 and 1.49, respectively. Within the Xenopus tropicalis genome, we have 86 hits of 
CPS within 500 bp of TSS which is over 50 times more than the 1.49 that would be expected 
by chance. In addition, we have 586 APS within 500 bp of the TSS from the simulation which 
is 100 times more than the statistically predicted 5.90. 
 
3.2.1 The five of 86 hits selected for further analysis 
In order to validate APTE, we randomly selected five of the 86 hits identified from the JGI 4.2 
assembly to study further. These five hits lay within 500 bp upstream the following genes: 
kif27, unknown gene 1, gtf2e1.2, thrsp and unknown gene 5 (table 3.3). It was hypothesised 
that these genes may have putative promoters with a structure similar to the gata2 promoter, 
and therefore, be responsive to the same Ilf3 transcription factor found in the CBTF complex.  
The 36 bp sequences corresponding to the five selected CPSs are shown in figure 3.2 with their 
predicted transcription factor binding sites. The theoretical A-form propensities for the five 
selected duplexes were predicted using the Basham et al. algorithm and the exact base by base 
APE values are displayed graphically in figure 3.3. Experimentally I wished to confirm that  
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Table 3.1 Frequencies of in-direct and direct read out putative promoter elements in 
Xenopus tropicalis JGI 4.2 genome assembly.  (A) Frequency of A-DNA promoter sequences 
combined with known promoter motifs identified using the following genome screening 
parameters: apelen ≥ 10, motifgap ≤ 20 (B) Frequencies of motifs: CCAAT, GGGCGG, 
AGATA, TGATA combined with A-DNA putative promoter sequences. 
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Gene ID Gene name Motif 
ENSXETG00000003537 plcxd3 GGGCGG 
ENSXETG00000008410 c5orf4 GGGCGG 
ENSXETG00000030719 unknown1 GGGCGG 
ENSXETG00000006282 unknown2 GGGCGG 
ENSXETG00000003943 lrsam1 CCGCCC 
ENSXETG00000027883 c3orf10 CCAAT 
ENSXETG00000028111 unknown3 CCAAT 
ENSXETG00000016171 gata2 CCGCCC 
ENSXETG00000029861 unknown4 CCAAT 
ENSXETG00000009337 unknown5 CCAAT 
ENSXETG00000012462 gtf2e1.2 CCAAT 
ENSXETG00000017744 XB-GENE-5853280 CCAAT 
ENSXETG00000004674 eef1d CCAAT 
ENSXETG00000004472 mcts1 CCAAT 
ENSXETG00000032447 LOC100488751 CCAAT 
ENSXETG00000000668 xkr5 CCGCCC 
ENSXETG00000033055 unknown5 CCAAT 
ENSXETG00000007609 thrsp CCAAT 
ENSXETG00000002252 unknown6 CCAAT 
ENSXETG00000026459 ywhaz TATCA 
ENSXETG00000029162 unknown7 TATCA 
ENSXETG00000015053 gdpd5 TATCA 
ENSXETG00000009868 tars TATCA 
ENSXETG00000010686 sepn1 TATCA 
ENSXETG00000016524 LOC100493317 TATCT 
ENSXETG00000018194 fam176a TATCT 
ENSXETG00000009404 adipor2 CCAAT 
ENSXETG00000018026 sec22a AGATA 
ENSXETG00000002371 kif27 AGATA 
ENSXETG00000010991 ercc4 TATCT 
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ENSXETG00000025304 unknown8 ATTGG 
ENSXETG00000002603 gas2 TATCT 
ENSXETG00000023254 zfp36l2.2 TATCA 
ENSXETG00000009124 clcn7 CCAAT 
ENSXETG00000018965 crat.1 CCAAT 
ENSXETG00000027013 NP_001016033.1 CCAAT 
ENSXETG00000027419 a4galt TATCA 
ENSXETG00000020165 mkrn2 CCAAT 
ENSXETG00000029144 unknown9 ATTGG 
ENSXETG00000030437 tnrc6a ATTGG 
ENSXETG00000018553 XB-GENE-5960869 TATCA 
ENSXETG00000016062 znf184 GGGCGG 
ENSXETG00000016933 ehmt1 ATTGG 
ENSXETG00000014657 slc25a30 AGATA 
ENSXETG00000003950 traf2 CCGCCC 
ENSXETG00000030164 NP_001120021.1 AGATA 
ENSXETG00000030426 unknown10 TATCA 
ENSXETG00000022553 fam120a ATTGG 
ENSXETG00000007987 arg2 AGATA 
ENSXETG00000023393 osbpl11 TGATA 
ENSXETG00000017669 usp21 AGATA 
ENSXETG00000013130 magi1 TATCT 
ENSXETG00000023739 wrb CCAAT 
ENSXETG00000007387 bmi1 AGATA 
ENSXETG00000016524 LOC100493317 ATTGG 
ENSXETG00000013350 tfg ATTGG 
ENSXETG00000009412 unknown11 TATCT 
ENSXETG00000000267 ccndx CCAAT 
ENSXETG00000010533 piwil2 ATTGG 
ENSXETG00000007609 thrsp TGATA 
ENSXETG00000027421 HIST1H4G TGATA 
ENSXETG00000014657 slc25a30 ATTGG 
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ENSXETG00000014963 ctdsp1 TGATA 
ENSXETG00000019650 myh11 AGATA 
ENSXETG00000018194 fam176a TATCT 
ENSXETG00000029977 LOC100495404 ATTGG 
ENSXETG00000008526 LOC100495179 GGGCGG 
ENSXETG00000033908 UBE2U AGATA 
ENSXETG00000032885 P5F13_XENTR ATTGG 
ENSXETG00000019263 pdss2 CCAAT 
ENSXETG00000008969 rad51l3 TATCA 
ENSXETG00000022325 unknown12 TATCA 
ENSXETG00000020057 utp6 CCAAT 
ENSXETG00000007609 thrsp TATCT 
ENSXETG00000013463 zmynd12 ATTGG 
ENSXETG00000015404 shc1 TATCT 
ENSXETG00000027433 otop2 ATTGG 
ENSXETG00000021081 sgcg GGGCGG 
ENSXETG00000006922 ss18 TATCA 
ENSXETG00000033607 asxl1 CCAAT 
ENSXETG00000023477 hdhd3 ATTGG 
ENSXETG00000003248 strada TGATA 
ENSXETG00000033920 F166B_XENTR CCGCCC 
ENSXETG00000010684 dnajc19 TGATA 
ENSXETG00000027998 prss8 CCGCCC 
ENSXETG00000010250 chrnb3 TGATA 
 
 
 
 
 
Table 3.2 Gene IDs and names of the immediately downstream genes of the 86 putative 
A-form promoter elements identified in the JGI 4.2 genome assembly (Ensembl). The 
associated promoter motif sequence for each hit is shown alongside. The five hits highlighted 
in bold were taken forward for experimental validation. 
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Figure 3.2 The five selected sequences and their predicted binding proteins. Each of the 
putative promoter elements (ppe) lay within 500 bp upstream of the transcription start site of 
genes unknown5, gtf2e1.2, kif27, thrsp, unknown1. The key elements with potential gene 
regulatory function are underlined with grey arrows. The black arrow above each 
oligonucleotide indicates a putative transcription factor binding site and its direction of binding. 
The putative transcription factor binding sites were predicted using the EMBOSS database run 
through Geneious R7, 7.1.4 (Biomatters, http://www.geneious.com/). 
unknown5ppe 
gtf2e1.2 ppe 
Kif27 ppe 
thrsp ppe 
unknown1 ppe 
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Figure 3.3 The A-form propensity values for each duplex in kcal/mol.  The A-form 
propensity of the five selected putative promoter sequences is shown in A-E. Negative values 
indicate A-form and positive values indicate B-form propensities of base pairs.  
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these sequences were (i) A-form in character and (ii) indeed a target for a DNA binding protein. 
DNA duplexes of 36 bp (appendix II) were designed corresponding to the genomic hits centred 
about the A-form element and including the motifs (either CCAAT, GGGCGG, AGATA or 
TGATA). These duplexes were annealed (figure 3.4) and further studied with CD and EMSA. 
Firstly, CD was used to test for the presence of A-form DNA within the duplexes.  
 
3.3 Circular dichroism  
Circular dichroism (CD) is a powerful technique for the analysis of both nucleic acid and 
protein secondary structure. It exploits a phenomenon whereby circularly polarised light is 
absorbed differentially by chiral (‘handed’) molecules. Light can be circularly polarised either 
left or right, chiral molecules (such as DNA) absorb these two rotated beams differentially. 
Chiral molecules are molecules that can exist in non-superimposable, non-interchangeable 
mirror images. After passing through the sample the two beams are recombined and the 
differential absorption is reported as the degree difference between the sum of the actual vector 
and that expected from equal absorption. CD is a variant of UV spectroscopy and generally, 
the absorption of a range of wavelengths corresponding to the near and mid UV are recorded 
(350 nm to 200nm) as is used for standard UV analysis. The bulk of the absorption takes place 
in the 260 nm range arising from absorption of the bases, although extra information about the 
structure of the molecule is available across the length of the spectra. It is hard to determine 
exact DNA structures from CD spectra but empirical interpretation is possible when compared 
against the spectra of known A-form of B-form control sequences. CD is inexpensive, quick 
and works well at concentrations suitable for nucleic acid analysis (Cary & Kneale 2009).     
    
3.3.1 Calculation of extinction coefficients of DNA duplexes 
DNA or RNA concentrations are normally determined by measuring the absorbance (A) and 
computer software automatically inserts the value in the Beer-Lambert formula to give the 
final concentration of the sample. The Beer-Lambert law represents the relationship between 
absorbance/optical density (OD), the molar extinction coefficient (ε), nucleic acid 
concentration (C) and the pathlength of the cuvette (L) or presented with the formula A(OD)= 
ε. C. L. The molar extinction coefficient is a measure of how much a defined amount of DNA 
or RNA can absorb light at a specific wavelength. It is a natural property of the molecules 
where a certain sequence of DNA or RNA has an extinction coefficient value which is a sum 
of the extinction coefficients of the individual bases. The extinction coefficient values for each  
deoxy- or ribonucleotide base has been previously experimentally determined (Cavaluzzi & 
Borer 2004). 
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Figure 3.4 Annealed oligonucleotides analysed on a 12% polyacrylamide gel. The five 
selected 36 bp sequences were ordered as complementary single stranded oligonucleotides and 
annealed. The successful annealing was confirmed by their mobility on a native acrylamide gel. 
The name of the respective duplexes are shown above the gel lanes. Lane M corresponds to 
NEB low molecular weight ladder.  
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Using these ε values allows for theoretical calculation of the DNA or RNA concentration of a 
sample. 
CD is a sensitive spectroscopic technique and the correct determination of the DNA or RNA 
extinction coefficient is directly proportional to the DNA or RNA concentration. Determining 
the exact DNA concentration of a duplex requires consideration of an additional factor which 
influences DNA absorbance and this is a hyperchromicity effect of base stacking. In DNA, the 
nucleotide base pairs are bonded via hydrogen atoms and stacked in a double strand helix 
where each base partially overlaps with a base above and a base below, as the steps in a spiral 
staircase. This base stacking reduces the light absorbance of a duplex because of the 
overlapping Pi orbitals between the bases. The absorbance of a duplex will increase when the 
latter is digested into single bases. Thus, the hyperchromicity of DNA duplexes affects the 
correct calculation of the DNA or RNA concentration using the Beer-Lambert law. 
 In order to overcome the discrepancy caused by base stacking, an experiment was undertaken 
where phosphodiesterase I (snake venom from Adamanteus crotalus) was used (Cary & 
Kneale 2009). This enzyme, present in snake venom, digests the phosphodiester bonds of the 
DNA backbone which converts the duplex into single bases. The reaction was monitored as a 
time course of absorbance where initially the absorbance increased as the bases became 
separated and hence unstacked and eventually the curve plateaued indicating reaction 
completion. The absorbance of each duplex was measured before and after completion of the 
snake venom digest. The difference between the initial and final OD was more than 20% in 
some cases. This number was applied to the calculated extinction coefficient of a given DNA 
duplex and the correct concentration could be calculated. This exact concentration values 
could then be applied in the subsequent experiments. A summary of the values of the corrected 
extinction coefficient are presented in table 3.3. 
 
3.3.2 CD results 
Circular Dichroism studies of all five selected sequences confirm that these GC-rich duplexes 
are largely in the A-form conformation. The CD spectra of the previously characterized gata2 
promoter compared to both A-form and B-form DNA controls, is shown in figure 3.5A. The 
data obtained from the CD analysis of the duplexes studied here is plotted in figure 3.5B and 
shows two strong positive bands with maxima between 186-189 nm and 267-269 nm 
respectively for all five constructs with a negative band minima between 240-243 nm, these 
spectra are indicative of A-form. The absence of a clear, strong positive band at 186 nm suggest 
there is little B-form DNA duplex present in any of the five sequences, although there is weak  
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Figure 3.5 The selected promoter elements showed A-form structure as determined by 
circular dichroism. (A) The gata2 promoter element compared to control sequences of total 
A-form and total B-form DNA propensities. (B) The CD results from the analysis of the five 
selected sequences. All spectra were taken in 5 mM Phosphate buffer at pH 7.4 and 100 mM 
KF. 
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positive contribution between 185-190 nm for thrsp, obp, kif27 and unknown5 causing a slight 
distortion to the main positive band (260 nm to 300 nm). Further, the intensity of the band 
maxima at (267-269 nm) is significantly more positive than expected for B-form (+2.5 to 3.3) 
and the experimental ellipticity values are more typical of A-form duplexes (+4.3 to 6.86). 
Using the triple base APE prediction for A and B-form DNA duplexes all five selected DNA 
sequences have strong continuous A-form runs upstream of the CCAAT, AGATA, and 
GGGCGG motifs. These continuous A-form regions only represent 28 to 39% of the total 
duplexes in the A-form for all five sequences, the CD measurements suggest that the A-form 
content is at least between 50 to 80% for all five duplexes. Using the triple base APE prediction 
for A and B-form DNA duplexes the total A-form prediction content for Gtf2e1.2, for example, 
is 56% with 20% having no bias for A or B-form, 14% undetermined APE values, 11% with 
a preference for B-form duplexes. This would suggest the minimum A-form content is 56% 
and may be as high as 85%, however in all cases, the duplexes are mainly in the A-form 
conformation. Having confirmed that all five of the selected sequences possessed A-form 
structure we next tested them as targets for protein binding.  
 
3.4 EMSA  
The electrophoretic mobility shift assay (EMSA) is a technique mainly used to study nucleic 
acid-protein interactions by polyacrylamide gel electrophoresis under non-denaturing 
conditions. Any DNA-protein complex formed migrates more slowly through the gel than the 
free species. In order to be able to visualise the retardation of the complex (band shift), the 
DNA duplex is normally specifically radioactively labelled so that only complexes involving 
the specific DNA (and not endogenous or competitor nucleic acids) can be visualized. In the 
current studies, the DNA was terminally labelled through the transfer of 32P from γ [32P]-ATP, 
catalysed by T4 polynucleotide kinase. Importantly EMSA can also be used to examine the 
affinity of the DNA binding protein for its cognate sequence if different unlabelled 
oligonucleotides are used in competition for the protein.  
 
3.4.1 EMSA and Supershift EMSA 
We next tested that the oligonucleotides corresponding to the five selected putative promoter 
hits were specific targets for DNA binding proteins such as transcription factors. Radioactively 
labelled duplexes were mixed with whole embryo extract and electrophoretic mobility shift 
(EMSA) assays were performed. All the sequences tested gave specific, shifted species (i.e. 
specific DNA-protein complexes) when incubated with stage 18 embryo extract at which stage 
the only previously characterised A-form Xenopus promoter (the gata2 promoter) is active 
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(Llewellyn K. J. et al. 2009). These shifted species were unable to be competed by a 
randomised oligonucleotide of 36 bp that also contained a CCAAT box sequence but were 
competed by unlabelled self-sequence at 100-fold excess (figure 3.6). All five of the tested 
putative promoter elements displayed a specific affinity for a specific protein complex. One of 
these, designated unknown5, was taken forward for more extensive testing, both of the putative 
promoter and the uncharactrised downstream gene (discussed in depth in chapter 4). In order 
to determine whether a protein of interest is present within a protein-DNA complex a specific 
antibody can be used in the “supershift” assay (Guille 1999). In this technique, an antibody 
raised against Xenopus Ilf3 was co-incubated with the unknown1 putative promoter element 
and total Xenopus protein extract mix. This resulted in a distinct higher ‘supershifted’ band in 
the EMSA which confirmed the presence of Ilf3 in the nucleic acid-protein complex in vitro 
(figure 3.7A).  
 
3.5 Discussion 
It has been previously reported that an unusual A-form DNA structure in combination with the 
known promoter sequence motif CCAAT can drive early embryonic expression of Xenopus 
gata2 gene (Llewellyn K. J. et al. 2009). A combination of A-form DNA propensity rules with 
various motifs were bioinformatically implemented in a Perl Script program to allow for rapid 
identification of unusual DNA promoter elements within the Xenopus tropicalis genome. 
Using this software, the Xenopus JGI 4.2 genome assembly was screened and 86 hits in close 
proximity to transcription start sites of a gene were found.  
From the 86 hits obtained we selected five to test for both actual A-form structure and as 
specific targets for DNA binding proteins. All five of the selected targets were experimentally 
validated as A- form by CD and as protein binding sites by EMSA in vitro. One of these five 
sequences, containing a CCAAT motif, as does the previously identified gata2 promoter, was 
selected for further validation. In EMSAs using an oligonucleotide probe containing this 
element when mixed with embryo extract a specific complex forms and is supershifted by an 
antibody recognising the ilf3 transcription factor.  
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Figure 3.6 EMSA analysis of the five radioactively labelled putative promoter elements. 
(A) gtf2e1.2 associated putative promoter element (ppe) (B) kif27 ppe (C) thrsp ppe (D) 
unknown1 ppe (E) unknown5 ppe. In all cases lane 1 contains X. laevis total protein extract 
from stage 18 embryos mixed with the respective ppe DNA duplex probes. Lanes 2 and 3 are 
as lane 1 but in the presence of 10 and 100-fold excess of unlabelled self-competitor. Lanes 4 
and 5 are as lane 1 but in the presence of 10 and 100-fold excess of unlabelled B form CCAAT 
box containing DNA competitor. 
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Figure 3.7 Supershift EMSA on unknown 5 using the Ilf3 antibody. Lane 1contains the 
labelled probe without protein extract. Lane 2 contains the labelled probe with protein extract. 
Lane 3 contains the labelled probe with protein extract and ilf3 Ab. Lane 4 the labelled probe 
with protein extract and 100 times excess of unlabelled cold self-competitor. Lane 5 contains 
the labelled probe with protein extract and 100 times excess of mutant self-competitor where 
the mutant had no CCAAT motif.  
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Chapter 4: Characterization of the gdi3 gene 
4.1 Background 
Having identified 86 putative promoters that were candidates for A-form dependant regulation 
we analyzed five in more detail (chapter 3). The downstream gene of one of these 5 promoter 
elements was previously uncharacterised, investigating the expression pattern and function of 
this unknown gene may suggest potential function of the A-form promoter type. Therefore, it 
was decided to study this gene in more depth. In chapter 4 we will study the function of this 
previously uncharacterized gene downstream of the unknown5 promoter, before returning to 
the promoter itself in chapter 5. 
Downstream of the putative promoter element, unknown5, on scaffold GL172680.1 of the 
genome assembly JGI 4.2, there is a predicted gene designated ENSXETG00000009337 and 
its transcript ENSXETT00000020569. In order to identify the function of this unannotated, 
predicted gene the first step was to BLAST its open reading frame against the human genome, 
as by convention the human genome is the reference against which genes from other species 
are named. The result revealed that the highest similarity of ENSXETG00000009337 was with 
human GDI2 (identity 70.8%) and GDI1 (identity 68.8%). The next step was to BLAST 
ENSXETG00000009337 against the Xenopus tropicalis JGI 4.2 genome assembly which was 
the only available Xenopus genome at the time. The first hit was of itself (identity 100%), the 
second highest similarity was with gdi1 (70.5%) and the third high similarity hit was of gdi2 
(69.2%). This suggests firstly that ENSXETG00000009337 is a GDI-related gene and 
secondly, that it may be a novel version present in frogs but absent in humans. 
The transcript ENSXETT00000020569 was translated and the resulting protein sequence was 
compared by BLAST with both the human and the Xenopus proteomes. The two highest 
similarity values obtained were 73.2% identity to GDI1 and 72.6% identity to GDI2 in human. 
In Xenopus tropicalis, apart from a 100% hit for itself, the two highest values were a 73.2% 
identity to gdi1 and a 72% identity to gdi2. Levels of homology are often higher when protein 
sequences are compared due to the degeneracy of the genetic code. Additional bioinformatic 
tools are available on the NCBI website (http://blast.ncbi.nlm.nih.gov/Blast.cgi), these tools 
provide information such as the putative conserved domains. Analysis by these tools revealed 
that ENSXETT00000020569 belongs to the conserved protein domain family of guanine 
dissociation inhibitors (GDI) and the NADB Rossman superfamily (Marchler-Bauer et al. 
2015; Hanukoglu 2015) previously known as CHM/GDI superfamily (Alory & Balch 2001).  
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I next reviewed the literature concerning gdi family of genes. Firstly, we found that gdi genes 
regulate Rab GTPases, not Rho GTPases which have their own set of gdis (known as 
RhoGDIα, RhoGDIβ and RhoGDIγ, reviewed by Dovas & Couchman 2005). Rab GTPases  
belong to the Ras superfamily of monomeric G-proteins (Colicelli 2004). Rabs control the 
vesicle trafficking between different organelles such as the Golgi and endoplasmic reticulum 
(ER) and also between these organelles and the cell membrane (Stenmark 2009; Pfeffer 
2001).There are more than 70 different Rab proteins in mammalian cells involved in vesicle 
sorting (Kelly et al. 2012; D’Adamo et al. 2014; Stenmark 2009; Pereira-Leal & Seabra 2001; 
Schwartz et al. 2008). They act as molecular switches, cycling between the Rab-GTP-bound 
active form and Rab-GDP-bound inactive form. As they become recycled to an inactive form 
they can be reused for a next round of vesicle shuttling. Rabs are anchored to membranes 
through a lipid isoprenoid attachment at their C-terminus, which aids the fusion of the vesicle 
with the target membrane. This isoprenoid is a geranylgeranyl molecule attached to Rabs by 
an enzyme known as geranyl-geranyl transferase (Leung et al. 2006; Preising & Ayuso 2004). 
Rabs have several known effector proteins that assist them in performing their function. These 
include Rab escort protein (REP), GDP exchange factor (GEF), GDP activating protein (GAP) 
and GDP dissociation inhibitor (GDI) (Pfeffer 2001; Segev 2001; Segev 2011; Seabra & 
Wasmeier 2004; Grosshans et al. 2006). Here our main focus will be the Gdi family of Rab 
effectors. Gdis are involved in the recycling of Rab GTPases (Sivars U. 2003; Collins R. 2003). 
The gdi protein sequence is well conserved from yeast to human with pairwise identity of 54%.  
Gdis can bind only to the GDP-Rab form, where they inhibit the dissociation of the complex 
and as a result its interaction with membranes. Furthermore, in order for a gdi to bind a Rab 
protein, Rab prenylation (isoprenoid lipid modification) is an absolute requirement (Ignatev et 
al. 2008; Wu et al. 2007; Pylypenko et al. 2006). Rabs have an attached isoprenoid hence, they 
are insoluble in the hydrophilic cell cytoplasm environment. Gdi proteins bury the fatty acid 
residues within a pocket so that they are not exposed to the hydrophilic environment (Schalk 
et al. 1996; Pylypenko et al. 2003; Pylypenko et al. 2006).  In general, Gdis specifically 
regulate the modified form of Rabs, extracting them from membranes and maintaining a 
soluble pool in the cell cytosol. 
An overview of the Rab recycling process, which involves the known effector proteins, is 
shown in figure 4.1. Firstly, Rab-GDP is prenylated, a REP delivers it to a geranylgeranyl 
transferase which catalyzes the modification process. Once the Rab-GDPs are prenylated, gdi 
has a high binding affinity for them, preventing premature GDP dissociation (Garrett et al. 
1994; Zhang 2003). An effector protein that catalyses the process of converting Rab-GDP 
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 to Rab-GTP is GEF, which enhances the gdi dissociation from Rab-GDP and allows the 
conversion to Rab-GTP. Once a Rab-GTP complex is formed it can deliver its associated cargo 
as it anchors it to a target membrane through the Rab-GTP prenylated tail. Following that, a 
GAP converts Rab-GTP into Rab-GDP with an associated release of energy. In order for Rab-
GDP to be reused in the next cycle of vesicle trafficking, gdi extracts Rab-GDP from its 
membrane and solubilises it. Together REPs, GDIs, GEFs and GAPs contribute to the effective 
targeting of Rab to membranes and subsequent Rab recycling (reviewed by Seabra & 
Wasmeier 2004). 
There are only a small number of gdis in contrast to large number of Rabs, for example, in 
yeast there are 11 Rabs and only one gdi which is critical for cell survival (Garrett et al. 1994; 
Lazar et al. 1997). In human, there are two identified gdi paralogues called GDI1 and GDI2, 
and also, a processed GDI2 pseudogene, while there are 60 genes encoding for Rab proteins 
(Seabra et al. 2002; Pereira-Leal & Seabra 2001), hence both GDI1 and GDI2 must be able to 
bind more than one Rab protein. Depletion of the gdi in yeast has been shown to lead to loss 
of the soluble pool of all rabs in the cytosol which leads to inhibition of vesicle trafficking 
(Garrett et al. 1994). So far human GDI1 has been the most extensively studied gdi protein and 
since frog ENSXETG00000009337 is 74% identical to human GDI1, one could suggest 
similar functions for ENSXETG00000009337 in frogs. The crystal structure of gdi1 was first 
solved for bovine gdi1 as human and bovine gdi1 amino acid sequences have 98% identity 
(Schalk et al. 1996). Gdi1 has two distinct domains, domain I which is a Rab binding platform 
and domain II which contains a mobile effector loop and also a region which interacts with the 
Rabs geranylgeranyl attachment (Luan et al. 2000). Domains I and II share three sequence 
conserved regions with REP, SCR1, SCR2 and SCR3, which as the protein folds come in close 
proximity to form the distinct gdi domains (figure 4.2). Domain I contains SCR1 and SCR3A 
and as validated by site directed mutagenesis are required for interaction with various Rab 
members (Luan et al. 1999; Schalk et al. 1996). SCR2 links domain I with domain II whereas 
SCR3B interacts with different membrane receptors. SCR2 and SCR3B together form domain 
II of gdi1 which contains the effector loop (Luan et al. 2000). Furthermore, domain II forms a 
pocket which shields the Rab`s isoprenoid attachment so that it remains soluble (Luan et al. 
2000)(Rak et al. 2003). In general, membrane recruitment of Rabs is enhanced with GEFs 
which results in gdi release while extraction from membranes is facilitated by gdi. As the Rab 
is anchored to the membrane via its prenylated C-terminus, gdi recognizes an exposed, specific 
region of Rabs and binds via gdi domain I. This triggers a conformational change which 
enhances the binding of gdi domain II to the isoprenoid and Rab`s subsequent extraction from 
the membrane. Once the Rab`s isoprenoid is buried within the gdi pocket it is solubilised and  
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A 
B 
Figure 4.2 Primary and tertiary structure of Gdis.  (A) Protein sequence alignment of 
Xenopus tropicalis Gdi1, Gdi2 and Gdi3 and known sequence conserved regions (SCR1 in 
orange, SCR2 in green and SCR3 in red) across species. (B) Bovine Gdi1 tertiary structure with 
the highlighted SCRs in domains I and II and the key amino acid residues contributing to the 
various gdi interactions. The orange colour corresponds to SCR1, the green colour corresponds 
to SCR2 and the red colour corresponds to SCR3 (Luan et al. 2000). 
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ready for subsequent reuse (figure 4.3) (Pylypenko et al. 2006).  
Given the large ratio of Rabs to gdi proteins, there must be a mechanism ensuring the 
specificity of Rab-Gdi interactions. Either the specificity for Rab localization within the cell 
is encoded within the Rabs themselves or, alternatively, the Rab binding platform of gdis may 
be flexible enabling the gdi interaction with various Rabs. It has previously been shown that 
some Rabs preferentially bind gdi1 or gdi2, irrespective of the gdi abundance within the cell 
(Erdman & Maltese 2001).  However, there are exceptions where certain Rabs bind gdi1 or 
gdi2 depending on their availability (Erdman & Maltese 2001). For example, gdi1 was able to 
modulate the membrane association of a wide variety of Rabs in permeabilized canine kidney 
epithelial cells (Ullrich et al. 1993). Furthermore, gdi2 was also able to extract a diverse range 
of Rabs from membranes in vitro. Interestingly, a point mutation introduced into the SCR3 
sequence would direct the gdi2 selectivity towards specific Rabs.  Also, partial deletion of the 
gdi2 C-terminal variable sequence did not affect the Rab binding properties of gdi2 (Shisheva 
et al. 1999).  
Gdi1 was first found in bovine brain as a protein which prevents the dissociation of GDP from 
Rab3A (Matsui et al. 1990). Subsequently, gdi1 and gdi2 have been characterized in rat and 
mouse where gdi1 in rats is predominantly expressed in the neural tissues while gdi2 is 
ubiquitously expressed (Shisheva 1994 and Nishimura et al. 1994). A single gdi gene has also 
been identified and its expression analysed during Amphioxus development where gdi was 
expressed predominantly in neural tissues, similar to gdi1 (Sedlacek et al. 1999).  
It is important to elucidate the functions of Rab effectors such as gdis as they control GTPases 
involved in vital cell functions. Furthermore, GTPases are known to be target for bacterial 
effectors and toxins which modify their regulatory function within the host (reviewed by 
Aktories 2011). Importantly effectors of GTPases, for example, Rab-gdi2, have been proposed 
as a biomarker for pancreatic cancer diagnosis (Sun et al. 2007).  
 
4.2 Cloning and sequencing of the ENSXETG00000009337 cDNA 
Prior to beginning characterization of a novel gene such as ENSXETG00000009337 it must 
first be isolated and cloned in order to obtain its actual sequence. The ENSXETG00000009337 
cDNA sequences available on Ensembl (genome assembly 4.2, figure 4.4A) and Xenbase 
(genome assembly 7.1, figure 4.4B) differ from each other in terms of both exon structure and 
sequence. According to Ensembl the predicted ENSXETG00000009337 cDNA is 1.3 kb but 
according to Xenbase, it is 1.4 kb. To resolve this issue and determine the true 
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ENSXETG00000009337 sequence, total mRNA was isolated from stage 18 Xenopus 
tropicalis embryos (figure 4.5A) and used to synthesize cDNA using reverse transcriptase. The 
cDNA quality was tested with previously optimised primers (appendix II) specific to a gene 
(lmo2) known to be expressed at this stage (figure 4.5B). The cDNA was then amplified by 
PCR with ENSXETG00000009337 specific forward and reverse primers (appendix II) 
designed against its predicted exon 1 and exon 12 sequences, respectively (figure 4.5C). The 
PCR amplicon of ENSXETG00000009337 cDNA was then cloned into the pGEM-TEasy 
vector (appendix VIII). Standard Taq polymerase adds an A-overhang to the PCR product, a 
useful phenomenon when using TA cloning vectors. pGEM-TEasy vector possesses a T-
overhang, which can hybridise with the A overhang on the PCR product. However, high 
fidelity Taq polymerases, which possess proofreading as used in this amplification, fail to add 
the terminal adenine. Hence prior to the ligation, an additional step was required where an A-
overhang was introduced to the ENSXETG00000009337 PCR product by incubating the insert 
with standard non-proof reading Taq Polymerase for 20 minutes at 72 °C.  
Once the ligation process between the plasmid and the insert was completed 1 μl of ligation 
reaction was transformed into DH5α competent cells. The cells were grown overnight and the 
next day the colonies were PCR screened using the ENSXETG00000009337 specific primers 
for exon 1 and exon 12 that were used in the original cDNA amplification. A colony harbouring 
the correct recombinant plasmid should give a 1.3 kb PCR amplicon as shown on figure 4.6A 
where colony 11 was positive for the presence of ENSXETG00000009337. This positive 
colony was then grown further and the recombinant plasmid was extracted using a small scale 
plasmid purification kit (Macherey-Nagel). In order to further validate the presence of a correct 
recombinant, the plasmid was restriction digested with EcoRI. EcoRI sites flank the 
ENSXETG00000009337 insert and hence it is expected to excise it upon digestion. As seen 
on figure 4.6B, in lane 3, EcoRI successfully restricts the ENSXETG00000009337 insert out 
of the vector and the insert is in the expected size range of 1.3-1.4 kb.  
In order to resolve the ENSXETG00000009337 sequence disagreement between Ensembl and 
Xenbase databases, a sample of the ENSXETG00000009337 containing recombinant plasmid 
was sent for sequencing (Source Bioscience). A series of custom synthesized primers were 
designed in order to determine the complete ENSXETG00000009337 sequence via primer 
walking. Assembling the obtained sequencing results into a contig gave a finally determined 
full ENSXETG00000009337 cDNA sequence (appendix III). In figure 4.7 the actual observed 
sequence of the gene is aligned against that obtained from the JGI 7.1 assembly, which was 
released during this phase of the work. There were a number of short nucleotide  
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Figure 4.5 RNA extraction, test RT-PCR and gdi3 amplification. (A) Lane 1- RNA was 
extracted by the Trizol method from ten Xenopus tropicalis embryos at stage 18.  (B) Lane 1 –
no super script III negative control, Lane 2 is a positive control containing cDNA known to 
work amplified using an lmo2 primer set. Lane 3 is cDNA reverse transcribed from RNA 
extracted in (A), amplified with an lmo2 primer set. (C) Lanes 1 and 2 are negative and positive 
controls, respectively. Lanes 3 and 4 are gdi3 specific amplicons. In all panels, M corresponds 
to 2-log ladder DNA marker.  
A 
M            1 
RNA 
3 kb 
1 kb 
0.5 kb 
M        1       2        3       
B  
RT-PCR LMO 
3 kb 
1 kb 
0.5 kb 
C 
M        1       2        3       4 
RT-PCR gdi3 
3 kb 
1 kb 
0.5 kb 
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Figure 4.6 Confirmation that the gdi3 full cDNA is present within pGem-TEasy vector. 
(A) Lane 1 is a positive control containing cDNA template; Lane 2 is a negative no template 
control; Lanes 3 to 12 contain the results from PCR screening of the twelve DH5α colonies 
transformed with the putative plasmid construct (B) Lane 1 shows the uncut putative plasmid 
identified from the PCR screen, lane 2 contains single digest with XbaI to linearize the plasmid. 
Lane 3 shows a single digest with EcoRI in order to excise the 1.4 kb long gdi3. Lane M 
corresponds to 2-log DNA ladder marker. 
3 kb 
    M     1        2       3       4       5       6       7       8       9      10     11     12     13    14 
A 
3 kb 
1 kb 
0.5 kb 
M        1       2       3      
B 
3 kb 
1 kb 
0.5 kb 
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polymorphisms (SNPs) present between the two, although if this represented true biological 
variation or errors in sequencing of the genomic sequence is unclear. A major difference 
between the two sequences is that the JGI 7.1 assembly (which became available during this 
work) predicted a longer sequence, containing an extended exon 10, which is absent in the 
actual observed sequence I obtained. However, despite PCR amplification of cDNA extracted 
at a number of different developmental stages no evidence of alternative variant was found 
(data not shown). The observed and predicted ENSXETG00000009337 sequences were also 
compared on the protein sequence level, in order to evaluate the differences on translational 
level. Out of 72 SNP mutations at the DNA level, only 9 are non-synonymous and are 
translated as different amino acid (figure 4.8). In the next section using phylogenetic methods, 
the observed protein sequence of ENSXETG00000009337 will be analysed in the context of 
gdi1 and gdi2 from various species. Given these initial findings concerning the sequence 
identity of ENSXETG00000009337, this gene was putatively designated gdi3. 
 
4.3 Bioinformatic analysis of putative gdi3 
Sequencing of the human and other genomes has contributed an enormous amount of data to 
human knowledge (Grenet 2001), so much so that a new branch of science has been developed 
to process it, a field now known as bioinformatics. Bioinformatics applies the power of 
computer analysis to the large amounts of data generated by modern biological technologies. 
Bioinformatics has become a powerful tool in the last few decades and in particular it allows 
the identification of evolutionary conserved sequence motifs within gene vicinities.  
Alternatively, it can allow for the comparison of different DNA, RNA or protein sequences to 
provide structural, functional and evolutionary insight (Bentley 2000; Dunn & Ryan 2015) . 
Examples of powerful bioinformatics tools are the BLAST engine, genome browser databases 
such as NCBI, EMBL, Ensembl, Xenbase, Flybase, and ZFIN. In addition to genome databases 
and tools, there are protein databases such as RSCB, SWISS-Prot, UniProt and PDB where 
protein sequences and structures can be analysed in detail. There are increasing numbers of 
bioinformatics software tools allowing scientists to professionally annotate and study DNA, 
RNA and protein sequences and their structures and functions. For example, programs like 
SNAPGENE, Bioedit, Geneious, VectorNTI, MEGA, BioEdit 7.2.5 and FigTree 1.4.2. 
Furthermore, algorithms have been built where nucleic acid and protein interactions 
predictions can be made. Such software includes TRANSFAC, Geneious, and rVISTA. Here 
I present data collected and analysed with various bioinformatic tools using the DNA and 
protein sequences of the gdi family of genes with emphasis on Xenopus gdis.  
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Figure 4.8 Xenopus tropicalis Gdi3 observed protein sequence aligned against the Xenopus 
tropicalis JGI 7.1 Gdi3 predicted protein sequence.  Row 1 corresponds to the observed Gdi3 
protein sequence and row 2 the Gdi3 predicted protein sequence obtained from Xenbase 
genome assembly JGI 7.1 of Xenopus tropicalis. Amino acids highlighted in grey indicate 
mismatched amino acids but are physico-chemically similar. Amino acids highlighted in black 
are mismatched and possess more distinctive physicochemical properties. The black 
highlighted horizontal lines represent missing amino acid sequence. 
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4.3.1 Phylogenetic analysis of putative gdi3 
In order to perform the phylogenetic analysis and validate that gdi3 is a novel gdi gene I first 
performed an extensive BLAST search against the whole nucleotide and protein databases of 
NCBI. The results revealed that gdi3 was highly similar to observed and predicted gdi genes 
from various species across the Eucarya domain. In order to obtain a more complete evaluation 
of gdi evolution and origin gdi sequences from 36 species, across six Eucarya kingdoms are 
represented here. The gdi sequences analysed in this study were taken from various databases 
(Ensembl, NCBI, Xenbase). The genomic gdi sequences collected for most of these species 
are complete with exception of elephant shark and axolotl whose genome sequences are only 
partially complete. 
The 36 gdi sequences were aligned using ClustaW multiple sequence alignment method.The 
aligned sequences were analysed with PhyML (Phylogeny.fr platform, Dereeper. A., et al. 
2008) and a maximum likelihood phylogenetic tree was produced and is shown in figure 4.9A 
and B. The tree branching was further tested for statistical significance by Bootstrap analysis. 
A cladogram is also displayed in figure 4.9A with the Bootstrap results for each branch. In 
addition to a cladogram, the tree was also transformed so that each branch to present the 
evolutionary distance between the species (figure 4.9B), the longer the branch the more diverse 
that sequence. The phylogenetic tree of the examined gdi genes clearly shows that gdi3 is a 
novel gene and a paralogue of gdi1 and gdi2. Given these observations, it was confirmed that 
gdi3 is indeed a new paralogue in the gdi family and therefore the gdi3 designation is correct.  
A closer interpretation of the phylogenetic results is presented as a schematic in figure 4.10. 
From the phylogenetic tree, it can be seen that the appearance of gdi genes begins with the 
origin of the Eucarya domain, when the first gdi evolves, in the deep past protozoa organisms 
such as yeast, contained only a single copy of gdi. The plant kingdom also possess a single 
gdi, however in Metazoa with the emergence of deuterostome organisms more than one gdi 
gene evolved. The origin of the additional gdi3 copy coincides with a second genome 
duplication event in vertebrate evolution (2R) (Dehal & Boore 2005). Deuterostomes contain 
(at least) two gdi copies which form three distinct paralogous groups in the tree corresponding 
to gdi1, gdi2, and gdi3. The gdi3 group first emerges in the Gnathostomes (jawed vertebrates). 
Interestingly, the class Chondrichtyans (cartilaginous fish) possess a variable number of gdi 
gene copies across the class. For instance, the elephnat shark possess gdi1, gdi2, and gdi3 
while the cloudy cat shark (S.torazame) appear to have only gdi2 and the spotted catshark 
(S.canicula) contains gdi2 and gdi3. However, this observation required further analysis once 
complete genomes of these species become available. All four species representing  
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Figure 4.9 Phylogenetic analysis on the gdi genes. Rooted trees produced by using a 
Maximum-Likelyhood method using an online PhyMl analysis tool of Phylogeny.fr at 
http://www.phylogeny.fr/simple_phylogeny.cgi. The coloured sections represent the different 
paralogous gdi genes. The human CHM gene is the out-root of the tree since it belongs to the 
same family of genes as gdis. The trees were formatted using FigTree 1.4.2. (A) Bootstrap tree 
showing the statistical analysis of the most probable out-branching of each species. (B) Tree 
showing the evolutionary distance between gdi, gdi1, gdi2 and gdi3 in various species 
(Dereeper. A. et al. 2008). 
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Actinopterygians (a class of the boney fish Osteichtyans) which are used in our phylogenetic 
tree group their gdi genes into three paralogous groups corresponding to gdi1, gdi2, and gdi3. 
Sarcopterigyans are represented by coelecanths and tetrapods and Coelecanths also contain 
gdi1, gdi2, and gdi3 genes. In tetrapods gdi3 occurs only in amphibians and more specifically 
in Anuras. In the phylogenetic tree I use Axolotl (A. mexicanum) as a representative of 
Salamanders, however, I was only able to identify gdi1 and gdi2 for Axolotl, although again 
this may be a consequence of poor genomic data for the species.  
Mammals, reptiles and birds have lost gdi paralogues, in particular, birds have lost gdi1 and 
gdi3 and reptiles and mammals have lost gdi3. It is striking that the gdi3 loss coincides with 
the origin of amniotes. This phylogenetic information concerning gdi1, gdi2 and gdi3 was next 
used to analyse the synteny of the gdi family. 
 
4.3.2 Synteny of the gdi family 
Synteny is the conserved order of genes in related species arising due to their origin from a 
common ancestor. Although there may be little conservation on the larger chromosomal scale, 
the local gene order is often far more conserved. Closely related species generally have a 
highly conserved gene order, which will change over time with the process of evolution. Such 
changes are due to gene duplication events, gene loss, gene sequence divergence or 
chromosomal rearrangements. The synteny of a gene allows one to infer whether the gene is 
an orthologue or a paralogue of another gene (Pennacchio et al. 2001). In the process of 
evolution, a chromosomal region can be rearranged or recombined between chromosomes. 
Regions can be deleted or duplicated and in the process, new genes can evolve. Then these 
new genes can evolve new functions necessary for the organism’s survival. The mapping genes 
on to a genome can allow for the detection of global gene loci conservation, which can give 
evolutionary information about the origin of the gene of interest 
Gdi3 is surrounded by a set of unique genes which are not orthologous to the genes surrounding 
either gdi1 or gdi2. When analysing figure 4.11A it can be seen that gdi1 has the most divergent 
surrounding of genes and is absent in birds. Higher levels of divergence occur over long 
periods of time, which suggests that gdi1 has had more time to evolve than gdi2 or gdi3. 
However, to confirm this would require further analysis. Gdi2 is the only gdi which occurs 
across all of the species analysed in the figure and has conserved gene loci across these species 
while gdi3 is absent in birds, reptiles and mammals.  
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Figure 4.11 Organisation of the gdi family genome loci from 5` to 3 `with respect to gdi 
transcription start. In A,B and C panels pentagons represent gdi1, gdi2 and gdi3 genes, 
respectively. The ordering of the genes is indicated by shape where circles are upstream and 
squares are downstream relative to the human GDI. Empty pentagons represent a deleted gdi. 
Thickening of the outline represents a gene which is shared between the different panels. Within 
a panel the gene positions are colour coded with reference to the human arrangement. Grey 
indicates genes that are not present in the human synteny and occur only once in their respective 
panel. Red, pink, brown, dark blue, dark green and turquoise refer to genes that are also not 
present in the human synteny within a panel but occur multiple times across species at this gdi 
loci.  
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The three panels of figure 4.11A, B, C show that among the species there is presence or absence 
of distinctive genes, associated only with gdi1, gdi2 or gdi3. For example, gdi1 in all of the 
species shown is associated with ATP6AP1 and/or FAM50A. Gdi2 is always associated with 
ANKRD16 and FAM208B. There are less representative species which contain gdi3 but in 
Coelecanths and Spotted gar it is associated with slc25a20 and arih2, of these genes arih2 
appears to be always present as a gdi3 neighbouring gene. The order of the four neighbouring 
genes, two upstream and two downstream of gdi3 are conserved from Coellecanth and Spotted 
gar to amniotes but in amniotes, there is a gap corresponding to the missing gdi3 gene. This 
suggests that gdi3 was indeed lost in the process of evolution. Another observation from figure 
4.10C is that the genes further downstream from gdi3 may be absent in some species or may 
not be in a conserved order, however, they are always present in the genetic environment of 
gdi3. An example of such genes are NDUFAF3 (yellow square), impdh2 (pink square), frzb2 
(dark blue) and ttll3 (red circle) which can be seen in lizard, X. tropicalis and Zebrafish.  In 
panel B, such genes across the species associated only with gdi2 are copg2 (brown circle), 
pfkb3 (dark green circle), mest (red circle), tuba3e (dark blue square), podxl (turquoise square) 
and mkln1 (pink square). In panel A, these genes are pfkb1 (pink square), itih6 (red square) 
and dnase1l3 (dark green circle). The genes which are highlighted with a bold outline are 
shared between the gdi1, gdi2, and gdi3 panels. The observations again further validate that 
gdi3 is a novel gdi gene and support the phylogenetic interpretation of section 4.3.1. Further 
analysis on the gdi evolution and conservation in species will be performed in the next section.  
 
4.4 Gdi3 temporal expression analysis     
In order to determine the expression levels of the newly designated gdi3 during early Xenopus 
development, a RT-PCR time course was performed. Since the gdi3 cDNA sequence had been 
fully sequenced (section 4.2), specific primers (appendix II) could be designed so that they 
would span an intron, thus avoiding false positive gdi3 amplification from any residual 
genomic DNA (gDNA). Furthermore, to prevent any false positives from amplification of the 
related gdi1 and gdi2 genes the primers were designed at the 3’ end of the gdi3 sequence since 
this is the most variable region when aligned to gdi1 and gdi2. These primers were also 
analysed using BLAST against the whole Xenopus genome in order to check for any non-target 
binding to other DNA sequences. Having confirmed that the RT-PCR primers are specific for 
gdi3, I next proceeded to the experimental procedure.  
Xenopus tropicalis and Xenopus laevis embryos were collected at the following stages: stage 
2 (prior to the midblastula transition); stage 8 (blastula); stage 11 (early gastrula); stage 13 
(late gastrula); stage 16 (mid-neurula); stages 18, 19, 20, 21, 22, 23, 25 (late neurula) and 
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finally tailbud stages 30 and 41. Once total RNA was extracted, its integrity was confirmed on 
a 1% agarose gel (figure 4.12A and figure 4.13A) and then the RNA was converted to cDNA 
with reverse transcriptase. Internal reference PCR reactions were performed on the cDNA 
using Xenopus tropicalis and Xenopus laevis Ornithine DeCarboxylase (ODC) specific 
primers (appendix II) (figure 4.12B and figure 4.13B). The ODC PCR is a quality control step, 
which confirms the presence of cDNA after reverse transcription.  Also as this house keeping 
gene is expressed at constant levels throughout the various developmental stages (Sindelka et 
al. 2006) it can be used as a standard reference when evaluating unknown gene expression 
levels. ODC was successfully amplified from all the stages at a uniform intensity. After the 
ODC analysis, PCR was performed using gdi3 specific primers (appendix II) where the 
expected PCR amplicon was 210 bp for Xenopus tropicalis and 360 bp for Xenopus laevis. 
The gdi3 PCR products were separated on a 1% agarose gel (figure 4.12C and figure 4.13C).  
Both Xenopus laevis and Xenopus tropicalis gdi3 PCR products were of the expected size.  
Xenopus laevis Gdi3 mRNA is maternally present and remains constant to NF stage 16 where 
there is a dip in the equilibrium levels of Gdi3. However, there is a slow recovery of Gdi3 
transcript amounts until, at stage 41, levels have returned to those observed pre-stage 16. In 
contrast gdi3 expression in Xenopus tropicalis is only very weakly maternal and begins to 
increase from stage 13, where it rapidly increases to stable levels and stays constant across the 
examined developmental stages. After examining the gdi3 temporal expression, I proceeded 
with identifying the spatial expression pattern of gdi3 which will be described in the following 
section. 
 
4.5 Gdi3 spatial expression analysis 
In addition to the temporal expression analysis, identifying the location where a gene product 
is present may also help elucidate the potential function of an unknown gene. For example, the 
presence of the transcript in a certain type of tissue or organ can suggest a cell-type specific 
function. This information will aid the design of future experiments encompassing both 
regulation and function of gdi3. 
 
4.5.1 RT-PCR on dissected Xenopus tissues 
Firstly, the spatial expression analysis began with tissue dissections from adult Xenopus laevis 
and Xenopus tropicalis frogs. The dissected tissues (thanks to Dr. Anna Noble for assistance) 
were from brain, eyes, liver, leg muscle, intestine, heart, and kidney. Total RNA was extracted 
and converted to cDNA using reverse transcription. As in section 4.4 the quality of the cDNA 
was analysed by PCR of the ODC house keeping gene. 
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Figure 4.12 RT-PCR developmental time course of gdi3 expression in Xenopus tropicalis. 
(A) Embryos were harvested at stages 2, 8, 11, 13, 16, 18, 19, 20, 21, 22, 23, 25, 30 and 41 and 
RNA extracted. RT-PCR was performed using ODC (B) and gdi3 (C) specific primer sets. Each 
lane corresponds to an embryo stage. Lane M corresponds to 2-log DNA ladder marker. Lane 
NTC is a no PCR template control. 
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Figure 4.13 RT-PCR developmental time course of gdi3 expression in Xenopus laevis. (A) 
Embryos were harvested at stages 2, 8, 11, 13, 16, 18, 19, 20, 21, 22, 23, 25, 30 and 41 and 
RNA extracted. RT-PCR was performed using ODC (B) and gdi3 (C) specific primer sets. Each 
lane corresponds to an embryo stage. Lane M corresponds to 2-log DNA ladder marker. Lane 
NTC is a no PCR template control. 
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The amplicon was analysed by 1% agarose gel electrophoresis and the result is shown in 
figures 4.14A and 4.15A for Xenopus tropicalis and Xenopus laevis respectively. 
Subsequently, gdi3 transcript specific PCR amplification was then performed to detect which 
adult frog organs express gdi3.  The results are presented in figures 4.14B and 4.15B, again 
for tropicalis and laevis respectively. It can be seen that there is a differential tissue expression 
of gdi3 in both species of frog. In Xenopus laevis gdi3 is expressed at the highest level in the 
eye, however, a weak presence of the gdi3 transcript can be seen in lanes corresponding to 
brain, liver, muscle and intestine. There is no transcript evident in either heart or kidney. The 
expression of gdi3 in Xenopus tropicalis organs is observed at equal levels in the eye, heart 
and leg muscle but no transcript was detected in brain, liver or intestines.  
 
4.5.2 Wholemount in situ hybridization 
An alternative to dissection and RT-PCR for detecting the spatial distribution of the gdi3 
expression is in situ hybridisation methodology. This technique is more suited to the analysis 
of tadpoles, as opposed to adult frogs, and also allows for easier assaying of developmental 
stages. In situ hybridization is a technique which utilizes hybridization of labelled RNA to the 
mRNA of a gene of interest. Once the DIG-labelled probe hybridizes to the target mRNA 
within formaldehyde fixed embryos an anti-DIG antibody conjugated to alkaline phosphatase 
(AP) is added. The anti-DIG antibody binds the DIG. The AP reaction produces a blue 
precipitate within the embryo which corresponds to the spatial expression pattern of the gene 
of interest. The principle of in situ hybridization staining is shown as a schematic in figure 
4.16.  
 
4.5.3 In situ probe cloning and synthesis 
Prior to spatial expression analysis by in situ hybridisation a specific probe against the target 
mRNA needs to be designed and cloned into a vector.  A more variable region of the gdi3 
transcript was selected and was to be used as a template for a specific probe anti-sense RNA 
probe of 500 bp (appendix II), designed to hybridize only with gdi3 mRNA and not gdi1 or 
gdi2 mRNAs (figure 4.17), that this probe should also be suitable for use in Xenopus laevis 
was also a consideration. However, since gdi3 is highly conserved between the species this 
was not a significant issue (figure 4.18).  
Primers were designed (appendix II ) to synthesize a 500 bp (appendix II) region of gdi3 with 
5’ and 3’ XhoI and XbaI restriction sites respectively, to allow directional cloning. After each 
restriction site was a six base pair overhang (the clamp) to facilitate the restriction enzyme 
digestion. The selected region was amplified from the recombinant pGem-TEasy vector 
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Figure 4.14 RT-PCR showing expression of gdi3 in various tissues dissected from adult 
Xenopus tropicalis. (A) ODC control confirming successful reverse transcription. (B) Gdi3 
primers used to detect specific presence of gdi3 cDNA in the various tissue samples. Each lane 
corresponds to an examined organ. Lane M contains 1 kb+ DNA ladder. 
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Figure 4.15 RT-PCR showing expression of gdi3 in various tissues dissected from adult 
Xenopus laevis. (A) ODC control confirming successful reverse transcription. (B) Gdi3 primers 
used to detect specific presence of gdi3 cDNA in the various tissue samples. Each lane 
corresponds to an examined organ. Lane M contains 1 kb+ DNA ladder. 
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Figure 4.16 Schematic of in situ hybridization principles and probe synthesis. The in situ 
antisense and sense probe synthesis process is summarised in steps one and two (1 and 2), where 
initially the plasmid vector is linearized at the 5` or 3` end of the probe, using a restriction 
enzyme. As the probe is synthesised DIG-labelled rUTPs are incorporated into the RNA strands. 
In step three (3) the antisense or sense probes are incubated with formaldehyde fixed embryos 
in order to hybridize to the endogenous mRNA transcripts. In step four (4) the spatial location 
of the probe is detected by an anti-DIG antibody conjugated to Alkaline Phosphatase (AP). 
Once the substrate for AP is added the enzyme reaction results in a blue precipitate. This blue 
colour product indicates the location of the mRNA of interest.  
1. 
2. 
3. 
4. 
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Figure 4.17 Xenopus tropicalis gdi1, gdi2 and gdi3 alignment to select the optimal sequence 
for an in situ probe.  The blue line corresponds to the 0.5 kb section of gdi3 which was cloned 
in pBluescript in order to make the antisense and sense DIG-labelled mRNA probes. Lines 1, 2 
and 3 contain gdi1, gdi2 and gdi3, respectively. 
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Figure 4.18 Alignment of Xenopus tropicalis and Xenopus laevis gdi3 ORFs. 
Lines 1 and 2 contain Xenopus tropicalis and Xenopus laevis gdi3 open reading frames, 
respectively. The highlighted base pairs are SNPs. 
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containing the entire gdi3 cDNA, whose presence I had previously confirmed by restriction 
digest and DNA sequencing (section 4.2). The resulting PCR product (4.19A) was cloned into 
the pBluescript KS+ expression vector (appendix IV, appendix VIII). pBluescript was chosen 
as it contains both T3 and T7 RNA polymerase promoters flanking the multiple cloning site to 
allow in vitro transcription of both the required anti-sense and a sense control probe. Both the 
pBluescript plasmid and the PCR amplicon were double digested using XhoI and XbaI 
restriction enzymes. The plasmid and the probe insert were gel eluted and purified using 
phenol/chloroform extraction and ethanol precipitation, the probe sequence was then 
directionally cloned into pBluescript via a T4 DNA ligation reaction.  
The ligation mix was transformed into DH5α cells and resulting colonies screened for the 
presence of the insert by double restriction digest using XhoI and SacII. In the case of the 
presence of a successful recombinant, XhoI and SacII will excise a 0.5 kb insert, this is seen 
in lanes 6, 8 10 and 12 (figure 4.19B). The successful clones were sequenced by Source 
Bioscience to confirm the presence of the correct probe sequence. After confirmation of both 
the presence and sequence of the clone the plasmid was linearized with either KpnI or Not I 
for synthesis of the anti-sense and sense RNA probes, respectively.  In vitro transcription 
reactions were then conducted where sense and anti-sense probes were synthesised using T3 
and T7 RNA polymerases, respectively (figure 4.20). The reaction mix contained digoxygenin 
labelled uridine 5`-triphosphate (DIG-UTP) labelling mix which would incorporate modified 
UTPs into the RNA probe.  
Developmental stages of Xenopus tropicalis and Xenopus laevis embryos were fixed in order 
to be probed with the antisense in situ probe against the 0.5 kb gdi3 C-terminal end of the 
mRNA. As a control, a sense in situ probe was synthesized alongside which is not expected to 
bind the sense mRNA of gdi3. The RT-PCR temporal analysis (section 4.5.1) showed that gdi3 
is mainly expressed from mid-neurula stages onwards, therefore, the collected developmental 
stages for spatial analysis were from NF stages 16, 18, 22, 25 and 30 for Xenopus tropicalis 
and NF stages 15, 18, 25 and 28 for Xenopus laevis. The obtained results for Xenopus tropicalis 
are shown in figure 4.21 and the results obtained for Xenopus laevis are shown in figure 4.22. 
In both cases gdi3 is expressed within the neural tissues of embryos however at the later stages 
it is more clearly seen at the anterior areas of the embryos. 
  
95 
 
 
  
Figure 4.19 Cloning the 0.5 kb gdi3 in situ hybridization probe in pBluescript. (A)PCR 
amplification of the gdi3 in situ probe. Lane 1 contains negative control, lane 2 and lane 3 
contain specific in situ probe amplicon of 0.5 kb. (B)Screening by restriction digest of putative 
plasmid recombinants for presence of the gdi3 in situ probe. Lanes 1, 3, 5, 7, 9, 11 and 13 
contain the uncut putative plasmid constructs. Lanes 2, 4, 6, 8, 10, 12 and 14 contain the putative 
construct linearized with restriction endonucleases XhoI and SacII. Lane M corresponds to 2-
log DNA ladder marker.  
96 
 
 
 
  
Figure 4.20 RNA synthesis of DIG-labelled antisense and sense in situ probes. Lane 1 
contains antisense RNA probe before DNAseI digest, lane 2 contains antisense RNA probe after 
DNAseI digest, lane 3 contains sense probe before DNAseI digest, lane 4 contains sense RNA 
probe after DNAseI digest. Lane M corresponds to 2-log DNA ladder marker. The in situ probes 
shown above correspond to 510 bp of the gdi3 C-termini. 
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Figure 4.21 Wholemount in situ hybridization analysis of gdi3 spatial expression in 
Xenopus tropicalis embryos. A developmental time course of Xenopus tropicalis embryos was 
hybridized with 0.5 kb gdi3 antisense and sense DIG-labelled RNA in situ probe to examine 
the spatial expression pattern of gdi3. The analysed embryos are presented in groups according 
to their NF stages. The red arrow shows the anterior site of the embryos.  
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Figure 4.22 Wholemount in situ hybridization analysis of gdi3 spatial expression pattern in 
Xenopus laevis embryos. Xenopus laevis embryos hybridized with the 0.5 kb Gdi3 antisense and 
sense DIG-labelled RNA. The embryos shown above are at NF stages 15, 18, 25 and 28.  The red 
arrow shows the anterior of the embryo.  
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4.6 Gain of function analysis 
In developmental biology gain of function analysis is a technique used to enhance the activity 
of a protein of interest, this may be an overexpression in the cells that normally have the protein 
or an ectopic expression in cells that do not. This is an experiment which allows us to test the 
potential function of a gene by over-producing its encoded product. In Xenopus, this is done 
by injecting an mRNA encoding the protein of interest into an early stage embryo. Gain of 
function experiments in the past have shown that overproducing a gene product can be 
informative. For example, pax6 overexpression produces an ectopic eye in Drosophila and 
deletion of pax6 leads to eye malformation (Halder et al. 1995). Once an mRNA is introduced, 
its translation level can be monitored by western blot, using an antibody against the protein of 
interest. However, very often antibodies against the target protein are not commercially 
available. Therefore, an artificial small protein tag is introduced at a specific location of the 
protein sequence of interest. This small protein tag is not naturally produced by the model 
organism and can be bound by commercially available antibodies. The human Myc-tag is a 
common way of labelling proteins since the tag is only 12 amino acids long and an antibody 
is readily available, although multiple tags are often used to increase detection sensitivity. In 
our studies, Xenopus gdi3 mRNA was cloned into the pCS2-MT (appendix IV, appendix VIII) 
expression vector which contains six N-terminal Myc sequences (a total of 72 additional amino 
acids) and the protein expression of this construct was validated by Western blot analysis.  
In order to PCR amplify gdi3 for cloning into pCS2-MT vector, specific gdi3 primers 
(appendix II) were designed to contain restriction sites for XhoI and XbaI in order to provide 
directionality in the cloning. The PCR product was assayed by agarose gel electrophoresis, 
phenol chloroform purified and double digested with XhoI and XbaI. Meanwhile, the plasmid 
was also double digested with XhoI and XbaI in order to create compatible ends for the gdi3 
insert. After the double digest, both the insert and the vector were gel eluted prior to ligation 
in order to remove any residual undigested plasmid which may propagate in the plasmid 
preparation steps. The ligation reaction was transformed into competent DH5α cells and 
colonies selected for plasmid extraction, the putative plasmid clones were isolated and 
screened for the presence of the insert with a single XhoI digest and a double XhoI, SacII 
digest (figure 4.23). XbaI could not be used because of methylation of the XbaI recognition 
site in DH5α cells. Once the successful clone was identified it was purified and its sequence 
confirmed by Sanger dideoxy sequencing, performed by Source Bioscience.  
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Figure 4.23 Restriction digests to confirm that N-termini tagged Gdi3 is present within 
pCS2MT.  (A) Lanes 1, 3, 5, 7, 9, 11, 13 top gel and lanes 1, 3 and 5 bottom gel, contain the 
uncut putative plasmid constructs. Lanes 2, 4, 6, 8, 10, 12, 14 top gel and lanes 2, 4 and 6 
contain the putative construct linearized with restriction endonuclease XhoI. (B) Lane 1 shows 
the uncut putative plasmid, lane 2 contains double digest with XhoI and SacII in order to excise 
the 1.4 kb long gdi3, lane 3 shows a single digest with XhoI.  Lane M corresponds to 2-log 
DNA ladder marker. 
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As an anti-Gdi3 antibody is not available the six c-Myc-tag fusion version of the gdi3 gene 
was used in the over-expression assays. There is a commercially available antibody raised 
against c-Myc and the c-Myc epitope fused to the N-terminal region of Gdi3 would allow a 
Western blot to test for the ectopic presence of the fused myc-tagged version of the Gdi3 
protein. However, labelling proteins with tags may cause potential problems with protein 
folding and function (Chant et al. 2005). In order to have a control, an additional construct was 
sub-cloned where an untagged form of Gdi3 was produced. This construct was the wild-type 
sequence at the N-terminal but contained a short (13 aa) extension at the C-terminal, a 
consequence of the cloning strategy adopted to create an untagged form in the plasmid pCS2-
MT. If the same phenotypes were obtained with both of the N-terminally tagged and untagged 
forms it may be deduced the tag is not affecting the protein function. Once it was confirmed 
that both the tagged and untagged forms of Gdi3 were successfully cloned an in vitro 
transcription reaction was set up to produce the respective synthetic Gdi3 mRNAs. The 
produced mRNA integrity and amount were examined by agarose gel electrophoresis and UV 
spectroscopy (figure 4.24A, B, and C) prior to proceeding with microinjections into one cell 
Xenopus embryos. 
After injecting embryos separately with each of the Gdi3 mRNA versions, embryos were left 
to develop until NF stage 14, at which point ten embryos of each batch were harvested and 
analysed by Western blot. Western blot was used in order to confirm that the N-terminally 
tagged mRNAs were successfully translated. The western blot result is shown in figure 4.24D 
and shows that all concentrations of the injected N terminal tagged Gdi3 mRNA are 
successfully translated into protein.   Ensuring the functionality of these clones allowed us to 
continue with the over-expression analysis of gdi3 in Xenopus embryos. Tagged and untagged 
forms of the Gdi3 mRNAs were injected at increasing concentrations of 100 pg, 150 pg, and 
200 pg. The obtained phenotypes were photographed at NF stages 27 and 40 and the results 
are shown in figures 4.25 and 4.26, respectively. Statistics of survival rates and normal to 
abnormal ratios are shown in figure 4.27. From the results, it can be seen the two gdi3 
constructs (tagged and untagged) show very similar phenotypes. Loss of anterior structures are 
observed and the embryos exhibit anterior-posterior axis malformations whose effects can be 
seen more clearly at the later developmental stages. Having shown the effects of gain of 
function of gdi3 expression the next step was to examine the effects of loss of Gdi3 protein 
during early Xenopus development. The results obtained from the loss of function experiments 
are presented below.  
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Figure 4.24 Synthetic Gdi3 mRNA for microinjection into Xenopus laevis embryos. (A) 
Lane M 2-log ladder, Lane 2 Gdi3 mRNA after purification by G-50 spin column. (B) Lane 1 
shows mRNA transcribed with Sp6 from pCS2MT-gdi3 prior to DNAse I treatment. Lane 2 
shows the same sample after DNAseI treatment. (C) UV spectroscopic analysis was used to 
determine the mRNA concentration prior the injection. (D) Western blot confirming Myc-
tagged Gdi3 mRNA translation. Increasing amounts of the Gdi3 mRNA were injected in one 
cell stage embryos. The embryos harvested at stage 14 when total protein extract was blotted 
with anti-Myc antibody. The sizes were estimated by comparison to a pre-stained protein 
marker.  An uninjected control is shown as a control alongside.  
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Figure X. Overexpression of gdi3 mRNA in X. Laevis embryos, photographed at stage 
27. (A) Uninjected control. (B-D) Embryos injected with increasing amounts of  C-terminal 
myc tagged RNA. (E-G) Embryos injected with increasing amounts of  N-terminal myc tagged 
RNA. Embryos exhibit shortening of the A-P axis and reduction of anterior structures.
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Figure 4.25 Ov rexpression of Gdi3 m NA in Xenopus laevis embryos, photographed at 
stage 27. (A) Uninjected control. (B-D) Em ryos injected with increasing amounts of untagged 
Gdi3 mRNA. (E-G) Embryos injected with increasing amounts of N-terminal Myc tagged Gdi3 
mRNA. Embryos exhibit shortening of the A-P axis and reduction of anterior structures. 
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Figure 4.26 Overexpression of Gdi3 mRNA in Xenopus laevis embryos, photographed at 
stage 40 (A) Uninjected control. (B) Embryos injected with 100 pg of the untagged form of 
Gdi3. (C) Embryos injected with 100 pg of N-terminal tagged Gdi3 mRNA. (D) Close up of a 
common phenotype. The exhibited shortening of the A-P axis and reduction of anterior 
structures. The most severe phenotype is loss of head formation (D). 
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Figure 4.27 Graph showing survival rates and effects of gdi3 overexpression in Xenopus 
laevis. One cell embryos were injected with a range of Gdi3 mRNA concentrations and numbers 
of abnormal and normal embryos were recorded at stage 27. 
n= 308 n= 71 n= 50 n= 135 n= 71 n= 50 
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4.7 Loss of function analysis 
In order to understand the function of an unknown gene product knock-out or knock-down 
analysis is a popular approach. A gene product can be removed completely by knock-out 
methodologies, in these cases, the gene copy is eliminated at the DNA level. The other 
approach, known as knock-down, is to greatly reduce the gene expression levels. Most 
commonly this is done by preventing the specific mRNA being translated into protein. The 
knock-down approach is quicker to perform and may allow the analysis of genes whose knock-
out can be embryonic lethal. There are number of methods to generate knock-down 
phenotypes, in Xenopus studies the most common technique involves an anti-sense nucleic 
acid analogue called morpholino oligonucleotides (MOs) (reviewed by Summerton & Weller 
1997). Morpholinos for knock-down studies are usually composed of 25 analogue nucleic 
bases, where the ribose rings (pentameric sugar backbone) are replaced by morpholine rings 
(i.e. a hexameric backbone) but which still allows for Watson-Crick base pairing with the 
target mRNA (Heasman et al. 2000).The morpholine rings make the morpholinos very stable 
since it is not recognised by the endogenous nucleases that would normally digest foreign 
nucleic acids. Since morpholino knock-downs exhibit the phenotypic effects of protein 
depletion, it is quicker than the knock-out experiment and it makes a good starting point in 
gene characterization of studies. Morpholinos are designed to prevent translation of the target 
mRNA by binding to and blocking the translation start site (AUG) thus hindering the ribosome 
progression. Recently morphlinos have also been used to abrogate alternative splicing, by 
blocking spliceosome binding sites, thus inhibiting a specific splice variant or leading to non-
functional protein product. Morpholinos have been widely used in gene characterization 
studies in both Xenopus laevis and Xenopus tropicalis (Nutt et al. 2001). However, Xenopus 
laevis is allotetraploid (Hughes and Hughes, 1993) which means that a given gene could have 
up to four alleles encoding the same protein, therefore much higher concentrations of 
morpholinos may be required than in diploid model systems. In Xenopus tropicalis (which is 
diploid) the same effects may be achieved with lower morpholino concentrations since they 
have half the number of alleles. Therefore, the best way to test for a gene knock-down 
phenotype by morpholino is to test in both species.  
 
4.7.1 Injection of morpholinos and resulting phenotypes 
Firstly, a translation blocking morpholino1 (MO1) was designed against the gdi3 Xenopus 
tropicalis sequence to overlap the AUG start codon of the Gdi3 mRNA. The morpholino was 
designed and synthesized by Gene-Tools LLC (http://www.gene-tools.com). The selected 25 
bp sequence (figure 4.28) was analysed by a BLAST search against both the 
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 Xenopus tropicalis and Xenopus laevis genomes on Xenbase to confirm that the MO1 was 
specific to the gdi3 gene only.  The BLAST search gave only one hit for each species 
corresponding 100% (25 of 25 bases) to the gdi3 sequence in Xenopus tropicalis and 96% (24 
of 25 bases) to gdi3 in Xenopus laevis. In the Xenopus laevis Gdi3 MO1 sequence, there is a 
single mismatch at the eleventh base pair, in the middle of the MO1. Hence, the MO1 should 
still hybridize to the Gdi3 mRNA given the stabilising effect of the flanking sequences. Since 
there was only one hit after the BLAST in both species the MO1 should not bind any other 
mRNA and therefore, there should be no off target effects. 
 MO1 was first injected in various amounts in Xenopus laevis. Although the MO1 had a single 
mismatch to the Xenopus laevis genome, Xenopus laevis embryos are much larger and more 
robust than Xenopus tropicalis embryos. Hence are far more tolerant of injection with 
improved survival rates. In order to determine the optimum concentration to obtain a distinct 
phenotype, with sufficient survival rates, the Xenopus laevis embryos were injected at one cell 
with either 33, 42 or 84 ng of MO1 alongside a standard control MO (SC MO), this control 
morpholino was designed not to target anywhere within the Xenopus transcriptome. Some of 
the SC MO injected embryos, exhibited non-specific mild kinked-tail phenotype.  
Abnormalities in the MO1 injected batch were first detected at NF stage 27 and the percentage 
of surviving embryos, the percentage of abnormalities and the severity of abnormal phenotype 
recorded (figure 4.29). Although the abnormalities were first detected at NF stage 27 some 
embryos were allowed to grow on to stage 40, where distinct phenotypes become more 
apparent.  The chosen MO1 mass was 42 ng as this gave a clearly distinct phenotype, unlike 
33 ng where the survival rate was higher but the embryos` abnormality level was mild and it 
was difficult to draw valid conclusions. However, the 42 ng injected embryos gave a range of 
distinct phenotypes, which encompassed those seen at 33 ng, and these phenotypes were 
broken down into severity levels of mild, severe and very severe (figure 4.30 and 4.31). 
Xenopus tropicalis embryos were next injected at much lower morpholino concentrations since 
the MO1 had 100% match to the target gdi3 sequence, hence it should work more efficiently 
than in Xenopus laevis. In addition Xenopus tropicalis is a diploid species unlike Xenopus 
laevis which means that only copy of gdi3 is expressed hence a lower protein dose. The amount 
selected for Xenopus tropicalis injections was 4 and 8 ng, only 8 ng data are shown which gave 
a corresponding penetrance and severity to 42 ng MO1 injections in Xenopus laevis embryos. 
The phenotypic effect after 8 ng MO1 injections was photographed at NF stage 40 in Xenopus 
tropicalis, resulted in distinct phenotype and nearly 70% survival rate (figures 4.32 and 4.33).  
In theory, morpholinos should not cause any non-specific effects in embryos, however, there 
is always the potential for unexpected morpholino effects which may contribute to the 
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Figure 4.29 A graph showing survival rates and effects of gdi3 knock-down in Xenopus 
laevis. One cell embryos were injected with 33, 42 and 84 ng of morpholino (MO1), uninjected 
embryos and embryos injected with 42 ng of standard control morpholino (SC MO) were grown 
alongside. The results presented above were derived from 3 separate experiments and numbers 
of abnormal and normal embryos were recorded at st 27.  
n= 318  n= 86  n= 94 n= 364 n= 367 
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Figure 4.30 Knockdown of gdi3 by antisense morpholino in Xenopus laevis embryos, 
photographed at NF stage 30 (A) Embryos injected at one cell stage with 42 ng of control 
morpholino (SC MO). (B-D) Embryos injected at one cell stage with 33, 42 and 84 ng of anti-
gdi3 morpholino, respectively. (E) Embryos injected at one cell stage with 42 ng anti-gdi3 
morpholino (bottom three embryos) alongside an uninjected embryo (top embryo) to 
demonstrate loss of anterior-posterior axis. 
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Figure 4.31 Graph showing percentage embryos displaying various degrees of phenotypic 
severity levels resulting from Gdi3 knock-down.  (A) Embryos were injected at one cell stage 
with 42 ng antisense Gdi3 MO1 and grown until stage 26. Embryos were assayed for severity 
of the morphant phenotype. Embryos were categorized as normal (0), mild (1), severe (2) and 
very severe (3). (B) Description of phenotypic severity levels. 
B 
A 
113 
 
B
 
A
 
U
n
in
je
ct
ed
 c
o
n
tr
o
l 
C
 
SC
 M
O
 
Anterior 
Posterior 
D
o
rs
al
 
V
en
tr
al
 
Ey
e 
C
em
en
ta
l g
la
n
d
 
  
 
  
F
ig
u
re
 4
.3
2
 K
n
o
ck
-d
o
w
n
 o
f 
G
d
i3
 b
y
 M
O
1
 i
n
 X
en
o
p
u
s 
tr
o
p
ic
a
li
s 
em
b
ry
o
s,
 p
h
o
to
g
ra
p
h
ed
 a
t 
st
a
g
e 
4
1
. 
E
m
b
ry
o
s 
in
je
ct
ed
 a
t 
o
n
e 
ce
ll
 s
ta
g
e 
w
it
h
 
8
 n
g
 a
n
ti
-G
d
i3
 m
o
rp
h
o
li
n
o
 a
lo
n
g
si
d
e 
an
 u
n
in
je
ct
ed
 e
m
b
ry
o
 (
to
p
 e
m
b
ry
o
) 
to
 d
em
o
n
st
ra
te
 l
o
ss
 o
f 
an
te
ri
o
r-
p
o
st
er
io
r 
ax
is
. A
n
 e
m
b
ry
o
 i
n
je
ct
ed
 w
it
h
 
8
 n
g
 s
ta
n
d
ar
d
 c
o
n
tr
o
l 
m
o
rp
h
o
li
n
o
 i
s 
sh
o
w
n
 t
o
 d
em
o
n
st
ra
te
 a
n
y 
se
co
n
d
ar
y
 e
ff
ec
ts
 c
au
se
d
 b
y
 t
h
e 
m
o
le
cu
le
 i
ts
el
f.
 T
h
e 
p
ic
tu
re
s 
g
ro
u
p
ed
 i
n
 t
ri
p
li
ca
te
s 
sh
o
w
 t
h
e 
v
ar
io
u
s 
le
v
el
s 
o
f 
p
h
en
o
ty
p
ic
 s
ev
er
it
y.
 A
- 
M
il
d
, 
B
-S
ev
er
e,
 C
-v
er
y
 s
ev
er
e 
114 
 
B 
67
30
81
3
19
0
20
40
60
80
100
uninjected 8 ng
gdi3 MO1
Su
rv
iv
al
 r
at
e 
(%
)
dead (%)
Loss of A- P
axis (%)
normal (%)
0 8 11
66
0
20
40
60
80
100
0 1 2 3
Em
b
ry
o
s 
d
is
p
la
yi
n
g 
p
h
en
o
ty
p
e
 (
%
)
Severity
gdi3 8 ng
MO1
 
 
  
Figure 4.33 Survival rates and phenotypic severity levels of gdi3 knock-down in Xenopus 
tropicalis. One cell embryos were injected with 8 ng of antisense morpholino (MO1), 
uninjected embryos were cultured alongside. (A) The embryos were grown until the control 
reached NF stage 40 when the numbers of survivals were recorded. (B) The embryos were also 
assayed for the severity distribution of the morphant phenotype. Embryos were categorized as 
normal (0), mild (1), severe (2) and very severe (3).  
A 
n= 256 n= 120 
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observed abnormality. These are referred as ‘off-target effects’. In order to account for off-
target effects, a control experiment was designed. As a control, a second morpholino (MO2) 
against Gdi3 was designed and synthesized by gene-tools. MO2 was designed to be non-
overlapping and 5’ to the first morpholino (figure 4.28). However, sequence restrictions in 
variation of the promoter sequence at this location meant that MO2 was specific only to 
Xenopus tropicalis since there were more than two mis-matches against the laevis 5’ UTR. 
The resulting phenotypes of injection with MO2 should agree with the observed phenotypes 
obtained with MO in Xenopus tropicalis and Xenopus laevis. As with with the first MO the 
MO2 morpholino was also checked by a BLAST search against the Xenopus tropicalis genome 
on Xenbase, which resulted in only one, expected 100% (25 of 25 bases) hit. The 8 ng MO2 
amount was chosen for injections in Xenopus tropicalis and the various phenotypes observed 
were photographed at NF stage 40 (figure 4.34). The severity and the phenotypes correlated to 
those observed with MO1 (figure 4.35). 
 
4.7.2 Interpretation of the morpholino phenotypes  
The translation blocking function of the Gdi3 morpholinos should result in a lack of the target 
protein. This may or may not lead to a developmental abnormalities depending on a number 
of factors such as the level of redundancy of the gene and the stage of its expression and 
depending on the location and severity of these effects, the potential gdi3 function may be 
inferred. The first morpholino (MO1) was selected to work in both Xenopus tropicalis and 
Xenopus laevis and an optimal MO1 dose was chosen for Xenopus laevis and subsequently 
Xenopus tropicalis. The injected embryos displayed a consistent phenotype between the two 
species which were analysed in detail. However, as expected, the dose required for Xenopus 
tropicalis was significantly lower than that required for Xenopus laevis. In both cases, the 
phenotypic effects of the embryos were shortened AP axis and severe anterior defects and 
more specifically head size reduction (microcephaly). These effects were visible from stage 
26 onwards, Xenopus laevis morphant embryo morbidity rate increased significantly after this 
stage. Those that did survive until later stages displayed enhanced phenotypes and the affected 
tissues were more distinctive. In general, the Xenopus Xenopus tropicalis morphants exhibited 
similar phenotypes to the Xenopus laevis morphants. However, Xenopus tropicalis embryos 
were able to survive until stage 40 possibly as a consequence of a lower total injection amount, 
hence, they were photographed at that point.  
A second morpholino MO2 was used in order to control for any unpredicted off target effects 
of the morpholino technology. The MO2 was designed to target the Xenopus tropicalis Gdi3  
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Figure 4.35 Survival rates and phenotypic effects of gdi3 knock-down in Xenopus 
tropicalis with MO2. (A) One cell embryos were injected with 4 and 8 ng of gdi3 morpholino, 
uninjected embryos and embryos injected with 8 ng of control MO (SCMO) were grown 
alongside. (B) Embryos were assayed for severity of the morphant phenotype and categorized 
as normal (0), mild (1), severe (2) and very severe (3). The results presented above were derived 
from 2 separate experiments and numbers of abnormal and normal embryos were recorded at 
st 40.  
A 
B 
n= 109 n= 101 n= 221 n= 230 
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5` UTR and not Xenopus laevis, since Xenopus tropicalis are more sensitive to changes in 
protein levels hence would easier show defects after the MO2 injections. Xenopus laevis are 
allotetraploid which means that they may potentially compensate the Gdi3 dose reduction. 
However, as we have been only able to identify a single allele of gdi3 in Xenopus laevis a more 
likely reason for this observation is that gdi3 is expressed maternally in Xenopus laevis. It 
would, therefore, require higher concentrations of morpholino in order to be knocked-down. 
The injections with the second morpholino showed similar phenotypic effects to the first one 
hence, it is unlikely that I observed off target phenotypes. In order to further support the 
specific MO activity and that no off-target effects were caused by the morpholine backbone, a 
standard control morpholino was injected alongside (SCMO). The injections with the 40 ng 
SCMO in Xenopus laevis and 8 ng SCMO in Xenopus tropicalis did not cause developmental 
abnormalities, these controls taken together suggest the observed morphant phenotypes with 
MO and MO2 were most likely a consequence of a specific Gdi3 knock-down. 
4.8 Rescue of MO phenotypes  
In addition to the use of a second morpholino as confirmation of the observed phenotype, it is 
recommended in the litartaure that a rescue experiment must be used as the “gold standard” 
control for all morpholino assays (Oelgeschläger et al. 2003).  Therefore, an additional control 
experiment was performed in order to validate the specific knock-down of gdi3 by MO1 and 
MO2. Embryos were injected at one-cell stage with MO1 and at two cell stage with 100 pg, 
150 pg and 200 pg of synthetic Gdi3 mRNA (N-terminally Myc-tagged), prepared by in vitro 
transcription, to rescue the phenotype caused by the Gdi3 knock-down. In theory, if the 
morphant phenotypes are due to lack of Gdi3 protein, the reintroduced Gdi3 mRNA should 
produce replacement protein that will recover the loss. Therefore, the morphant phenotypes 
should not occur or at least the severity levels should be significantly reduced.  
As a rule morpholino, oligonucleotides can successfully block translation when hybridized to 
up to 23 bp sequence starting from the translation start site of a gene (Summerton 1999). The 
25 bp MO1 sequence used to block Gdi3 here was selected by gene-tools to hybridize and 
cover the first 23 bp of the Gdi3 coding sequence. This MO1 sequence was also designed to 
be compatible for gdi3 hybridization in both Xenopus laevis and Xenopus tropicalis.  Even 
though these 23 bp are present within the Myc-fused Gdi3 mRNA the MO1 should not cause 
blocking since the Gdi3 open reading frame (ORF) is 250 bp downstream of the the c-Myc tag 
ORF hence the 23 bp rule is not fulfilled.  
Although rescue experiments are recommended to validate morpholino phenotypes, there are 
still problems associated with them. For example, in cases where the protein function is 
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dependent on exact concentrations, unavoidable errors leading to approximation of the 
concentration of the injected mRNA can lead to phenotypic consequences (Eisen & Smith 
2008).  
A fixed morpholino concentration of 42 ng was injected at one cell stage embryos while several 
gdi3 c-Myc mRNA concentrations were injected in both cells of two cell stage embryos. The 
injected morpholino amount was selected since it gave distinct and clear phenotypes which if 
successfully rescued would show clear reduction of severity. Four different amounts of mRNA 
were injected, 100, 175, 250 and 300 pg (half into each cell of a two-cell embryo). However, 
the attempted rescue of the knock-down phenotype proved unsuccessful. Despite the co-
injection of the Gdi3 mRNA the phenotypes observed in the rescue experiments were very 
similar to those obtained with the morpholino alone injections, embryos again displayed 
microcephaly and shortening of the A-P axis (figure 4.36). The higher the mRNA co-injection 
concentration, the higher the morbidity rates were observed. These results are graphically 
presented in figure 4.37. From the graph, it can be see that the co-injections with 100 pg mRNA 
gave the only potentially rescued embryos although argueably the obtained numbers are not 
large enough to be significant.  
 
4.8 Discussion  
The results described in this chapter led to several conclusions about the novel gene 
ENSXETG0000000933. Firstly, through bioinformatic analysis, I identified the family of 
proteins (NADB Rossman superfamily, previously known as CHM/GDI superfamily) to which 
it belongs and hence it was assigned the name gdi3 by the Xenopus gene nomenclature. Gdi3 
was found to belong to a paralogous group of genes consisting of gdi1, gdi2, and gdi3 itself. 
Gdi3 is a novel gene found currently only in fish and frogs. Further to this, the actual gdi3 
cDNA sequence possessed an exonic structure which differed to the exonic structure in the 
predicted sequence on Xenbase, in our sequence exon 10 is shorter than that annotated on 
Xenbase. It is interesting to speculate why Xenopus and fish have an additional gdi gene which 
is not found in mammals. From an evolutionary perspective, there must be an explanation for 
the preservation of this gene to be only in fish and frogs. Since gdi1, gdi2 and gdi3 are highly 
similar (>72%) it could be that there are three copies of a gdi in order to accomplish efficient 
coordination of gene expression or to increase the dosage of the protein (Massé et al. 2007). 
From the synteny and phylogenetic analysis, it is clear that gdi3 is a unique gene preserved 
only in some orders of species.  
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Figure 4.36 Attempted rescue of Gdi3 knock-down by co-expression of Gdi3 mRNA.  
Embryos were injected with either 33 or 42 ng of MO at one cell stage (A and B, respectively), 
alongside embryos from the same batch were injected with 250 pg of N-terminal myc tagged 
Gdi3 mRNA alone(C). Morpholino injected embryos were rescued by co-injection of 250 pg 
mRNA at both cells of two cell stage for both 33 ng (D) and 42 ng (E) morpholino 
concentrations. 
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Figure 4.37 A graph showing survival rates of Gdi3 morpholino (MO1) rescue 
experiments in Xenopus laevis. One cell embryos were injected with 42 ng of morpholino, 
subsequently both cells of the two cell stage embryos were injected with various concentrations 
of Myc-tagged Gdi3 mRNA. Survival rates and phenotypes were recorded at st 27. Data 
represents aggregates from multiple experiments. 
n= 654 n= 539 n= 80 n= 40 n= 59 n= 44 
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Gdi1, gdi2, and gdi3 have distinctive genetic environments in terms of their surrounding genes. 
However, some of these neighbouring genes are paralogues of those at the corresponding 
position across the gdis, indicating the common origin between these gdis and their loci. The 
more diverse the genetic environment presumably the longer that particular gdi has had to 
diverge from the ancestral form. Despite this, it is not clear whether the common ancestor of 
vertebrates had the three copies where gdi3 was subsequently deleted in Agnathas but 
preserved in Gnathostomes. Gdi3 appears to be conserved until the common ancestor of 
amphibians and amniotes where it became deleted in amniotes and suborders of the 
amphibians. An alternative hypothesis could be that gdi3 evolved independently in 
Chondrichtyans, Teleosts, Coelecanths and Anura. To resolve this a wider range of species 
genomic data is required for comparison.  
 Examining the spatio-temporal expression pattern of gdi3 during early Xenopus tropicalis and 
Xenopus laevis development, showed a different temporal expression pattern between the 
Xenopus species. For instance, gdi3 in Xenopus laevis is maternally present at NF stage 2 and 
is present until stage 12, after which zygotic gdi3 is activated. Expression stays on, although 
at a slightly decreased level, for all stages analysed. However, in Xenopus tropicalis gdi3 is 
present maternally but only in very low levels until after NF stage 12, when the zygotic Gdi3 
mRNA increases and again stays on for all analysed stages. However, the in situ experiments 
demonstrated that the spatial expression pattern in embryos was mainly in the neural regions 
from NF stages 15 to 35, and was overlapping in both species.  
In adult frogs, gdi3 spatial expression was detected in the eye in both species but in Xenopus 
tropicalis it was also found in leg muscle and heart. However, given the heterogenous nature 
of the dissected material, it is impossible to comment on whether all cells or just a subset of 
the dissected cells are expressing gdi3. It is difficult to be precise on the exact transcript levels 
since the RT-PCR is a semi-quantitative method. Real Time PCR must be used to determine 
exact Gdi3 mRNA levels.  
When gdi3 is knocked-down or overexpressed, the phenotypes observed in Xenopus laevis and 
tropicalis are very similar. The main phenotypes are lack of head structures and shortening of 
the anterior-posterior axis. Rescue experiments were also attempted but were never completely 
successful, the phenotype displayed was very similar between knock-down, overexpression or 
rescued embryos. This is potentially due to a dominant-negative effect of gdi3 overexpression. 
There are several potential reasons for the similarity of the phenotypes obtained after knocking 
down or overexpressing gdi3. The primary explanation is that there is a stringent concentration 
dependence of Rab-GTPases on Gdi3, an exact concentration is required for complete Gdi3 
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function. Another possible reason is that Gid3 is competing for Rabs with other effector 
proteins. If Gdi3 concentration is excessive it will prevent GEFs, GAPs, and other effectors 
from performing their function on the Rab-GTPases.  Observing a dominant negative effect 
when introducing exogenous mRNA has also been observed in for the PacMan-
exoribonuclease in Drosophila imaginal discs (Woldron et al. 2015). Another example is 
observed in studies of G-protein coupled receptors, where mutations in the G-protein α-subunit 
can result in dominant negative effects. In these studies, it was shown that these mutants 
competed with the wild-type α-subunit for binding to other proteins involved in the G-protein 
cycle and thus preventing or reducing the signal produced by the wild-type α-subunit 
(reviewed by Barren B. and Artemyev N. O. 2007). 
In summary, gdi3 has distinct but overlapping expression patterns in Xenopus laevis and 
Xenopus tropicalis, in particular, it is neural during early development. Both loss and gain of 
function experiments produce severe anterior and axial defects in embryos, strongly suggesting 
that the specific levels of Gdi3 are critical for normal development.  
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Chapter 5: Gdi3 promoter analysis by reporter assays 
5.1 Background: Reporter gene assays 
Cell communication events in multicellular organisms are regulated by a number of signalling 
proteins. These signals act on the receiving cell and are transduced to the nucleus where 
changes are driven on genetic (i.e. transcriptomic) level, these transcriptomic changes are 
governed by transcription factors. Transcription factors bind cis-acting elements associated 
with gene activity. These cis-elements can be difficult to identify since they are diverse and 
have variable locations from the transcription start site (Bulger & Groudine 2011). In order to 
identify the cis-acting elements and characterise their function, they are often experimentally 
validated by using them to drive a reporter gene which encodes a non-endogenous protein, the 
expression of which can be easily detected. These types of experimental systems are known as 
reporter gene assays and they utilise a wide range of different reporter genes. For example, 
fluorescent proteins encoded by gene reporters that emit in the visible or UV regions of the 
spectrum. In general, a DNA sequence of interest with putative response elements is cloned 
upstream (5`) of a reporter gene and this construct is then introduced into either a live cell or 
lysate.  Depending on the levels and/or the pattern of expression the studied element can, 
therefore, be categorized.  
An important factor when designing a reporter gene experiment is the length of the putative 
construct which then can be cloned into a plasmid. Basal promoters are generally within 500 
bp of the TSS, however, enhancers may be many hundreds or even thousands of base pairs 
away (Miele & Dekker 2008; Bulger & Groudine 2010)  and may also contribute considerably 
to expression levels. Other parameters to consider are the sensitivity of the reporter gene, the 
requirement for a substrate and also the stability of the final reporter protein. In cases where 
the cis-acting elements are already characterized it is also possible to test the effects of drugs 
or transcription factors on the activity of the promoter. Selection of the correct reporter gene 
assay, therefore, depends on a number of criteria which can be summarized as: 
1. Is spatial and intensity information required or just intensity?  
2. What is the size of promoter element to be tested? 
3. What is the expected levels of signal?  i.e. how sensitive should the detecting device 
be set.  
In chapter 3 I described the initial characterisation of five putative Xenopus promoters while 
in chapter 4 I undertook a more extensive analysis of the downstream gene of one of these 
(gdi3). In this chapter, I return to the promoter of gdi3 and describe the analysis of the gdi3 
promoter by two different gene reporter systems, the luciferase assay, and I-SceI transgenesis. 
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5.2 The luciferase reporter gene assay 
This assay was performed in order to characterize the minimum promoter sequence required 
to regulate gene expression. The Promega dual luciferase system is a commercial kit that 
facilitates luciferase reporter gene analysis of promoters. Luciferase assays were performed 
with two different reporter plasmids. These plasmids were pGL4.10 and pGL3.enh, which are 
commercial plasmids (Promega), designed to study promoter activity in a range of host cells. 
These vectors differ in the pGL3.enh containing a general enhancer SV40 element that is 
absent in pGL4.10. This allows compensation for promoters whose activity is very low in the 
absence of their cognate enhancers, and therefore signal may be below the detection threshold. 
A particular advantage of the luciferase assay is that it allows for an estimation of the relative 
strength of different promoters of different lengths. The expression levels can be accurately 
quantified as the strength of the putative promoter driving a firefly luciferase reporter is 
normalised to a reference promoter thymidine kinase (TK) which is on a co-injected plasmid 
driving the Renilla luciferase.  
The Promega dual luciferase assay also has the advantage of being a relatively quick assay. It 
takes only a week to perform, in comparison to the transgenesis, described later in this chapter, 
where the analysis can last for more than a year. However, a downside of this assay is the lack 
of spatial expression information, which can be obtained from transgenic procedures. 
Moreover, in transgenesis an integration of the putative promoter construct occurs into the 
genome, hence it is replicated and the expression of the reporter gene is maintained across the 
cell generations. In the luciferase assay the plasmid is not integrated, although it is 
chromatinised (Reeves et al. 1985), and therefore over a series of cell division the plasmid will 
become diluted per cell. In general, the Promega Dual luciferase is a quick assay and is ideal 
for the measurement of the relative activities of a series of promoter constructs.  
 
5.2.1 Cloning into the pGL4.10 and pGL3.enh 
Three different putative gdi3 promoter constructs were analysed. They were 246 bp (small), 
472 bp (medium) and 667 bp (large) upstream of the gdi3 translation start site (figure 5.1 A). 
They were initially cloned into pGL4.10 (by V. Runfola) and the resultant recombinant 
plasmids designated pGL4.10-S (small insert); pGL4.10-M (medium insert); pGL4.10-L 
(large insert). The constructs were then sub-cloned into pGL3.enh vector, which in contrast to 
pGL4.10 provides a promiscuous SV40 enhancer. The three different length inserts were 
directly sub-cloned into pGL3.enh using the restriction endonucleases HindIII and SacI 
(cloning strategy shown in appendix VIII). The two different enzymes produce non-compatible 
sticky ends which allowed for directional cloning of the inserts. Although the multiple 
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Figure 5.1 Sub-cloning the gdi3 promoter constructs into pGL3.enh vector. (A) Schematic 
representing the small, medium and large promoter constructs. The ATG start site is indicated 
by short black lines, green lines indicate the A-form DNA region and yellow the CCAAT (both 
direct and indirect) sequences. (B) The three excised promoter constructs (Small 246bp; 
Medium 472 bp; Large 667bp) analysed on a 1% agarose gel before ligation into pGL3.enh. 
(C) Screening for correct pGL3.enh recombinant with HindIII and SacI for the presence of the 
large promoter construct.  
  M        1         2         3                        
B 
    M     1        2      3      4        5              
C 
246 bp Small  
472 bp Medium  
667 bp Large  
TSS 
128 bp 
354 bp 
549 bp 118 bp 
118 bp 
118 bp 
A 
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cloning sites on the plasmids contained more than two restriction enzyme sites HindIII and 
SacI were chosen as they allowed the minimum amount of non-promoter sequence to be 
included. Once the pGL4.10 DNA was digested the reaction was loaded on a 1% agarose gel 
and the excised inserts were gel eluted for maximum purity. The pGL3.enh was also digested 
with the same set of restriction enzymes and the final step was the ligation of the inserts into 
the pGL3.enh plasmid. The ligation was transformed into DH5α and colonies were screened 
for the presence of the correct recombinant by digestion with HindIII and SacI (figure 5.1B 
and C). Identified clones were then fully sequenced prior to use. 
  Once sub-cloned into pGL3.enh, the new constructs were designated pGL3.enh-S (small 
insert); pGL3.enh-M (medium insert); pGL3.enh-L (large insert). Non-recombinant pGL4.10 
and pGL3.enh was injected alongside these plasmids as a negative control. As a positive 
control, the minimal regulatory element of the previously characterised gata2 promoter cloned 
into pGL4.10 and was injected.    
 
5.2.2 Microinjection and expression analysis 
Previous work (Llewellyn K. J. 2009., personal communication) has shown that the variable 
degree of supercoiling of the Promega Dual-Glo plasmids obtained from standard Qiagen 
purification kits can lead to a corresponding variation in levels of gene expression. Therefore 
prior to injection, all plasmids were linearised with BamHI to improve the consistency of the 
results. One-cell Xenopus laevis embryos were injected with 200 pg (200 fmol) of DNA (in a 
9 to 1 ratio of firefly to renilla luciferase containing plasmids) in a total volume of 4 nl per 
embryo, cultured and harvested at stage 18. The data collected from the luciferase assay (figure 
5.2) show that none of the promoter constructs were able to drive luciferase gene expression 
since the expression of the reporter gene is insignificant compared to the gata2 positive control. 
This suggests that extra cis-acting elements are required for the reporter gene to be expressed.  
 
5.3 Transgenesis as a tool for reporter gene assays 
The term transgenic was first introduced in 1981 by John Gordon and Frank Ruddle when they 
successfully inserted external genetic material into the genome of fertilized mouse eggs 
(Gordon & Ruddle 1981). Since then transgenesis has evolved into a widely used method 
across a number of species for both commercial and academic purposes. Examples include the 
“spider goat” for spider silk production in goat milk and golden rice, which is fortified for the 
precursor to vitamin A (Tang et al. 2009; Williams D. 2003). The first transgenic frog was 
made in 1984 by Laurence Etkin when he introduced, via microinjection, DNA constructs into 
one cell Xenopus laevis embryos (Etkin Ld et al. 1984).     
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Figure 5.2 Luciferase reporter gene expression levels driven by gdi3 deletion promoter 
constructs. Results were obtained after microinjecting one cell stage Xenopus laevis embryos 
with a mixture of 200 fmol plasmid constructs and 50 fmol TK/Renilla control plasmid. 
Embryos were grown until stage 18 prior to examining their lysates for luciferase expression in 
a luminometer. Firefly and Renilla luciferase activities are measured in relative light units 
(RLU) and the ration Firefly/Renilla is presented on the graph. In red are the results obtained 
after injecting embryos with pGL4.10 plasmid constructs. The gata2 minimal promoter in 
pGL4.10 was used as a positive control. The blue bars represent the results obtained after 
injecting embryos with pGL3.enh plasmid constructs. pGL3.enh contains an extra controlling 
element- Simian virus enhancer element 40 (SV40) in order to enhance gene expression.  
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Various constructs (including the sea urchin pSp102 gene and the Drosphilia adh gene) were 
injected as linear pieces of DNA or circular DNA. Following the injections, they traced the 
fate of either linearised genes or circular plasmid constructs. They discovered that circular 
plasmids were integrated into the embryo genome less often than the linearised genetic 
material e.g. 10-30% and 60-70%, respectively.  The main problem with the method at that 
time was the highly mosaic expression pattern, where the plasmid was integrated into the 
genomes of only patches of cells. The reporter genes were also expressed at incorrect locations, 
suggesting gene mis-regulation due to positional epigenetic influence (Etkin Ld et al. 1984). 
However, since this Xenopus transgenesis has undergone extensive development and 
successful examples include the introduction of the Gal4/UAS system (Hartley et al. 2002), 
ubiquitous expression of GFP (Kroll & Amaya 1996) and specific eye expression under control 
of the γ-crystallin (Smolich et al. 1993). 
 
5.3.1 Transposons, REMI, and I-SceI 
Labelling specific cell types, and the subsequent establishment of transgenic lines, through the 
incorporation of foreign DNA into the germ-line of a species can be currently done in several 
ways. The first of these utilises the genomic insertional potential of transposons. There are a 
number of transposon-based systems such as sleeping beauty, frog prince, piggy bac and Tol2 
(Kawakami 2007). Transposons are composed of a gene encoding a transposase and 
transposase target flanking sequences which allow for self-excision from the genome. This 
natural mechanism has been modified into an artificial method for generating transgenic 
organisms. A desired DNA construct is designed so that the DNA to be introduced is flanked 
by transposase flanking regions, an additional mRNA encoding the transposase is injected 
alongside the DNA construct. This mRNA is translated and the transposase enzyme excises 
the transposon DNA construct which is then inserted into the host organism genome. However, 
transgenesis rates remain low, insert size is limited and the use of transposons poses a possible 
risks to the researchers` health.  
The second method that has been developed is the restriction enzyme-mediated integration 
(REMI). This method was first developed by Enrique Amaya (Kroll & Amaya 1996) and 
involves a modified sperm nuclear transplantation technique into frog eggs. A simpler method 
was developed by Sparrow et al. 2000, where the requirement for sperm decondensation and 
the co-injection of a restriction enzyme was removed. However, REMI is a technically 
demanding technique and is associated with poor survival rates of less than 10%. 
The third method for creating transgenic frogs is the utilisation of restriction meganuclease I-
SceI. Unlike in the transposon method, I-SceI method is not restricted by the DNA insert size 
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encoded in between the restriction sites. Another I-SceI advantage is that it has higher survival 
rates of embryos than REMI, as it is less invasive to the putative transgenic frog embryo. 
Therefore, given these considerations, it was decided to apply the I-SceI methodology in the 
making a gdi3 reporter transgenic Xenopus.  
 
5.3.2 The I-SceI technique and the pGateway system  
In order to produce a transgenic frog using the I-SceI technique, one-cell stage embryos are 
injected with an expression clone (figure 5.3) containing the putative promoter and reporter 
gene. This construct must also contain a selectable marker driven by a well characterized 
species compatible promoter, therefore, key to the I-SceI transgenesis protocol is the assembly 
of the injectable construct. In the I-Sce,I published protocol, which was adopted, the cloning 
of the plasmid construct to be injected is produced via a recombinase based approach. This 
process involves four vectors, each of which carries one of the modules (such as the putative 
promoter or a GFP reporter) that will build the cassette. These vectors are based upon the 
pGateway plasmids and are known collectively as the pTransgenesis system (Hartley et al. 
2000; Love et al. 2011). The pGateway system is a modular system and is transferable between 
different species such as Drosophila, Zebrafish, Xenopus and mammalian cells. The four 
vectors corresponding to the four required modules used in this system have been designated 
as p1 which is a selectable marker; p2 which carries a putative promoter; p3 containing the 
reporter gene and p4 is the vector that carries the elements required for recombination (table 
5.1). An interesting aspect of the pTransgenesis vectors is the inclusion of the ccdB gene in 
the vectors. This gene encodes a gyrase inhibitor that is toxic to most E. coli strains, however, 
successful recombination removes this gene from the plasmid. Therefore, only successful 
recombinants will be able to grow, drastically reducing background.    
Initially, the PCR amplified putative promoter construct is cloned into p2 entry vector using 
BP Clonase® II which catalyses the recombination event. Entry vectors p1 and p3 had already 
been produced and kindly supplied by Dr. Ania Noble. Vectors p1, p2, and p3 have to be 
recombined with p4 in the presence of LR Clonase® II in order to produce the final expression 
clone (figure 5.4). The final expression clone will contain a module consisting of γ- crystallin 
promoter driving Katushka expression, adjacent to the putative regulatory element of interest 
associated with GFP. In the final expression clone, these modules will be adjacent to a SAR-
CH4 insulator and flanked by I-SceI meganuclease sites. If the transgenesis is successful, the 
frog`s eyes will glow green as γ- crystallin promoter will drive GFP expression specifically in 
the frog eye lens. If the putative regulatory element is functional, it will drive Katushka 
expression and therefore, red fluorescence will be detected using a fluorescent microscope. 
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Figure 5.3 Outline of the I-SceI transgenic procedure. A mix of I-SceI and an expression 
clone is injected into one-cell Xenopus laevis embryos. The expression vector carries internal 
control modules. These include flanking I-SceI restriction sites and 5’ and 3’ insulator (SAR-
cHS4). A γ-crystallin promoter driving a GFP reporter gene (indicated in green) is used as a 
marker for later identification of successful transgenics. A second set of modules within the 
expression clone consists of the putative promoter to be tested (dark blue) and a second reporter 
gene Katushka (red). Depending on the properties of the putative promoter, red fluorescence 
may be observed at developmental stages. 
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pTransgenesis 
plasmid name 
Cassette modules 
p1 γ-crystallin promoter/ GFP coding region 
p2 Putative promoter 
p3 Coding region Katushka 
p4 I-SceI sites; Tol2 sites; SAR- cHS4 insulators 
Table 5.1 pGateway plasmids used to create the transgenic Xenopus. List of the plasmids 
used in the recombination process and their associated modules. The I-SceI sites were used in 
this process. 
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Figure 5.4 MultiSite gateway 3-fragment recombination reaction. An overview of the 
pGateway cloning procedure where the first step is PCR-amplification of a putative promoter 
construct to be recombined with the pDONR vector. The resulting new plasmid designated entry 
clone p2 (putative promoter) is recombined with p1 (Ү-crystallin/GFP), p3 (Katushka), and 
destination vector p4 in order to produce the expression vector. The crossed lines represent 
recombination events between the designated att-sites and segments B1, B2, B3 and B4 
represent the positions of the resulting recombination sites. The selected recombination att-sites 
in all of the plasmids guarantee the specific order of the cassette elements.  
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5.3.3 Selecting the promoter region 
Prior to starting the transgenic procedure, the length of the putative promoter to be used must 
be decided. In the luciferase analysis described earlier, there were three constructs, where the 
longest was 667 bp. However, since this length did not drive luciferase expression it was 
decided that a longer construct might provide any missing regulatory elements. Therefore, a 
2820 bp construct was selected, this included 88 bp of exon 1 (consisting 50 bp of the 5’ UTR 
and 38 bp of the coding sequence) and an extended further sequence upstream -2732 bp from 
the transcription start site. This selected region was analysed with the bioinformatic programs 
Geneious and APTE in order to identify putative regulatory elements and also to predict TF 
binding sites. Although at the time of the experiment only the Xenopus tropicalis sequence 
was available subsequently the Xenopus laevis sequence of this region has become available. 
However, here only the Xenopus tropicalis sequence is considered, figure 5.5 shows the 
selected region containing the putative gdi3 promoter sequence. 
The next step was to screen a fosmid library containing the Xenopus tropicalis genome 
sequence. A fosmid is a single copy number plasmid that is widely used for genomic libraries 
as it is capable of containing stable inserts of up to 40 kb. The Xenopus tropicalis fosmid 
library genomic sequence data is stored on Xenbase (http://www.xenbase.org/) while the 
physical plasmids are held at the EXRC in Portsmouth, where each fosmid is held as an isolate 
which can be identified by a reference tag. Since I had already obtained the gdi3 coding 
sequence this was used to BLAST against the Xenopus tropicalis genome assembly JGI 4.1 on 
Xenbase. The corresponding hit to gdi3 also displayed those fosmids containing the gdi3 
genomic sequence. One of those fosmids (ASHY9083) also contained a long enough stretch 
of genomic DNA spanning both upstream and downstream of gdi3. This fosmid was selected 
and the appropriate plasmid obtained from the EXRC. Once the fosmid 
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clone was obtained a high purity stock was prepared by standard Qiagen plasmid purification. 
Primers (appendix II) were then designed in order to amplify the upstream genomic region that 
would be analysed using the I-Sce-I transgenesis method.  
 
5.3.4 PCR and Cloning of the putative promoter constructs 
The PCR primers (appendix II) contained recombination sites which will allow for subsequent 
recombination of the PCR product into p2 entry vector. The optimal PCR conditions including 
the primer annealing temperature was first determined by a gradient PCR across the range of 
58 ̊ C to 66 ̊ C (data not shown). The final conditions required to amplify the 2.8 kb promoter 
fragment was 62.4 ̊ C Tm, 2 mM MgCl2 and 50 ng fosmid DNA template.  Due to the large 
size of the fragment the Taq Polymerase extension time was set to be 7 min for 35 PCR cycles. 
Once the putative regulatory fragment was amplified and purified by gel elution the quality 
and quantity of the DNA product was analysed by 1% agarose gel (figure 5.6A). The next step 
was to clone the prepared PCR product into the p2 entry vector using BP Clonase® II. The BP 
recombination reaction was set up by mixing BP Clonase® II, p2 entry vector and the 2.8 kb 
gdi3 putative regulatory element. The BP reaction mix was then transformed in competent 
bacterial cells. Figure 5.6B shows the screening of a three putative recombinants by restriction 
digest with PvuII. This restriction enzyme was chosen as there are three restriction sites within 
the putative recombinant vector and when cut the expected fragment sizes were 1.9 kb, 1.8 kb, 
1.5 kb while restriction digest of the non-recombinant would give rise to fragments of sizes 
2.2 kb, 1.9 kb and 0.6 kb. The expected fragment sizes of a successful recombinant were seen 
in two of the clones shown (lanes 4 and 6). In Lane 2 a PvuII restriction digest of the non-
recombinant p2 is shown for comparison. One of the successful recombinants was selected 
and purified by Qiagen medium scale plasmid purification kit and fully sequenced by Sanger 
dideoxy sequencing. Only two mismatches against the published sequence were identified at 
positions -704 (G to A) and -941 (C to T). This clone was then used in a recombination reaction 
with p1, p3 and p4 vectors in the presence of LR Clonase® II. Putative final recombinants 
were screened with either EcoRI or I-SceI restriction enzymes and the reactions were analysed 
by 1% agarose gel (figure 5.7). EcoRI has three recognition sites within the putative p4 
recombinant hence the expected fragment sizes after a digest were 7.3 kb, 4.5 and 3.9 kb kb. 
However, EcoRI has only two restriction sites within the non-recombinant p4 and the two 
expected fragment sizes were 7.4 kb and 2.6 kb. Two bacterial colonies were obtained after 
transformation with the LR reaction mix and only one putative recombinant gave correct size 
products shown in lane 4. A restriction digest of non-recombinant p4 is shown for comparison.  
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Figure 5.6 Initial PCR of the 2.8 kb upstream promoter and confirmation of successful 
recombinants in the pDonr221 vector. (A) Lane 1 contains specific amplicons of the Gdi3 
2.8 kb putative promoter amplified from genome DNA. Lane M contains a 2-log ladder. (B) 
PvuII restriction digest of non-recombinant and putative recombinant plasmids. Lane 1 contains 
uncut non-recombinant p2, lane 2 cut p2, lane 3 uncut clone 1, lane 4 cut clone 1, lane 5 uncut 
clone 2, lane 6 cut clone 2, lane 7 uncut clone 3, lane 8 cut clone 3. Lane M corresponds to 1 
kb DNA ladder marker.  
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Figure 5.7 Confirmation of successful cloning of p2 containing gdi3 2.8 kb promoter 
construct in destination vector p4. (A) Lane 1 contains uncut wild-type p4, Lane 2 EcoRI 
restriction digest of p4, Lane 3 uncut putative clone 1, Lane 4 clone 1 cut with EcoRI, Lane 5 
uncut clone 2, Lane 6 cut with EcoRI (B) Lane 1 I-SceI restriction digest of pDest_2.5_gdi3 
Lane M is a 1 kb DNA ladder 
A 
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5.3.5 Microinjection of the transgene and the F0 generation 
Prior to beginning the injections of the p4 recombinant DNA, it was important to purify the 
Qiagen purified plasmid with an additional two phenol/chloroform extractions (personal 
communication with Peter Coxhead) as the purity of the injected nucleic acid can have a 
significant effect on the mortality rate. The next step was to adjust the final concentration of 
the p4 DNA working stock to 100 ng/μl. Once this was done an I-SceI restriction digest of the 
recombinant p4 plasmid was set up 5 minutes before fertilization of the eggs. An important 
factor for success of the transgenesis procedure is full activity of the I-SceI enzyme, therefore, 
the I-SceI enzyme was stored in aliquots at -80 ̊ C prior to use. As a general observation higher 
numbers of successful transgenic embryos coincided with quality of both the plasmid and the 
I-SceI enzyme. After 15 minutes post fertilization the eggs were de-jellied and immediately 
injected with 5 nl of 100 ng/μl I-SceI restriction digest mix correlating to 500 pg of p4 
recombinant per embryo. The promptness of the procedure was critical in order to reduce the 
number of mosaic, transgenic embryos, since once the embryos begin the first cell division the 
insert may become isolated to only one of the two cells.  
Once injected the embryos were allowed to recover at 12 ̊ C and from stage 18 onwards were 
periodically observed for any red fluorescence. However, no red fluorescence was observed at 
any developmental stage, although the presence of an intact p4 construct was confirmed by 
PCR (figure 5.8A).  At the later stages, once the lens was formed, GFP expression in the eye 
was used to select transgenic tadpoles since GFP expression was under control of the lens 
specific promoter γ-crystallin (figure 5.8B). Selected tadpoles with two green eyes were 
allowed to develop to adult frogs for breeding for the F1 generation, numbers of F0 transgenics 
displaying green eyes is shown in table 5.2A.  
 
5.3.6 The F1 generation  
Analysis of the F0 generation is problematic due to a number of factors such as mosaicism 
(where not all cells of the transgenic contain the transgene), copy number and position insertion 
in the genome. Many of these issues can be resolved by outbreeding for the F1 generation. The 
outbreeding was set up between a transgenic female/male frog (as identified by green eyes) 
and a wild type female/male frog. The transmission pattern of the transgene cassette into the 
F1 generation allows for evaluation of the insertion status and also genetic consistency 
(homogeneity) among the embryos. This is because only a single F0 haploid germ line cell 
from each mosaic parent can transmit genetic material, thus giving a homogeneous generation 
at the F1, which can be analysed with further experiments. The ratio of the tadpoles with green  
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Figure 5.8 F0 transgenic tadpoles and PCR screening for cassette insertion in the genome 
of two transgenic Xenopus. (A) F0 embryos grown to stage 45 display GFP expression in the 
eye, a non-expressing tadpole from the same batch is shown alongside. (B) A schematic of the 
transgene cassette as expected to be inserted in the frog genome with three selected PCR primer 
sets used for screening. Primer set 1 is indicated as FW1 and RV1; primer set 2 –FW2 and RV2; 
primer set 3 –FW3 and RV 3. (C) Screening of two female frogs for the presence of the cassette 
components using primer set 1 and primer set 2. Lane 1 NTC, lane 2 an amplicon obtained with 
primer set 1 from female 3 gDNA; lane 3 an amplicon obtained with primer set 2 from female 
3 gDNA. Lane 4 and lane 5 shows screening of female 5 gDNA using primer set 1 and 2, 
respectively. (D) Screening for the presence of the Katushka transgene in extracted genomic 
DNA from F0 frogs: female 3 and 5. Lane 1 contains NTC, lane 2 and lane 3 show the PCR 
result using primer set 3 on female 3 gDNA and female 5 gDNA respectively. 
A 
eyes 
142 
 
 
  
A 
B 
Table 5.2 Transgene expression analysis in F0 and F1 generations. 
(A) Transgene insertion efficiency in the genome of F0 Xenopus embryos and observed reporter 
gene expression. (B) F0 adult frogs analysed and bred to F1. In column 1 are is the designation 
of each frog. Column 2 shows the success of the transgene transmission to F1. Column 3 shows 
the GFP expression intensity of the F0 frog eyes, the eyes are shown as green circles. Column 
4 shows whether Katushka expression was detected.  
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eyes to the tadpoles with no green eyes gives information about the copy number of the insert 
(Pan et al. 2006). The interference of neighbouring genetic elements to the integration of the 
transgene has been restricted via the introduction of insulator sequences on both sides of the 
transgene cassette. Despite the presence of these insulator elements, the transgene may still be 
affected by the chromatin environment in which it finds itself giving variability across F0 
generation but the insertion is stabilised in the F1 generation. Therefore, analysis of the F1 
generation is preferable to the bulk analysis of the F0 offspring.  
From the twelve F0 frogs analysed only one transmitted the transgene cassette, as identified 
by green eyes in the F1 screening (table 5.2B). Only the most intense GFP-expressing F0 frog 
(female 3) transmitted to the F1 generation. However, this was at a high germline transmission 
rate of 50%. A 50% transmission is indicative of a single insertion event of the transgene, 
although it is not necessarily related to the insert copy number i.e. the insert may be 
concatemerized at a single insertion site (Pan et al. 2006). To overcome this the I-SceI 
technology is designed to prevent concatamer formation, therefore, I can expect a single insert 
copy number at a single insertion site. In cases when the transmission rate is higher than 50%, 
it is indicative of multiple insertions sites within the genome of the founder germline. Although 
again these rates correspond to the insertion site number, not the insert copy number.  
Transmission rates are lower than 50% indicates mosaicism in the germ line of the F0 
generation (Pan et al. 2006).   
Although F1 tadpoles descended from female 3 expressed strong GFP (figure 5.9A, B), no 
Katushka fluorescence was detected at any stages. In an attempt to increase sensitivity for 
Katushka expression, the RNA from stage 18 embryos (one of the previously identified stages 
at which the promoter was active) was extracted for RT-PCR analysis. Figure 5.9F shows that 
no Katushka mRNA could be detected even by this more sensitive method. 
   
5.4 Discussion 
In this chapter, I describe the analysis of various lengths of the putative gdi3 promoter using 
both the Promega dual luciferase assay and I-SceI transgenesis. First, three different lengths 
(246 bp, 472 bp, and 667 bp) of the gdi3 putative promoter constructs were cloned into the 
pGL4.10 vector and also into pGL3.enh, which includes a promiscuous enhancer element. The 
667 bp construct contains multiple upstream CCAAT motifs and an A-form DNA element. 
The medium sized construct of 472 bp contains only one CCAAT motif and an A-form DNA 
element. While the smallest construct of 246 bp contains only a single CCAAT motif and no 
A-form element.   
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Figure 5.9 F1 tadpoles obtained from two different females, female 3 and female 5, display 
GFP expression in the eye however RT-PCR showed no Katushka expression. (A and B) 
GFP expression is visible in the lens by fluorescent microscopy. (C) Light microscopy image 
of the tadpole shown in (B). (D) RNA extracted from F1 embryos collected at NF stage 18 from 
females 3 (lane 1) and 5 (lane 2). (E and F) RNA was reverse transcribed and tested for the 
presence of ODC and Katushka (lanes 2 and 3 respectively), lane 1 is a NTC negative control. 
Lane 4 in panel F is a positive PCR control for Katushka. 
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It has been previously shown in vitro that a combination of the CCAAT box and an A-form 
element together are required for correct gene expression levels. Furthermore, as seen in 
EMSA studies from chapter 3 (section 3.4.1), the transcription factor Ilf3 is able to supershift 
a putative partial promoter sequence containing these elements. Ilf3 which is part of the CBTF 
complex has been previously shown to interact with DNA with A-form propensity (Scarlett et 
al. 2004). 
Using the Promega dual luciferase assay the activity of these putative promoter constructs was 
measured from total protein extract of injected Xenopus laevis embryos. The results showed 
that none of the three different putative promoter constructs were able to drive the luciferase 
reporter gene, either with or without the presence of a promiscuous enhancer. These results are 
supported by the positive control where the well characterized basal gata2 promoter 
successfully drove reporter gene expression. It could be that the putative promoter constructs 
lack additional controlling elements required for transcriptional activity. Alternatively, as the 
injected plasmid constructs into the one cell embryo are episomal, and possibly not properly 
chromatinised, potentially required epigenetic modifications could not be established. A third 
possibility is species incompatibility of the Xenopus tropicalis putative promoter constructs 
with the Xenopus laevis transcriptional control mechanisms.   
Firstly, to tackle the lack of upstream controlling elements, the putative promoter construct 
length was increased to 2.8 kb upstream of the translation start site of the gdi3 coding sequence, 
including approximately 50 bases of the first exon. Secondly, this construct was cloned into a 
plasmid which, through I-SceI transgenesis, could be introduced into the genomes of Xenopus 
laevis embryos. The use of transgenic frogs, since its first published reports nearly twenty 
years ago (Kroll & Amaya 1996), has provided a powerful tool for the study of promoter 
activity. Since transgenesis provides the advantage of being truly in vivo it should put the 
putative promoter construct in the context of a true epigenetic environment. The construct to 
be introduced into the Xenopus laevis genome contained a positive control of γ-crystallin GFP, 
where in the case of successful construct integration within the genome the embryo`s eyes will 
fluoresce green. Part of the construct includes the putative promoter sequence driving the 
Katushka reporter gene. Although the presence of GFP expression in the eye indicated the 
successful cassette insertion into the frog genome this was further confirmed by PCR analysis, 
therefore demonstrating there were no extra recombination events internally to the construct 
post integration.  
Katushka red fluorescence should be observed at the gdi3 expression stages. However, after 
the transgenic F0 Xenopus laevis were produced the putative promoter activity was examined 
at a number of developmental stages and no Katushka expression was observed.   In order to 
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be sure that this is not due to mosaicism the F0 frogs were grown and outbred with wild-type 
frogs and the F1 generation was also examined for GFP and Katushka fluorescence. In the F1 
generation, the same result was observed, GFP expression in the eye was seen in 50% of the 
F1 generation (figure 5.9A-C) but no Katushka fluorescence was detected. Further RT-PCR, 
a sensitive technique for detecting transcripts, also failed to detect any Katushka expression 
(figure 5.9D-F). 
The possibility remains that critical promoter elements even further upstream are missing from 
the 2.8 kb transgenic promoter construct. An alternative possibility is that the Xenopus 
tropicalis promoter is not active in the Xenopus laevis embryos. It is interesting to note that 
the upstream gdi3 A-form element is present in the tropicalis genome but is not present in the 
recently released Xenopus laevis genome. Recent experiments within the laboratory have also 
shown that Katushka expression can be observed when a longer 5 kb gdi3 promoter construct 
is used in Xenopus tropicalis F0 embryos the promoter (figure 5.10). Whether this activity is 
a consequence of a longer promoter construct or that the Xenopus tropicalis promoter is in the 
context of a Xenopus tropicalis embryo remains to be seen and will require more investigation. 
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Figure 5.10 Gdi3 promoter analysis in Xenopus tropicalis. (A) Embryos screened for GFP 
expression at various stages (no glow is visible) (B) Embryos screened for Katushka expression 
(glow is evident in the anterior part of the embryo). (C) Control embryos observed without 
fluorescent microscope filter. The letters around each photograph indicate the anatomical 
direction of each embryo. A-P shows the anterior-posterior axis; D-V indicates the dorsal-
ventral axis. 
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Chapter 6: General discussion and future work 
6.1 General discussion 
In this thesis, I aimed to validate a perl-script software which screens for a set of physical 
characteristics of DNA associated with gene regulation. This was detailed in chapter 3 and I 
have shown that a random selection of five identified promoter elements all had A-form 
character and were targets for sequence specific DNA binding proteins. I next characterised 
a novel gene downstream of one of the selected putative promoter elements, identifying it as 
a previously unknown Rab-gdi paralogue found only in frogs and fish. This work is covered 
in chapter 4. Finally, in chapter 5, I attempted to examine the temporal and spatial activity 
of the promoter of the gdi gene using transgenic Xenopus. In this chapter 6, I discuss our 
findings in more detail, interpret the result chapters as a whole and place my work in the 
context of the cell and developmental biology fields.   
We have validated a bioinformatic software tool which we have called APTE. This program 
is able to locate A-form DNA elements in conjunction with known conserved motifs as part 
of putative gene promoters. A major obstacle in eukaryotic transcriptional regulation studies 
is that putative transcription binding sites occur with high frequency in genomes. This leads 
to ‘false positive’ identifications of promoter elements using conventional search methods. 
When considering DNA structures alongside motifs this may enhance the reliability of such 
search programs. For instance, there are 25,253 CCAAT sequences (counting multiples per 
gene) within 500 bp of a TSS in the Xenopus tropicalis 4.2 genome and 54,703 APS 
sequences anywhere in the genome. However, there are only 86 in conjunction, a far more 
manageable number to screen. Interestingly, using a Monte Carlo simulation of randomly 
generated 106 sequences of 500 bp according to the base composition of Xenopus tropicalis 
genome (0.3 A or T and 0.2 G or C) resulted in 100 times more APS and over 50 times more 
CPS in regions of 500 bp upstream of TSS, strongly suggesting these elements are enriched 
at promoters.  From the 86 hits, I have studied five of them in more detail. These elements 
were validated by CD and shown to contain significant partial A-form structure and were 
further characterised by EMSA. The EMSA results showed that the analysed putative 
promoter elements were indeed specifically shifted by protein(s). Furthermore, one of the 
five putative promoter elements, unknown 5, was analysed by supershift EMSA where an 
antibody against Ilf3 supershifted the DNA-protein complex. Previous results show that ilf3 
controls gata2 transcription, therefore, Ilf3 may also be a putative transcription factor 
regulating uknown5 in vivo (Llewellyn K. J. et al. 2009). In support of this, there is in-vivo 
evidence that the engrailed version of Ilf3 reduces uknown5 expression in vivo (Whitley et 
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al. 2014). In conclusion, this suggests that gata2 and unknown5 may share a common gene 
regulatory mechanism. 
One of the five downstream coding genes of the analysed CPS elements, uknown5 was taken 
on for further functional characterization. A series of experiments were designed to elucidate 
its potential function. After initial comparison of this novel gene to the published Xenopus 
and human genomes, it was identified as a putative Xenopus Rab-gdi and it was decided to 
investigate this novel gdi gene further. Firstly, its ORF was cloned into a plasmid and 
sequenced by primer walking, which allowed it to be compared to the predicted version of 
the gene available on Xenbase. The alignment result showed 71 SNPs in the DNA, from 
which 14 translated into non-synonymous amino acid substitutions. However, the new amino 
acid changes were largely conservative. That this gene was really a new gdi was further 
confirmed by synteny and phylogenetic analysis between the known gdi paralogous (gdi1, 
gdi2, and unknown5) obtained from a series of different species genomes. After these results, 
I designated unknown5 as gdi3, according to current gene designation rules. The 
phylogenetic analysis on all of the known gdi members showed a distinct grouping of gdi1, 
gdi2, and gdi3 with the ancestral form separated out. Our analysis showed gdi3 to be found 
only in fish and frogs and that its sequence is highly conserved among species and to have a 
high identity to gdi1 and gdi2 (at least 92% identity). Once I had confirmed that this was a 
unique gene and also, since I had the gdi3 coding sequence, I could now use reverse 
transcription-PCR to determine its temporal expression during early Xenopus development. 
The high level of sequence identity between gdi3, gdi1 and gdi2 was taken into account and 
the RT-PCR primers (appendix II ) were designed after choosing the most distinctive region 
of the gdi3 sequence. 
 A series of developmental stages were examined for the presence of the gdi3 transcript 
starting with NF stage 2.  This stage was before the onset of zygotic transcription which 
means detecting Gdi3 mRNA would only be possible if maternally deposited in the oocytes. 
Next the NF stages were 8, 11, 13, 16, 18, 19, 20, 21, 22, 23, 25, 30 and 41 were analysed. 
Taken together these stages encompass all the critical developmental events during early 
Xenopus development from 2-cell stage to later stage tadpole. The results showed that Gdi3 
is maternally deposited in Xenopus laevis oocytes but only weakly expressed prior to the 
mid-blastula transition in Xenopus tropicalis. In Xenopus tropicalis, the gene is activated at 
the beginning of neurula stages and stays constant until the tadpole stage. In Xenopus laevis 
gdi3 remains expressed after the mid-blastula transition, increasing slightly at neurula stages 
after which it stays constant. The major difference between gdi3 in the two species is that 
there is more maternal Gdi3 mRNA in Xenopus laevis and there is no significant change in 
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expression at neurula stages in this species. Gdi3 neural expression in Xenopus development 
is similar to gdi expression in Amphioxus where in situ hybridization also shows neural 
specific expression (Sedlacek et al. 1999). Gdi1 is neural specific and Gdi2 is ubiquitous in 
mouse  (Bächner et al. 1995) and similar results have been obtained from rat tissue analysis 
(Nishimura et al. 1994). This may reflect that the ancestral form of Amphioxus Gdi was 
neural specific and after genome duplication events a second ubiquitous form had evolved.  
It has to be noted that RT-PCR is a semi-quantitative method, for more precise quantification 
of transcript levels it is best to use real time-PCR (qPCR). Having identified the gdi3 
temporal expression pattern the next step was to determine the spatial location of the Gdi3 
mRNA, therefore, a unique antisense probe to the Gdi3 mRNA was designed. The selected 
in-situ probe was of sufficient length (500 bp) to provide a good detection signal. This 
sequence was then analysed by the BLAST tool in the context of the Xenopus genome. Only 
one hit was obtained and that was the gdi3 gene itself, hence, this confirmed that this probe 
should hybridize specifically to Gdi3 mRNA. The in situ hybridization results agreed with 
the RT-PCR data i.e. that Gdi3 mRNA was localised within the nervous system tissues and 
this persisted from neurula NF stages 16, 18 and 22 on to tailbud stages 25, 30 and 35 of the 
analysed embryos. This result was consistent both for Xenopus tropicalis and Xenopus laveis 
although the latest Xenopus laevis stage observed was only NF stage 30.   
Morpholino knock-down of Gdi3 was used to study the effect on embryo development after 
depleting the Gdi3 protein. In Xenopus laevis, the effects were not as severe as in Xenopus 
tropicalis but that may be due to the maternal Gdi3 mRNA compensating for the depletion. 
Xenopus laevis embryos rarely survived until stages after NF stage 33 while Xenopus 
tropicalis knock-down embryos could survive until NF stage 40, this was observed in more 
than three replicated experiments. However, this could be due to the variable resilience of 
the different embryo batches, hence more detailed statistical data would be required to verify 
this hypothesis. An additional observation was that in Xenopus tropicalis some of the 
injected batches displayed gastrulation defects, which would lead to higher mortality rates 
prior to beginning the neurula stages. This was not fully explored and would again require 
further study. The most consistent defects that were documented here were severe anterior-
posterior defects and a reduction in head size known as microcephaly. This phenotype was 
replicated by a second morpholino in Xenopus tropicalis. Several control sets of embryos 
were also injected with a standard control morpholino and no specific phenotypes were 
observed. When Gdi3 mRNA was overexpressed in Xenopus laevis embryos the observed 
phenotype resembled the knock-down phenotype e.g. microcephaly and shorter A-P axis, 
similar to the knock-down phenotype. 
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In general, a common problem with the injection of exogenous molecules into embryos is 
that they may have toxicity which results in high mortality rates. For this reason, Xenopus 
laevis embryos, which are bigger and more robust than Xenopus tropicalis, were chosen for 
the rescue experiment. Rescue experiments are considered to be the best control in 
confirming morpholino specificity. However, overexpression of gdi3 was never able to fully 
alleviate the phenotype observed from MO1 knock-down when they were co-injected. There 
are several explanations for these results since the knock-down and the over-expression 
results have similar effects it may be that the Gdi3 protein functions at a fixed concentration. 
Since gdi3 overexpression has a severe phenotype, enough mRNA needs to be injected to 
compensate for the knock-down but not too much to cause overexpression phenotype. 
Another point to consider is that the mRNA diffuses less than the morpholino (Saka & Smith 
2004) which may be a problem to reach all of the affected cells.  In order to rescue it may be 
necessary to try concentration ranges below the 100 pg and above the 300 pg range which 
were attempted in this thesis. The high morbidity rate associated with higher concentrations 
may be decreased by using more purified mRNA. Such RNA, synthesized by using a 
commercially designed kit which reduces the number of steps in the protocol to obtain a high 
quality final RNA product.  
Another possible reason for the shared phenotype between knock-down and overexpression 
could be that Gdi3 has a squelching effect on Rab-GTPases, where a critical regulator has 
been displaced. Since Gdi3 affects the A-P axis formation and the anterior structures of 
Xenopus embryo it is sensible to explore the signalling pathways responsible for the 
development of those structures. A literature review on Rab-GTPases involved in A-P axis 
formation and neural functions during Xenopus development can suggest potential Rab 
targets for Gdi3 binding. For example, Rabs which are known to be involved in early 
Xenopus development are, Rab3d Rab4, Rab5, Rab7, Rab8, Rab40 (Kim & Han 2011). 
 Rab40 is a GTPase known to be involved in the early Xenopus development where it was 
shown to be involved in A-P axis formation through the non-canonical Wnt/PCP signalling 
pathway (Lee et al. 2007). The elongation of the A-P axis is driven by the process of 
convergent extension of the dorsal mesoderm and the neural ectoderm (reviewed by 
Wallingford et al. 2002). Convergent extension is regulated by the non-canonical Wnt/PCP 
pathway (Veeman et al. 2003)  where Rab40 function was required for the correct spatial 
distribution of dishevelled during gastrulation. Knock-down and overexpression of Rab40 
show gastrulation defects and inhibition of the A-P axis elongation, phenotypes similar to 
those obtained with Gdi3, this makes Rab40 a putative target for Gdi3 (figure 6.1A-C). The 
authors showed maternal and ubiquitous expression of Rab40 and therefore partially 
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overlaps with Gdi3. They have also proposed a  mechanism of Rab40 activity (figure 6.1D) 
(Lee et al. 2007). Taking into account this evidence it can be speculated that Gdi3 may be 
regulating Rab-GTPases such as Rab40 involved in the regulation of this process. Gdi1 and 
Gdi2 have been previously analysed for their affinities to different Rabs and Rab40 has been 
shown to be extracted with very low affinity by both Gdi1 and Gdi2 (Kirsten M.L. 2011). 
As speculation, one can suggest that Gdi3 may be potential higher affinity extractor of Rab40 
in Xenopus. However, extensive experimental studies would be required to support this 
hypothesis. 
Another possible Gdi3 target GTPase may be Rab3d which has also been shown to be 
required for Xenopus anterior regulation where it regulates the secretion of BMP antagonist 
noggin in the neural plate (Kim & Han 2011). Other possibles are Rab4 and Rab5, which 
have been shown to regulate axon elongation via endosomes recruitment in the growth cone 
(Falk et al. 2014). Rab8 regulates rhodopsin transport in rod cells and mutant Rab8 leads to 
photoreceptor cell death in Xenopus, as Gdi3 is found strongly expressed in the eye of the 
adult frog this may also bear investigation.  
The Gdi3 knock-down phenotypes are similar to those observed in other species where Gdi1 
deficiency has neural specific effects. For example, the function of Gdi has been also 
investigated in Drosophila where lethal Gdi mutations affect the mitogenic signalling to the 
imaginal discs and brains. Failure of a Rab secreted signal leads to small imaginal discs and 
small larval brains with low mitotic activity and larval/pupal lethality (Ricard et al. 2001). 
Moreover, GDI1 mutations in human have been found to be one of the genes responsible for 
X-linked non-specific mental retardation. The GDI1 impairment in human leads to severe 
impairment of learning abilities (D’Adamo et al. 1998). In Gdi1 deficient mice, similar 
effects are again observed, gdi1 knock-out mice have cognitive impairments associated with 
altered synaptic vesicles (Bianchi et al. 2009). In general, although Gdi1 deficient mice are 
fertile and anatomically normal their ability to perform tasks requiring short-term memory 
is affected and have altered social behaviour (D’Adamo et al. 2002). All together these 
observations suggest that Gdi has a fundamental cellular function which is non-redundant in 
flies and although in vertebrates (frogs and fish), where Gdi3 is also present, that could 
potentially compensate for a loss of function. One of the surprising observations of this thesis 
is the difference between gdi3 expression in Xenopus tropicalis and Xenous laevis. In recent 
years it has become fashionable to use the species interchangeably, making use of the 
superior tropicalis genomic data and at the same time the robustness of Xenopus laevis. 
However, at least in the case of gdi3, it is important that both species need to be fully 
explored. Although adult frog tissue expression differs the early embryo in situ hybridization   
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showed that gdi3 has a very similar spatial expression. Further Gdi3 morpholino knock-
downs in the embryos exhibited similar phenotypes. This supports the hypothesis that gdi3 
either in Xenopus tropicalis and Xenopus laevis has a conserved function, most likely during 
neurulation since this is the temporal overlapping of gdi3 expression in both species. It has 
been previously shown that highly similar genes that have distinct spatiotemporal expression 
can have a conserved function. Studies performed by Masse K.L et al. 2007 showed that 
highly conserved anxa4 and anxa4a genes have different expression pattern in Xenopus 
laevis and Xenopus tropicalis but have conserved function (Massé et al. 2007). Anxa4a is 
required for the normal kidney development in Xenopus laevis and in anxa4 is expressed in 
the embryonic liver and not the kidney in Xenopus tropicalis. Knock-down of anxa4a 
impairs pronephric tubule development in Xenopus laevis. However, this phenotype can be 
rescued by Xenopus tropicalis Anxa4 mRNA (Massé et al. 2007). This suggests that highly 
conserved genes may have indeed conserved function, however, may be employed 
differentially in different types of cells, adapting over the process of evolution. A potential 
hypothesis that can explain the differential expression pattern is changes that occur in the 
promoter regions of these types of genes i.e. regulatory elements may become deleted or 
inserted during evolution.  
Initially, the putative promoter of gdi3 was investigated using the luciferase reporter gene 
assay where three different lengths of the promoter were investigated. One containing just 
the A-form element in conjunction with a CCAAT motif and the longest construct of 700 
bp, containing the A form element and two CCAAT motifs. The expression analysis obtained 
here was negative, this was supported by the positive control which was the gata2 promoter 
driving luciferase expression.  There are several hypotheses of why the results were negative. 
Firstly, it could be due to the lack of control element or the presence of a repressor element 
or an incomplete epigenetic environment. So to address these problems I used an in vivo 
approach and also I investigated a longer putative promoter construct of 2.8 kb.  
The gdi3 upstream region of 2.8 kb, including 38 bp of the downstream coding region, was 
engineered to be part of a transgenesis expression construct. This construct, after injection 
into one-cell Xenopus embryos, became incorporated into the host cell genome. Hence, it is 
in a more realistic environment to analyse putative promoters than in the luciferase assay 
where the plasmid remains episomal. After injection into Xenopus laevis one-cell embryos 
those expressing GFP driven by the γ-crystallin promoter in the eye were identified and left 
to develop to sexually mature frogs, and ultimately breed an F1 generation. The expression 
analysis of the gdi3 putative promoter was performed in the F1 generation embryos in order 
to avoid mosaicism often found in the F0 generation. The F1 embryos were observed 
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throughout key developmental stages, gastrula, neurula, and tailbud, stages consistent with 
the RT-PCR data showing expression of gdi3. The observations showed that while GFP was 
driven by γ-crystallin in the eye, no Katushka fluorescence was observed. We assessed the 
potential problems that could be preventing the expression of the Katushka gene. Firstly, we 
tested whether the expression vector cassette was entirely inserted into the genome. Three 
sets of primers (appendix II) were designed to test the genomic presence of GFP, 2.8 kb gdi3 
putative promoter, and Katushka and that they were in the correct order. The PCR confirmed 
the presence of an intact cassette within the frog genome.  Secondly, since it may be a weak 
promoter, the fluorescence signal was not strong enough to detect Katushka expression by 
eye. Therefore, a more sensitive biochemical method (RT-PCR) was employed, although 
still no Katushka expression was detected. Thirdly, the putative gdi3 promoter may be 
inactive because it is missing additional regulatory elements that would make it functional. 
Possibly related to this reason could be some form of species incompatibility between the 
injected Xenopus tropicalis promoter and the Xenopus laevis host. In order to resolve this, 
with the assistance of Dr. Anna Noble, the Xenopus tropicalis transgenic construct 
containing 5 kb of the putative gdi3 promoter was injected in Xenopus tropicalis one cell 
embryos. F0 embryos obtained from this experiment displayed Katushka fluorescence in the 
anterior part of the embryo.   
In summary, APTE has proven a successful method for identifying A-form DNA promoter 
elements and one of the genes identified is a new member of the gdi family with an important 
role in development and whose study revealed an unusual non-concordance between its 
expression in Xenopus tropicalis and Xenopus laevis. 
 
6.2 Future work 
Future work to further support findings from chapter 3 is to experimentally validate more of 
the 86 hits identified with the APTE program, also screening a Xenopus expression library 
should allow the discovery of more potential A-form DNA binding proteins. Identifying 
more A-form DNA binding proteins would shed light on a potential common themes for this 
class of transcription factor. The only currently known transcription factor of this type, Ilf3, 
is a well characterised dsRNA-binding protein involved in early Xenopus development and 
also binds A-form DNA. Therefore, ChipSeq analysis on Ilf3 would uncover the range of its 
cognate DNA binding sequences. Comparing those binding sequences would allow 
understanding in more detail of the preferences of ilf3 to sequence dependent structures. 
After ilf3 potential DNA binding sequences are identified the APTE program may be 
reviewed to search, in addition to GC-rich sequences, additional nucleotide combinations 
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with A-form DNA propensity. Analysing the Xenopus genome with various APTE 
parameters may allow for identifying additional genes with functional correlation. Since the 
human genome is better annotated than the Xenopus one, it may be interesting to screen the 
promoters of all annotated human genes and study the correlation between the associated 
genes. The bionformatic program known as DAVID is a gene functional classification tool 
and can be used to study list of genes, hence, it can be used to study the 86 hits from table 
3.2 from chapter 3. A possible limitation when studying those gene hits may that 30% of that 
list have unknown function and most of the rest are not well characterised. Therefore, for 
potential functional classifications of APTE gene hits is best to use very well characterised 
genomes, for example, those of Human and Drosophila. 
Extending the work from chapter 4 would require a Gdi3 rescue experiment of MO2 in 
Xenopus tropicalis. This approach appears promising since Xenopus tropicalis required 
lower injection amounts of MO2 and hence expected lower morbidity rates. Potentially 
affected neural gene markers of the gdi3 morpholino knock-downs should be explored by in 
situ hybridisation and RT-PCR. Moreover, RNA sequencing analysis on the knock-down 
embryos could show in great detail what genes have been miss-regulated during Xenopus 
development. Moreover, overexpression assays could allow us to understand what gene 
networks have been disrupted. For example, an obvious anterior neural marker to examine 
is otx2. In addition to neural markers, it will be interesting to examine whether the early 
signalling pathways patterning the Xenopus early neurula structures are affected, for 
example, the components of BMP and Wnt signalling pathways. Since normal anterior 
neural development requires BMP signals to be inhibited it would be interesting to examine 
whether those inhibitory signals (noggin, chordin, follistatin, Cerberus and Xnr3 (Hartley K. 
O. et al. 2001)) are affected in gdi3 knock-down embryos. Also, a technical point to consider 
is analysing the gdi3 temporal expression by Real Time RT-PCR which would allow for a 
more accurate measurement of the gdi3 transcript levels at each developmental stage. 
Immunoprecipitation of the Myc-labelled form of Gdi3 with putative Rab-binding partners 
will suggest a potential mechanism of Gdi3 effector activity. Since specific Rab antibodies 
are difficult to obtain, mass spec analysis may be an alternative way to uncover gdi3 binding 
partners. Some of the known Rabs in Xenopus have been previously characterised and shown 
to be required for early Xenopus development hence it may be a profitable line of enquiry to 
investigate whether those Rabs are bound by gdi3. Once gdi3 binding partners are identified 
one can study the affinity with which gdi3 binds Rabs and also through mutational analysis 
to pinpoint the key gdi3 residues required for distinct Rab binding.   
Preliminary data suggests that the longer 5 kb construct of the gdi3 putative promoter is 
functional when injected in Xenopus tropicalis. Further deletion mapping studies of this 
157 
 
construct would be necessary to locate the basal promoter elements and also tissue specific 
enhancers. Injecting different lengths of gdi3 putative promoter constructs from Xenopus 
laevis into Xenopus tropicalis may reveal conserved elements and regulatory function 
between these species. APTE has identified A-form DNA element within Xenopus tropicalis 
gdi3 promoter hence the Xenopus laevis gdi3 promoter for such structures should also be 
analysed using the recently published genome. Finally, transgenic constructs containing A-
form mutated into B-form DNA will show the effects of those elements in vivo as will 
introducing additional A-form DNA elements may show any potential functions in vivo. The 
effects on gene regulation of these mutant transgenic constructs may be explored with RNA 
seq in more detail. Any potentially affected genes may be correlated to those regulated by 
ilf3. 
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Appendix Ӏ: Solutions 
 
Ampicillin/Kanamycin/Chloramphenicol  
50 mg/ml stock kept at -20 °C 
 
2% Cysteine 
2 g Cysteine in 100 ml 0.1 X MBS 
pH to 7.8-8 with NaOH 
 
Coomasie brilliant blue staining solution 
10% methanol 
10% acetic acid 
1 g Coomasie brilliant blue for 1 litre 
 
Destain solution 
20% methanol 
10% acetic acid 
 
dNTPS (10mM) 
10 mM dATP 
10 mM dTTP 
10 mM dCTP 
10 mM dGTP 
 
ECL Solution I 
100 mM Tris-HCl (pH8.0) 
 1.1 mM Luminol 
 0.9 mM p-Coumaric Acid 
 
ECL Solution II 
 100 mM Tris-HCl (pH8.0) 
 0.06% Hydrogen Peroxide 
 
EMSA reaction buffer  
4 % (w/v) Ficoll 
20 mM HEPES (pH 7.9) 
2 mM MgCl2 
50 mM NaCl 
 
Ethidium Bromide 
10 mg/ml stock 
 
Extraction buffer EB (1 X) 
10 mM HEPES pH 8.5 
2 mM MgCl2 
1 mM EDTA 
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10 mM β-glycerophosphate 
1 mM DTT 
Protease inhibtor tables, one per 10 mls 
 
Ficoll solution 4 % 
4 g Ficoll, 100 ml 1 X MBS 
 
FB1 600 ml 
4.8 g Rubidium Chloride 
3.96 g MnCl2.4H2O 
2.4 ml 5 M Potassium Acetate 
0.6 g CaCl2 
60 g Glycerol 
Adjust to pH 5.8 with acetic acid and filter sterilise 
 
FB2 100 ml 
2 ml MOPS pH 6.8 
0.12 g Rubidium Chloride 
11 g CaCl2 
15 g Glycerol 
Adjust to pH 6.8 with NaOH and filter sterilize 
 
MEMFA salts 10 X 
1 M MOPS 
20 mM EGTA 
10 mM MgSO4 
Autoclave and store; turns yellow after autoclaving 
 
MEMFA solution 1 X 
10 x MEMFA salts 
10 % Formaldehyde 
dH2O to 50 ml 
 
Modified bath saline (MBS) 10 X 
   88 mM  NaCl 
     1 mM  KCL 
  2.4 mM NaHC03 
0.82 mM MgS04.7H2O 
0.33 mM Ca (N03)2.2H2O 
0.41 mM CaCl2.6H2O 
10 mM HEPES 
The pH was adjusted to 7.6 with 5 M NaOH 
Sterilise by autoclaving, add salts after autoclaving  
 
NETS buffer 
0.3 M NaCl 
1 mM EDTA 
20 mM Tris pH 7.6 
1% SDS) 
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Orange G DNA loading dye 
0.25% Orange G 
15% Ficolll (type 400) 
dH2O 
 
 
 
 
Phosphate buffer: 
Stock solution A: 
2 M monobasic sodium phosphate, monohydrate (276 g/l) 
Stock solution B: 
2 M dibasic sodium phosphate, monohyhdrate (284 g/l) 
8.5 ml of stock solution A mixed with 91.5 ml of stock solution B to give a 100ml pH7.8 
phosphate buffer 
 
SDS-PAGE Loading dye (5X) 
 150 mM Tris-HCl (pH 6.8) 
 10% SDS 
 5 mM Na2 EDTA (pH 7.5) 
 10% Glycerol 
 0.05% Bromophenol Blue 
 5% 2-β-mercaptoethanol 
 
SDS-PAGE Running Buffer (10X) 
 150 mM Tris-HCl (8.3) 
 2 M Glycine 
 1% SDS 
 
Solution I 
50 mM Glucose 
25 mM Tris HCL pH 8.0 
10 mM EDTA 
 
Solution II 
0.2 M NaOH 
1% SDS 
 
Solution III 
3 M Potassium acetate 
Add glacial acetic to obtain pH 4.5 
Make up to 100 ml with dH2O 
 
TNE (3X) 
30 mM Tris-HCL 
3 mM EDTA 
300 mM NaCI 
pH 7.5-8 
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TAE (50X) 
242 g Tris base 
57.1 ml Glaical acetic acid 
100 ml 0.5 M EDTA 
dH2O to 1 litre 
 
TBSTw (10X) 
 100 mM Tris-HCl (pH8.0) 
 1.5 NaCl 
 10% Tween-20 
 
Transfer Buffer 
20 mM Tris-HCl (pH7.5) 
 150 mM Glycine 
 20% Methanol 
 0.1% SDS 
 
In situ hybridization buffers: 
Active BLEACH (explosive- keep lid off) 
1 ml Bleach stock (10 X) 
5.5 ml dH2O 
3.5 ml H2O2 
 
Alkaline Phosphatase (AP) buffer                                   
0.1 M Tris pH 9.0 
50 mM Mg2Cl 
0.1 M NaCl 
0.1% Tween-20 
 
Alkaline Phosphatase conjugated antibody 
Fab fragments from polyclonal anti-Digoxigenin antibody conjugated to alkaline 
phosphatase (Roche) 
50% Formamide/5 x SSC 
 25 mL Formamide, 12.5mL (20 x) SSC, 12.5 mL dH2O 
 
25% Formamide/2 x SSC 
 12.5 mL Formamide, 5 mL (20 x) SSC, 32.5 dH2O 
 
12.5% Formamide/2 x SSC 
 6.25 mL Formamide, 5 mL (20 x) SSC, 39 dH2O 
 
Hybridization buffer 
50% Formamide 
5 X SSC 
1 mg/ml Torula RNA (tRNA) 
1 x Denhart`s 
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100 μg/ml Heparin 
0.1% Tween 
5 mM EDTA 
 
MAB (5X or 10X)  
100 mM Maleic acid 
150 mM NaCl,   
pH 7.5 (Maleic acid dissolves when reaches pH 7.5 with NaOH) 
 
MAB-2% BLOCK 
1g Blocking reagent (Sigma) 
5 ml 5 X MAB  
 45 ml dH2O 
 Heat up at 60 °C for 20 minutes in water bath 
 
75% Methanol/PBSTw 
 37.5 mL Methanol, 12.5mL PBSTw 
 
 50% Methanol/PBSTw 
 25 mL Methanol, 25 mL PBSTw 
 
25% Methanol/PBSTw 
 12.5 mL Methanol, 37.5 mL PBSTw 
 
PBS/ 0.1% Tween (PBSTw) 
 50 mL PBS, 50 µL Tween 
 
2 X SSC/0.1% Tween 
 5 mL (20 X) SSC, 50 µL Tween, 45 mL dH2O 
 
0.2 X SSC/0.1% Tween 
 500 µL (20 X) SSC, 50 µL Tween, 49.5 mL dH2O 
 
0.1 M Triethanolamine  
Weight 7.45 g of the liquid and 42.5 ml dH2O 
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Appendix II: Oligonucleotides and PCR primers 
 
Morpholinos 
Standard control morpholino (SC MO) 
5` CCTCTTACCTCAGTTACAATTTATA 3` 
Morpholino one (MO1) 
5` ATGACATCATACATCTCCTCCATGC 3` 
Morpholino two (MO2) 
5` TGTGGGTCTCGCTGATCTTAGCTTT 3` 
 
PCR Primers (5` to 3`) 
Exon1 FWXbaI   
GTACTAGACTCTAGAATGGAGGAGATGTATGATGTC 
Exon12 RV         
CATTCTTGGAAATCTGAGTTGTC 
FWXhoI   
GTACTAGACCTCGAGATGGAGGAGATGTATGATGTC 
RVXbaI   
GAACTATCCTCTAGATCATTCTTGGAAATCTGAGTTG 
 
Gdi3 in situ probe 
FWXhoI 
 GTACTAGACCTCGAGTTTGTGACCCCAGTTATGTG 
RVXbaI  
GAACTATCCTCTAGATCATTCTTGGAAATCTGAGTTG 
 
RT-PCR  
gdi3 FW trop  
TCAGATGGGAAATACGTGGC 
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gdi3 RV trop 
 ACACGTTGTCTCAAAGTGCG 
 
gdi3 FW laevis  
CGAGTGCACCTCGTGTCAA 
 
gdi3 RV laevis  
CACTGAAGTCCAGGGTAGC 
 
ODC FW trop 
 CAGCTAGCTGTGGTGTTG 
 
ODC RV trop  
CAACATGGAAACTTACACC 
 
ODC FW laevis 
 AAAAAGCATGTGCGTTGGTTT 
 
ODC RV laevis 
 TCGTTGCATTTTACGGCATAAA 
 
LMO FW trop 
GCTAGCATGTTCGGCCAGGACGGACTCTG 
LMO RV trop 
CTCGAGTCACTGCTCGCACACAATGTCCG 
 
Transgenesis 
pDonr221 FW 
attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTCCCAATAGGGCTGTTCTGCCCC   
   
pDonr221 RV 
attB2 GGGGACCACTTTGTACAAGAAAGCTGGGTCTCCTCCATGCCAGGCAGACGC     
 
pDEST 
GFP FW +686  
GATCACTCTCGGCATGGACG 
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Gdi3 2.8 kb RV -2367 
 GGTCAGATAACCAACAGGTGC 
 
Gdi3 2.8kb FW -432    
GGTAGGTATGAGTCTGCCTGC 
 
Kasia RV +151   
 CGACCACCTTGATCTTCATGG 
 
Kasia FW 516 
 CACCGAGAACATGCACATGAAAC 
 
Kasia RV  
GTGGTCTTGAGGGAGCAGTG 
 
 
EMSA and CD oligonucleotides 
Gdi3 FW 
TCAGGTACCCCCCCCCCCCCCAATATTTCTCACACC 
 
Gdi3 RV 
GGTGTGAGAAATATTGGGGGGGGGGGGGGTACCTGA 
 
Gtf2e1.2 FW 
CTATGGGCTCCCCCCCCCCCCAATCTCTCTGCATGT 
 
Gtf2e1.2 RV 
ACATGCAGAGAGATTGGGGGGGGGGGGAGCCCATAG 
Kif27 FW 
TTACAATGGGGGGGGGGGATCAGATAGGATCTGTGC 
 
Kif27 RV 
GCACAGATCCTATCTGATCCCCCCCCCCCATTGTAA 
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Thrsp FW 
GTCACCTTCCCCCCCCCCCAATGTGGTGGGTTGATA 
 
Thrsp RV 
TATCAACCCACCACATTGGGGGGGGGGGAAGGTGAC 
 
Uknown1 FW 
AGATTAAGGGGGGGGGGGGCGGTTCTGTTGGGTTAT 
 
Unknown1 RV 
ATAACCCAACAGAACCGCCCCCCCCCCCCTTAATCT 
 
EMSA competitors 
B-FORM  
GTGCATGCATGCCCAATGTCCATCTCAATGGGGGTT  
 
GDI3 no cat box 
TCAGGTACCCCCCCCGTCAGATTTCTCACACTGGCC 
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Appendix III: Cloned sequences 
Gdi3 ORF  
ATGGAGGAGATGTATGATGTCATTGTTTTGGGGACAGGGCTAAAGGAATGTGTATTATCGG
GAATCATGTCTGTGAATGGCAAGAAGGTTTTGCACATAGATCAGAATGATTACTATGGAGG
AGAGACTGCGTCTATTACTCCCCTGGAAGAGCTATATCGAAGGTTTAATGTTAATGGACCC
CCAGAACCAATGGGCAGAGGGAGGGAATGGAATGTGGATCTCGTACCAAAGTTCCTTATGG
CTAATGGACAGCTGGTGAAGATGCTTCTCTACACAGAAGTCACCCGATACATAGACTTCAA
AGTTGTAGATGGGAGTTATGTCTACAAAGCTGGCAAAATTCACAAAGTCCCTTGCACAGAG
GAAGAAGCTTTGGCTTCTGACCTAATGGGCATCTTTGAAAAGAGGCGTTTCCGAAAGTTCC
TTCTATTTGTGGTGAACTTCAATGATCAGTGTGCAAACACTCAGTATGATTTTGATCCGAC
AAAGACGACCATGAGAGAATTATATCGGAAGTTCGATTTAGGTCCAGAAGTCATGGCTTTT
ACTGGTCATGCCCTGGCCTTGTACAGAACGGATGACTACTTGGACCTTCCATGCTTAGAAA
CAATAAATCGTATTAAACTGTACTGTGAATCACTGGCCAAATACAGTAAAAGCCCATATCT
TTACCCTCTCTATGGACTAGGAGAACTTCCACAAGGATTTGCCCGGCTGAGTGCTCTGTTT
GGTGGGATATATATGTTAAATAAGCCTGTGGATGAGATCCTTATGAAAAATGGACAAGTAG
TTGGAGTAAAGTCAGAGGGAGAGATTGCTCACTGCAAACAGCTGATTTGTGACCCCAGTTA
TGTGCCTGATCAAGTCAAGAAGACTGGTCGGGTGATAAGAGCCATTTGTATTCTCAGCCAC
CCGATCCGAGACACCAACGAGTGCACCTCGTGTCAAATCATCATACCTCAGACTCAGGTTA
ACCGAAAATCAGATATCTATGTCTGCATGGTCTCCTGCTCACACTGCGTGGCATCAGATGG
GAAATACGTGGCTATAATTAGCACAACGGTGGAAACAGAGGATCCAGAGAAAGAGATCCAG
CCAGCCCTGGAGCTACTGGAGCCTGTTGATCAGAAATTTGTGTCCATAAATGATCAATTTA
AACCAAAGCATGATGGGACAAAAAATCAGATCTTCATTTCCAGATCATATGATGCCACCAC
AAACTTTGAGACAACGTGTGATGACATTAAGGACATGTTTAGGAGAATGACAGGTGCTACC
CTGGACTTCAGTGACATGTGGAGTTCCGACAACTCAGATTTCCAAGAATGA 
Gdi3 in situ probe 
TTTGTGACCCCAGTTATGTGCCTGATCAAGTCAAGAAGACTGGTCGGGTGATAAGAGCCAT
TTGTATTCTCAGCCACCCGATCCGAGACACCAACGAGTGCACCTCGTGTCAAATCATCATA
CCTCAGACTCAGGTTAACCGAAAATCAGATATCTATGTCTGCATGGTCTCCTGCTCACACT
GCGTGGCATCAGATGGGAAATACGTGGCTATAATTAGCACAACGGTGGAAACAGAGGATCC
AGAGAAAGAGATCCAGCCAGCCCTGGAGCTACTGGAGCCTGTTGATCAGAAATTTGTGTCC
ATAAATGATCAATTTAAACCAAAGCATGATGGGACAAAAAATCAGATCTTCATTTCCAGAT
CATATGATGCCACCACAAACTTTGAGACAACGTGTGATGACATTAAGGACATGTTTAGGAG
AATGACAGGTGCTACCCTGGACTTCAGTGACATGTGGAGTTCCGACAACTCAGATTTCCAA
GAATGA 
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Luciferase assay constructs  
Small (S) 
TCAGATGGATTACTGACAGGTGGTCCAGCTTTTGGGTCACTGGGGCTATTGGCTGATTGAAAGCTG
CCGGCTTATCAGTGTCTGGCAAATCAGATTAAGCTAAGGTTGTTTCTTGTCGCTCTGCTTTCAAAG
CTAAGATCAGCGAGACCCACACATGTGAGTGCCGCGTCTGCCTGGCATGGAGGAGATGTATGATGT
CATTGTTTTGGGGACAGGGCTAAAGGTAAGCAAAGAACAATTTGGGGG 
Medium (M) 
GCAATATTCCCATACAGAGGCGGCCCATCTAAATGCCTGGGGTCTGGTTGGACCACATGTTTGTCT
CCTTGTGCAGATCATAAAAAACACACACACAAAACCATAATAAATTGAAAGTGTAGCTACCAAGGC
ATTTATCTTCCTACTGTCTATTGTACAAATTCATTTTCAGGTACCCCCCCCCCCCCCAATATTTCT
CACACCGGCCTGCCCCTGTATGCAATACTCAGATGGATTACTGACAGGTGGTCCAGCTTTTGGGTC
ACTGGGGCTATTGGCTGATTGAAAGCTGCCGGCTTATCAGTGTCTGGCAAATCAGATTAAGCTAAG
GTTGTTTCTTGTCGCTCTGCTTTCAAAGCTAAGATCAGCGAGACCCACACATGTGAGTGCCGCGTC
TGCCTGGCATGGAGGAGATGTATGATGTCATTGTTTTGGGGACAGGGCTAAAGGTAAGCAAAGAAC
AATTTGGGGG 
Large (L) 
GATGGCCACCCACCCCTGCAATTTTATGTGCAGCCAATAACATGATTGGGGGTGGCAGGGAGTGTG
TGGGGGGGGCCTATTGGTTAGAAATGAAATTTGGGAAGTTTCTTCTCCTTCAACTACTTGTTTGCC
AAATTAACCACCAGTTTATAAGAACTCCAAAGATATTTAGGATGGGTAGGTATGAGTCTGCCTGCA
ATATTCCCATACAGAGGCGGCCCATCTAAATGCCTGGGGTCTGGTTGGACCACATGTTTGTCTCCT
TGTGCAGATCATAAAAAACACACACACAAAACCATAATAAATTGAAAGTGTAGCTACCAAGGCATT
TATCTTCCTACTGTCTATTGTACAAATTCATTTTCAGGTACCCCCCCCCCCCCCAATATTTCTCAC
ACCGGCCTGCCCCTGTATGCAATACTCAGATGGATTACTGACAGGTGGTCCAGCTTTTGGGTCACT
GGGGCTATTGGCTGATTGAAAGCTGCCGGCTTATCAGTGTCTGGCAAATCAGATTAAGCTAAGGTT
GTTTCTTGTCGCTCTGCTTTCAAAGCTAAGATCAGCGAGACCCACACATGTGAGTGCCGCGTCTGC
CTGGCATGGAGGAGATGTATGATGTCATTGTTTTGGGGACAGGGCTAAAGGTAAGCAAAGAACAAT
TTGGGGG 
Gdi3 2.8 kb transgenic construct 
CCCAATAGGGCTGTTCTGCCCCCAATAAGGGGTAATTATATCTTAGTTGGGATCAAGTACAGGTAC
TGTTTTATTATTACAGAGAAAAGGGAATCATTTAACCATTAAATAAACCCAATGGGACTGTTCTGC
CCCCAATAAGGAGTAATTATATCTTAGTTGGGATCAAGTACAGGTACTGTTTTATTATTACAGAGA
AAAGGGAATCATTTAACCATTAAATAAACCCAATAGGACTGTTCTGCCCCCAATAAGGGGTAATTA
TATCTTAGTTGGGATCTGGGCGCCCCGAGGCCGCCCCTGTTGGTGGCAGCATTTGTACCCCCCCCA
TGTGTTGCAATGTATATATTGATAAGTATCTTGAGTTTAATAAATGCAGATATTGTAGGATTTTAG
GCACCTGTTGGTTATCTGACCCAAATACCCACATTCACATATTCACTGTCTAACGCTTGTCTAACC
ACAGTCAATAATACAAACTCACTAATGTAATATAGAATTACCCAACAATTGAATTGACGATTTACA
GACAGAACTATGGCAAAGTATGCATCCAGGTAGTATTTAAATGTTGTACAGGTATGGGATCCCTTA
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TCCGGAAACCCATTATGCAGAAAGCTCAGAATTACAGAAAGCCCGTCTCCCATAGACTCCATTTTA
ATCAAATAAATTTAGAATTTTAAAACTGATTTCCTTTTTCTCTGTAGTAATAAAACAGCATCTTGT
AATTGATCCCAACTAAGATATAATTAATCCTTATTAGAGGCAAAACAATCCTATAGGGTTTAATTA
ATGTTTTATTGATTTTTTAGTAGACTTAAGGTATGGAGATCCAAATTACAGAAAGACCCCTTATCC
AGAATACCCTCGGGCCCGAGCATAAAGAGAGAGCTGTTGTGTTCCACTTCAATTATCCTGGTGGGG
GTTGGTGCGAGGAAAAAGTTCTTAATTTGCAGAGTTAATTAATTAATAATTAATATAGCCACTGCC
ACACTACTGGGCCTTATTTGAGGTGGGGCCCGGGTGCAATTAGGGTTGCAGCGACAAAAGGGGTGG
TCTGTGACTTAGAAGGGATGGGGTGATGACAAAAGTGGGTGGGGCTATGATATCATGGATGTCTCT
AGGCCAATGTAGAGAAAGAGTAAAGGATAAGAAAAGATAAATATCAGGTGGTTTCTGGGTGGATCA
TGGTGGGCCAGGGGCTGAACCTACAGTTATTACAAATTTACCAGCAACTACTTTTCCTGGTAAATT
TGTAAAACCAGCCTTGGCCTTGGCAGGCGTTTTACTGACTAGGCCAATAAAATACCAGCCAGGTGG
CAACATTAGGTGCAGCTGTATATTTTCAACAGTGCACCGTATTAGGTAATAAACCCTACAGTCTGT
ATATAGACTGCTCTTACAAAATAATGAATGTAGCTAACACCACCCAGCAGGAGCAAACTTGGTTAC
CATGGCAATTATATGACATCATACTGTATGATGTATATGTTCTCCCTGTGTCTGTATTGGTCTGCC
CCGGGTACTCCGGTTTTTCCACATTCCAAAAACATAATCGTCTCCTGGTAAAATTGACCTGGGGGT
AAACGTCCAAAAATTATCAAGGATAAATCTTCCCCTAATTTTGAGTTTTGTTGCAAAAATAATAAA
TAATTCTTGTTTCAAATATTTTCTACTATTTATAAAAGAATAGGCAAGCTGAAATGAATGCTTGGG
GAGGCCTACATGAGTTAATTTGGTGCAATACACACCAGGGGATGTCTGCCTTCCAGGGGGTGACAT
CCAACCCAGAGCAAGTGAAAGCCACTGTGTATGCTCTGACTAGCCAATCAGGTCATAATAGTCCTC
CCTGATTCAGTTGGCTGAAGTGATGCTCTCCTTACCCCCCGCGATTAACTTTTAGGCAAGGGGGCA
GGATTGTTAGTACAGAGAGTAAATGCACTCTCTGCAAAAGTGGAGCTAAAATTCCAGAAAAAAGAT
GAAATTTCAGCTCTTGAAGTTACCAGGAGTGGCTTTTTGCTGCCCTGGTAAACTGGGGAGGGGGGG
GAGTGCCACACAAGGAAAGATTCTCAACAAGCTTCTCAACTGCCAAAGCATCCATGTGGCCTATAC
TTTTGAGGGAGACGTGATACCAGATGTGATATGGTCAAAATTGATGGCCACCCACCCCTGCAATTT
TATGTGCAGCCAATAACATGATTGGGGGTGGCAGGGAGTGTGTGGGGGGGGCCTATTGGTTAGAAA
TGAAATTTGGGAAGTTTCTTCTCCTTCAACTACTTGTTTGCCAAATTAACCACCAGTTTATAAGAA
CTCCAAAGATATTTAGGATGGGTAGGTATGAGTCTGCCTGCAATATTCCCATACAGAGGCGGCCCA
TCTAAATGCCTGGGGTCTGGTTGGACCACATGTTTGTCTCCTTGTGCAGATCATAAAAAACACACA
CACAAAACCATAATAAATTGAAAGTGTAGCTACCAAGGCATTTATCTTCCTACTGTCTATTGTACA
AATTCATTTTCAGGTACCCCCCCCCCCCCCAATATTTCTCACACCGGCCTGCCCCTGTATGCAATA
CTCAGATGGATTACTGACAGGTGGTCCAGCTTTTGGGTCACTGGGGCTATTGGCTGATTGAAAGCT
GCCGGCTTATCAGTGTCTGGCAAATCAGATTAAGCTAAGGTTGTTTCTTGTCGCTCTGCTTTCAAA
GCTAAGATCAGCGAGACCCACACATGTGAGTGCCGCGTCTGCCTGGCATGGAGGAG 
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Appendix IV: Plasmid maps 
 
TA cloning vector 
 
 
 
 
 
 
 
 
 
 
 
  T    A 
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Standard cloning vector (cloning of in situ hybridization probes) 
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Expression vector 
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Luciferase assay vectors 
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pGateway vectors 
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Appendix V: DNA ladders 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    
2-log DNA ladder                                   1 kb DNA ladder 
   LMW DNA ladder                                   1 kb+ DNA ladder 
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Appendix VI: A triplet code table to predict DNA 
sequences with A-form propensity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A-form DNA prediction table taken from Basham et al. 1995. This table was used to predict 
the A-form propensity of a nucleotide in the context of its surrounding bases. The code is 
read for each base taken as the middle (Ni) of a triplet where the 5` base is Ni-1 and the 3` 
base is Ni+1. The values of possible triplet combination are presented in the table (in 
kcal/mol), ND indicates that the APE value has not been yet determined for the 
corresponding triplet. Positive ape values correspond to B-form and negative values 
correspond to A-form DNA propensities.   
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Appendix VII: Xenopus early embryo anatomical 
structures 
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Appendix VIII: Cloning strategies 
TA Cloning of Xenopus tropicalis gdi3 open reading frame 
(ORF) 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
Step 1 –Locate gdi3 cDNA on the available database (Xenbase.org) 
Step 2- Design primers to PCR amplify from Xenopus cDNA samples  
Step 3- Add A-overhangs with standard Taq-polymerase to facilitate TA-cloning into 
pGEM®-TEasy vector  
Step 4- Set a ligation reaction according to the TA-cloning kit protocol 
Step 5- Screen for successful recombinants by restriction digest reactions 
Step 1 
Step 2 
Step 3 
Step 4 
Step 5 
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Cloning of Xenopus tropicalis gdi3 0.5 kb in situ hybridization 
probe 
 
 
 
Step 1 –Chose length of gdi3 in situ probe and design primers containing XhoI and XbaI 
restriction sites plus 9 bp overhangs 
Step 2- Set double restriction digest reactions with XhoI and XbaI to create sticky ends. 
Step 3- Separate the restriction digest reactions of the plasmid and the insert using a 0.8 % 
agarose gel electrophoresis and then gel elute the correct size bands. Set a 3:1 T4 DNA 
ligation reaction. 
Step 4- Screen for successful recombinants by restriction digest reactions. 
Step 1 Step 2 
Step 3 
Step 4 
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Cloning of Xenopus tropicalis gdi3 open reading frame (ORF) in 
an expression vector 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 1 –Design primers containing XhoI and XbaI to PCR amplify from 
pGEM_TEasy_gdi3ORF. 
Step 2- Set double restriction digest reactions with XhoI and XbaI to create sticky ends. 
Step 3- Separate the restriction digest reactions of the plasmid and the insert using a 0.8 % 
agarose gel electrophoresis and then gel elute the correct size bands. Set a 3:1 T4 DNA 
ligation reaction. 
Step 4- Screen for successful recombinants by restriction digest reactions. 
Step 1 Step 2 
Step 3 
Step 4 
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Cloning of the gdi3 putative promoter constructs in pGL3.enh 
vector for luciferase assays 
  
Step 2 
Step 3 
Step 1 
Step 1- Set double restriction digest reactions with SacI and HindIII in order to sub-clone the 
-246 bp gdi3 putative promoter fragment into pGL3.enh. 
Step 2 - Separate the restriction digest reaction of the pGL4.10-246bp clone, using a 0.8 % 
agarose gel electrophoresis and then gel elute the correct size (246 bp) insert. Set a 3:1 T4 
DNA ligation reaction in order to clone into the linearized with SacI and HindIII, pGl3.enh 
vector. 
Step 3- Screen for successful recombinants using SacI and HindIII. 
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Step 3 
Step 2 
Step 1 
Step 1- Set double restriction digest reactions with SacI and HindIII in order to sub-clone the -
472 bp gdi3 putative promoter fragment into pGL3.enh. 
Step 2 - Separate the restriction digest reaction of the pGL4.10-472bp clone, using a 0.8 % 
agarose gel electrophoresis and then gel elute the correct size (472 bp) insert. Set a 3:1 T4 DNA 
ligation reaction in order to clone into the linearized with SacI and HindIII, pGl3.enh vector. 
Step 3- Screen for successful recombinants using SacI and HindIII. 
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Step 1- Set double restriction digest reactions with SacI and HindIII in order to sub-clone the -
667 bp gdi3 putative promoter fragment into pGL3.enh. 
Step 2- Separate the restriction digest reaction of the pGL4.10-667bp clone, using a 0.8 % 
agarose gel electrophoresis and then gel elute the correct size (667 bp) insert. Set a 3:1 T4 DNA 
ligation reaction in order to clone into the linearized with SacI and HindIII, pGl3.enh vector. 
Step 3- Screen for successful recombinants using SacI and HindIII. 
Step 3 
Step 1 
Step 2 
203 
 
 
